Emerging Medical Technologies Spotlight

Table of Contents

Company Overviews

Data includes:

- Company Name
- Technology Details
- Target Markets
- Key Executive
- Contact Info.
- Location
- Website
- Year Established
+ More

Executive Summaries

Data includes:

- All Company Overview Data +
- Development Status
- Competitive Landscape & Differentiation
- Financial Summary & Sales Forecasts
- IP Position & Status
- Financing Status
- Investment & Strategic Partnering Needs
- Management Team Bios
+ More

Companies Mentioned

Technology descriptions for companies currently covered include:

- Company 1 - An antibody that blocks the calcitonin gene-related peptide (CGRP) pathway to prevent migraine headaches
- Company 2 - Products that support transcatheter interventions for the heart
- Company 3 - A recombinant protein to treat X-linked Hypohidrotic Ectodermal Dysplasia (XLHED), a rare genetic disorder that can be life-threatening
- Company 4 - New avenue of nucleotide therapeutic drug discovery via modulation of cellular miRNA to treat a wide range of diseases, including cancer, fibrosis, inflammation, and infectious and degenerative diseases
- Company 5 - New generation of fully recombinant, protease-activated monoclonal antibodies that can achieve unprecedented levels of tissue-specific targeting
- Company 6 - Biology and chemistry platforms for the development of small molecule drugs to stop Alzheimer's disease and other CNS-related conditions
- Company 7 - Neuromonitoring devices to prevent nerve damage in all types of surgical procedures
- Company 8 - Ocular microinjection platform for non-surgical, targeted delivery of drugs and proteins into the suprachoroidal space
- Company 9 - Biomaterials for post-surgical adhesion prevention, scar prevention, wound care, and tissue reconstruction
- Company 10 - A custom fit, rehabilitative body suit that offers instantaneous back pain relief, trains and conditions the body to prevent or rehabilitate from back injuries, and increases the overall long-term health of the spine
- Company 11 - Micro-catheter platform that uses a proprietary microfluidic design for the delivery of drug/active molecules directly to the central nervous system for the treatment of difficult/chronic neurological conditions
- Company 12 - Unique diagnostic and monitoring technologies: 1-"Smart Optic Capillaroscope" for non-invasive diagnostics of early disorders in the smallest vessels-capillaries; 2-"Hemodynamic Lab" for simultaneous diagnostics of the whole vascular system; and 3-"Meteolaboratory with Feedback Effect" for controlling influence of meteorological factors on the human organism
- Company 13 - Novel technology for the treatment of acne
- Company 14 - A device that enables surgeons to check for remaining cancer cells at the tumor site, immediately following surgical removal of the tumor
- Company 15 - Drugs to improve health for patients by modulating disease-associated long non-coding RNA (lncRNA), thereby restoring normal expression of individual targeted genes
- Company 16 - Revolutionary topical antifungal with: exceptional potency, the ability to penetrate the nail, a dual mode of action, and exemplary safety profile
- Company 17 - First-in-class, small molecule compounds that successfully manage and treat chronic pain, by inhibiting P2X3 receptors
- Company 18 - Fully synthetic and targeted vaccines that induce an antigen-specific immune activation or an antigen-specific immune tolerance for therapeutic and prophylactic applications
- Company 19 - Protein therapeutics with extremely high target binding specificity for the treatment of cancer and immune-mediated diseases
- Company 20 - Nanopharmaceuticals optimized to make drugs more effective and with fewer side effects
- Company 21 - Fatty acid synthase (FASN) inhibitors with pharmaceutical properties that overcome the shortcomings of earlier generations of inhibitors, for the treatment of chronic hepatitis C virus (HCV) and pancreatic, prostatic, breast, and colorectal tumors
- Company 22 - The first vaccine to demonstrate efficacy in reducing the mortality of otherwise highly lethal bloodstream infections due to either Candida or S. aureus (including MRSA)
- Company 23 - Drugs for the treatment of depression, anxiety, epilepsy, pain, glaucoma, spasticity, and a variety of other CNS-related conditions
- Company 24 - Decision support software, integrated with vital sign monitoring equipment in hospital ICUs/EDs, to provide novel insights into a patient's current status and future trajectory
- Company 25 - A laser procedure that removes the brown pigment (melanin) from the top layer of the iris, in order to change human eye color (to blue) permanently
- Company 26 - Technology that will allow hospitals to consolidate the multiple types of infusion pumps used throughout their organization into a single type of device
- Company 27 - Diagnostic tests for the early identification of newborns suffering from critical oxygen supply deficit during birth (Asphyxia), a major cause for brain injury, often followed by life-long disability
- Company 28 - Non-invasive series of genetic tests, designed to offer valuable insights into the biology of patients with mood disorders and to support the development of personalized medicine
- Company 29 - Minimally invasive, image-guided breast biopsy and tissue removal technologies
- Company 30 - Biomaterial and regenerative medicine products for ophthalmological applications: ologen(R) Collagen Matrix, BioCornea, and Biolens
- Company 31 - New antibacterial drugs that target multi-drug resistant pathogens
- Company 32 - Targeted nanoparticles that selectively accumulate at disease sites and minimize the damage to healthy tissues for the treatment of cancer, cardiovascular conditions, and inflammatory diseases
- Company 33 - A fully-implantable continuous glucose monitoring system that utilizes fluorescence sensing technology
- Company 34 - Biological therapies targeting bone loss, blood and muscular weakness disorders, cancer, and rheumatoid arthritis
- Company 35 - Innovative protein, peptide, and antibody drug candidates for the treatment of cardiovascular disease, diabetes, muscle wasting, and obesity
- Company 36 - Therapeutic antibodies discovered and optimized using somatic hypermutation (SHM)
- Company 37 - Microfluidic automation systems used for rapid DNA analysis
- Company 38 - Therapeutics aimed at cellular targets in cancer metabolism, e.g., IDH1, IDH2, and PKM2
- Company 39 - Innovative therapeutics for cardiovascular disease and autoimmune/inflammatory diseases that are based on targets with established proof of concept and can offer advantages over existing therapies
- Company 40 - Low-cost, portable ultrasound systems that offer bone and 3D imaging capabilities
- Company 41 - Orthopedic plate and screw systems for large and small bone fragments
- Company 42 - A glaucoma-detection technology that superimposes images of the posterior pole of the eye to show changes over time
- Company 43 - Discreet sensors placed throughout the home for the purpose of monitoring elderly individuals
- Company 44 - A pain management patch comprising a dressing and skin-friendly adhesive
- Company 45 - Diagnostic assays for joint fluid analysis; these technologies use a lateral flow immunoassay designs and are used to rapidly detect the causes of joint pain
- Company 46 - A neurostimulation device for the treatment of lower back pain
- Company 47 - Orthopedic devices
- Company 48 - Intraurethral devices including a prostatic urethral stent and a urethral measurement device to enable the selection of proper stent sizes
- Company 49 - Portable x-ray technologies for medical applications
- Company 50 - Portable oxygen concentrator for active respiratory patients
- Company 51 - Develops polymer composite products for biomedical applications, including clear braces for orthodontic patients
- Company 52 - An electrical stimulation device that targets the weak/dysfunctional lower esophageal sphincter in order to treat severe Gastro Esophageal Reflux Disease (GERD)
- Company 53 - A cost-effective, efficient system for the production of ophthalmic lenses
- Company 54 - External radiation therapy technology
- Company 55 - A novel, short-peripheral intravenous (IV) catheter featuring a pre-assembled, closed design with high-pressure extension tubing, a multi-use flow control clamp, and stabilization technology
- Company 56 - A highly-articulated multi-link robot that enables the performance of minimally invasive surgery
- Company 57 - Lenses that address vision problems associated with higher-order aberrations of the eye, improving vision, contrast acuity, nighttime driving vision, and color dullness
- Company 58 - A continuous glucose monitoring device
- Company 59 - Offers technologies for drug delivery systems, including complex release products, fast-dispersing dosage forms, and biodegradable polymers for custom release profiles in implants
- Company 60 - Corneal inlay for the treatment of near vision loss
- Company 61 - A three-layered biological patch, called the LeucoPatch, which can be derived without additives from the patient's blood within 20 minutes; used for chronically non-healing and debilitating wounds
- Company 62 - Nanotechnology-based Point-of-Care products for the collection and screening of blood, urine, or oral fluids
- Company 63 - Small molecule drug candidates directed at ion channel targets to repurpose existing therapies for atrial fibrillation
- Company 64 - Novel spherical nucleic acid (SNA) constructs exhibiting biocompatibility and versatility as intended therapeutics to treat heart disease, cancer, skin conditions and bacterial infection
- Company 65 - Novel therapeutic intended to treat dry age-related macular degeneration and prevent blindness
- Company 66 - Innovative oral therapy to treat rheumatoid arthritis and inhibit disease progression
- Company 67 - First-in-class oncology therapeutics to treat female and male cancers utilizing membrane-disrupting peptides to target cancer cells without harming healthy tissue
- Company 68 - Blended active glycolic acid used in cosmetic and beauty products
- Company 69 - Novel DNA-based immunotherapies to treat HIV
- Company 70 - Research and development of innovative biotechnologies
- Company 71 - Catheter-based medical technologies for the treatment of cerebral aneurysm and other cardiovascular disease
- Company 72 - Formulations for lymphatic delivery of highly lipophilic pharmaceuticals
- Company 73 - Reformulation of existing pharmaceuticals to provide more targeted results, lessen the risk of side effects and reduce patient costs; lead product is an oral form of an existing IV-only cancer drug
- Company 74 - Therapeutics intended to treat diabetes, diabetic complications, and kidney disease through the inhibition of blood vessel growth, preventing hyperglycemia-induced damage to proteins and tissues
- Company 75 - Novel formulations of existing pharmaceuticals to expand applicable patient populations and therapeutic uses
- Company 76 - Affordable analytical instruments, biomanufacturing systems, and consumable labware products for biological research and drug discovery
- Company 77 - Novel therapeutic to treat age-related macular degeneration and prevent blindness
- Company 78 - Cell-based nuclear receptor reporter assay technology used in drug development that allows for the storage and preservation of cells for later use
- Company 79 - Innovative combination drug therapies to treat overactive bladder and urinary incontinence
- Company 80 - Targeted UV phototherapy device to treat dermatological diseases including eczema, psoriasis and vitiligo
- Company 81 - SMaRT RNA technology intended to treat a broad spectrum of diseases including HIV, hemophilia and dyslipidemia
- Company 82 - Sustainable chemicals using unconstrained metabolism technology for reaction flexibility
- Company 83 - Novel, first-in-class therapeutic utilizing beloranib to treat severe obesity
- Company 84 - Technology that enables Innovative reformulation of previously approved therapeutics to expand indications or improve safety
- Company 85 - Budesonide-based therapy for the treatment of eosinophilic esophagitis
- Company 86 - Optical measurement instruments using back-scattering interfermetry to detect molecular interaction assays and assist in developing drug applications
- Company 87 - Innovative platform that optimizes DNA to produce in vivo therapeutics with multiple indications
- Company 88 - SideView Mono trocar for single access laparoscopic surgery
- Company 89 - A patented electro-chemical technology for coating teeth with a high concentration of target materials that last for long periods of time, and include the following applications: (1) Fluoritray, a non-invasive, painless tooth fluoridation, producing a thick protective Fluoroapatite layer lasting for more than one year, reducing sensitivity and significantly improving resistance to bacteria and the acidic mouth environment; and (2) UltraWyte, for superior tooth whitening
- Company 90 - Patent-pending T-Loc(TM) Technology, used for the treatment of fractures and injuries to the shoulder joint and allowing precise, reproducible surgeon-controlled tensioning and low-profile, knotless fixation
- Company 91 - Molecular diagnostics technologies that perform directed analyses of cell-free DNA in blood and are used to provide safe, highly accurate, and affordable prenatal tests for maternal and fetal health
- Company 92 - A novel, disposable device used for intra-abdominal pressure monitoring in patients that are receiving gastric feeding, require safe monitoring of gastric residual volume, or are being screened for intra-abdominal hypertension
- Company 93 - Cost effective, non-invasive point of care diagnostics that use bio-sensor chips to provide direct, digital, state of the art sensitivity (fM - pM) and selectivity through proprietary semiconductor processing of CNT FETs and may be used to diagnose a variety of diseases and related health risks
- Company 94 - Highly compact intensity-modulated proton therapy medical system powered by a dielectric-wall accelerator and intended for use in oncology patients; features a revolutionary design with a substantially smaller structure and greater flexibility than other accelerators
- Company 95 - Spiral Laminar Flow (SLF) prosthetic grafts are used to reproduce the body's natural blood flow patterns and treat cardiovascular disease
- Company 96 - Novel MRI scanner to diagnose disease and provide real time guidance of thermal energy procedures such as lesion biopsies and tumor treatments
- Company 97 - Minimally invasive ultrasound device that allows for rapid evaluation of fallopian tubes to assess fertility at point of care
- Company 98 - Cellular Regeneration Technology (CRT) utilizing cell interaction and a functional polymer scaffolding to provide a single-surgery treatment for damaged articular cartilage in the knee
- Company 99 - A second-generation biomimetic coating comprised of 2 protein components (FN and SDF-1a) which may be applied to cardiovascular prostheses in order to help avoid tissue rejection and subsequent device failure
- Company 100 - Non-invasive system to detect and alert users of sleep-time hypoglycemia for the monitoring of type 1 diabetes
- Company 101 - Innovative products designed to alleviate pain and enhance physical comfort in those affected by illness, disability, injury, pressure and poor ergonomics
- Company 102 - Oral active molecule therapeutic to improve memory and learning in patients with Alzheimer's Disease
- Company 103 - Novel cervical collar used in emergency situations to immobilize the neck while chemically cooling to lower brain temperature to slow metabolism, improve cell membrane stability and reduce inflammation
- Company 104 - Diagnostic test for lung cancer using biological olfactory sensor arrays
- Company 105 - Innovative medical isotopes and cancer treatment elements used in thyroid and respiratory cancer therapies
- Company 106 - Novel small molecules and monoclonal antibodies for the treatment of vascular disease and to enhance wound healing, specifically diabetic macular edema and inflammatory bowel disease
- Company 107 - In vivo positron emission tomography imaging agents to detect cancer and autoimmune disease
- Company 108 - Novel therapeutics to remove acetaldehyde and other toxic aldehydes that impair protein function and cause mutation in DNA
- Company 109 - First-in-class subunit-selective NMDA receptor modulators to treat neuropsychiatric diseases, specifically schizophrenia and Alzheimer's
- Company 110 - Novel anti-angiogenic cancer therapy that inhibits blood supply to prevent tumor growth
- Company 111 - G protein-coupled receptor therapeutics to combat multiple sclerosis
- Company 112 - Novel therapy to treat iron overload caused by chronic transfusion therapy
- Company 113 - Blood-based molecular diagnostics that track multiple biomarkers for early diagnosis of a variety of diseases including cancer and Alzheimer's
- Company 114 - Magnetically targeted drug delivery system enabling patient specific delivery options to treat peripheral artery disease
- Company 115 - First-in-class oral therapeutic to disrupt the natural course of lactose intolerance by stimulating lactose-metabolizing bacteria in the colon and offering long-term symptom relief
- Company 116 - Molecular test to detect pathogens and bacteria that can lead to nosocomial infections
- Company 117 - Novel non-invasive test to asses infertility and egg quality in women through the use of genetic biomarkers
- Company 118 - Aneurysm embolization system that promote rapid, peri-procedural stasis in wide neck ruptured and unruptured aneurysms, taking the place of traditional coils
- Company 119 - Novel monoclonal antibody therapies targeting receptor tyrosine kinases to treat cancers
- Company 120 - Small molecule therapeutics to treat cardiometabolic diseases including dyslipidemia/hypercholesterolemia and diabetes
- Company 121 - Novel front-line therapies for the treatment of inflammatory bowel disease, specifically ulcerative colitis
- Company 122 - Novel therapeutics to treat diseases affecting mucosal tissue
- Company 123 - Oral therapeutics that inhibit the breakdown of calcitonin for the treatment and prevention of osteoporosis and related bone disease
- Company 124 - Comprehensive portable device to provide point-of-care diagnostics for a variety of diseases
- Company 125 - Point-of-care molecular diagnostic device utilizing electrochemicals to provide rapid, enzyme-free detection of nucleic acids for infectious disease
- Company 126 - Peptide-based immunotherapy intended to treat and prevent pancreatic cancer by targeting mutated ras genes
- Company 127 - Orthobiologic implant to fill bone voids utilizing parathyroid hormone peptides to prevent further bone loss in osteoporosis and spinal injuries
- Company 128 - Invasive fractional flow reserve device analyzer that uses computed tomography images to determine arterial blood flow and pressure, allowing better diagnosis of ischemic stenosis
- Company 129 - Selective small molecule histone deacetylase inhibitors to treat multiple myeloma with possible indications for inflammatory, neurodegenerative, infectious and genetic disease
- Company 130 - Small molecule therapeutics for acute central nervous system disorders; the company's lead product is intended to reduce brain swelling and hemorrhage resulting from ischemic and traumatic injury
- Company 131 - Innovative aortic valvuloplasty balloon for the treatment of calcific aortic stenosis
- Company 132 - Novel allogeneic cell graft with copper chelator technology for use in bone marrow transplants to treat leukemia and lymphoma in patients without an available familial donor
- Company 133 - Sophisticated implants and surgical tools featuring a biomechanically-compliant nail for the fixation of hip fracture in third age patients suffering from osteoporosis
- Company 134 - Novel screening technology based on oncoproteins to differentiate benign infection from true disease and detect cervical cancer and other cancers associated with human papillomavirus (HPV)
- Company 135 - Novel therapeutics that inhibits translation of neurotoxic proteins for the treatment of neurodegenerative disorders, including Alzheimer's and Parkinson's
- Company 136 - Innovative refractive ophthalmologic surgery technologies and instruments for flapless epithelial surface removal and the treatment of keratoconus
- Company 137 - Colorimetric blast dosimeter provides immediate information as to the level of blast exposure relative to brain injury via a color change imaging technology
- Company 138 - Innovative dental implants, prosthetics, bone graft materials and surgical tools to treat oral ailments with minimally invasive technologies
- Company 139 - Non-invasive medical devices and mobile health applications utilizing acoustic respiratory monitoring technology to improve the management of chronic respiratory diseases including asthma and COPD
- Company 140 - Small molecule oral therapeutic that combats osteoporosis and builds bone by inhibiting the activity of the Sclerostin protein
- Company 141 - Breakthrough implantable stimulation system that uses neuromodulation to treat refractory epilepsy
- Company 142 - Ultrasound instrument that combines light and doppler technology to monitor the efficacy of advanced breast cancer therapies; also offers a light-only version for home health
- Company 143 - Oncology and companion diagnostics with special capabilities in the area of mRNA and miRNA
- Company 144 - Biodegradable drug delivery implants to treat and prevent wound infection and manage pain
- Company 145 - Novel implantable and external brain stimulation devices for the treatment of neurological disorders
- Company 146 - Warm blood perfusion system to preserve hearts and lungs for transplantation
- Company 147 - Innovative drug candidates to reduce intraocular pressure and treat retinal diseases
- Company 148 - Osteoporosis treatment through novel nasal spray
- Company 149 - Technologies for genetic analysis preparation to predict disease risk and drug response
- Company 150 - Novel first-in-class pharmaceuticals to improve vascular access in renal and vascular diseases
- Company 151 - Small molecule therapies for neurodegenerative diseases
- Company 152 - Topical mechlorethamine gel therapy for the treatment of early stage mycosis fungoides, a type of Cutaneous T-Cell Lymphoma
- Company 153 - Novel oral therapeutics to treat cancer, chronic kidney disease, chronic obstructive pulmonary disease (COPD), and neurodegenerative disorders
- Company 154 - Antithrombotic therapies for use in acute and subacute care
- Company 155 - Inhaled therapies to treat and prevent respiratory conditions including infections, progressive diseases, and allergic rhinitis
- Company 156 - Therapeutics to treat disease-associated pain and inflammation
- Company 157 - Novel electronic whole-genome sequencing employing solid-state technology
- Company 158 - Novel prescription products targeting reduced submental fat
- Company 159 - Antibiotics focused on Riboswitches (RNA drug targets) to treat drug resistant fungal and bacterial pathogens
- Company 160 - Novel therapeutics for the treatment of drug addiction and smoking cessation through reduction of craving function in brain
- Company 161 - Gene-, protein-, and serum-based biomarker analysis technology to identify potential cancer
- Company 162 - Novel therapeutic antibodies for the treatment of infectious disease, cancer and inflammation
- Company 163 - Automated microfluidic systems and instrumentation for single-cell analysis
- Company 164 - Natural color dental implants to restore function and aesthetics
- Company 165 - Antiviral pharmaceuticals that bind to caspids to treat HIV and HBV
- Company 166 - Live tumor cell processing platform for predictive testing which uses functioning signaling profiles to guide cancer therapy
- Company 167 - Novel molecular therapies for the treatment and prevention of metabolic disease associated with altered mitochondrial function
- Company 168 - High concentrate Omega-3 fatty acids for use in pharmaceuticals, developed from algae
- Company 169 - Novel molecules to target chronic T-cell mediated inflammatory diseases
- Company 170 - Point-of-care blood and urine analyzer to detect infectious disease and test blood levels; lab-quality results available within minutes of testing
- Company 171 - Atraumatic, self-retaining surgical tissue retractors for thyroidectomy and related procedures that feature low profile, disposable designs
- Company 172 - Vertical lumbar traction system to realign spine, reduce disc herniation and lower back pain
- Company 173 - An FDA-cleared dual-balloon catheter for urinary drainage that is designed to reduce adverse events resulting from Foley urinary catheterization, including the occurrence of Catheter Associated Urinary Tract Infections (CAUTI), sepsis, and bladder cancer in long-term users
- Company 174 - Biopolymer implants, biomaterials and therapeutics to repair damaged heart structure and treat congestive heart failure
- Company 175 - DNA-based diagnostic tests used to detect diseases and conditions affecting women, such as endometriosis, infertility, and pre-term labor
- Company 176 - Brain Anaesthesia Response (BAR) monitoring system to improve existing EEG technology and reduce intra-operative awareness
- Company 177 - High-quality reconstructive total joint implants for the hip and knee
- Company 178 - Whole-Body Thermometry (WBT) advanced medical diagnostic device for non-invasive analysis, including tissue signature disorder recognition
- Company 179 - Innovative technologies for patient monitoring to include neurological, cardiovascular and pain management indications
- Company 180 - Novel allogeneic cell-derived biomaterials that do not require synthetic scaffolds and are used to regenerate cardiovascular and other soft tissues
- Company 181 - Innovative instrument to simplify insertion of artificial spinal disc implants
- Company 182 - ICDR, a simple yet sophisticated Internal Cavity Drug Retention system for controlled and highly effective delivery of therapeutic agents into the bladder. Based on advanced materials technologies, the ICDR system improves drug bioavailability and reduces toxicity, significantly enhancing treatment potential, safety, and compliance.
- Company 183 - An innovative enabling platform technology that harvests tens of millions of a patient's own adipose-derived regenerative cells in one hour, for immediate application
- Company 184 - Disposable medical device to improve stroke risk during heart bypass procedures
- Company 185 - A pioneering ozone-oxygen-vacuum system for healing chronic, hard-to-heal wounds. The technology is non-invasive and medically proven for diabetic foot, PVD, venous ulcers, and more.
- Company 186 - EpiLert is a wireless, watch-like device providing real-time ALERT to CAREGIVERS of an ongoing epileptic seizure
- Company 187 - Resin-based vehicles that quickly deliver medications transmucosally to the bloodstream and formulations that treat such conditions as smoking cessation, anxiety, chronic breakthrough pain, and migraines
- Company 188 - The Dilon 6800, is a high-resolution, small field-of-view gamma camera, optimized to perform BSGI/MBI - a molecular breast imaging procedure which images the metabolic activity of breast lesions through radiotracer uptake
- Company 189 - Self-adjustable vaginal ring pessary to treat urinary incontinence and genital prolapse without drugs
- Company 190 - Novel thyroid FNA analysis technology combines cytopathology and Afirma Gene Expression Classifier for nodule assessment
- Company 191 - Next generation G-protein coupled receptor-biased ligand pharmaceuticals which are intended to limit adverse drug effects
- Company 192 - Novel biotherapeutic technologies featuring self-contained subcutaneous delivery mechanisms
- Company 193 - Innovative ultra-sensitive immunodiagnostic systems for use in research and in-vitro diagnostics
- Company 194 - Therapeutics based on natural killer cells (NKT), a subset of immune cells, intended for the treatment of autoimmune and inflammatory diseases in addition to asthma, cancer, and dermatitis
- Company 195 - Innovative antibiofilm catheter lock technology to reduce infection associated with indwelling catheters
- Company 196 - Patient-specific epigenetic therapeutics utilizing small molecule histone methyltransferase (HMT) inhibitors for the treatment of cancer
- Company 197 - Expanding hydraulic implant for use in lumbar spinal fusion procedures
- Company 198 - Novel small molecule therapies for respiratory disorders
- Company 199 - Novel diagnostics utilizing protein based biomarker technology focused on nosocomial disease
- Company 200 - Targeted oral therapeutics to correct mineral metabolism and metabolic disorders
- Company 201 - Proprietary implant technology featuring a hypoglossal nerve stimulation system for the treatment of obstructive sleep apnea
- Company 202 - Cosmetic and drug delivery systems based on nanotechnology
- Company 203 - Innovative therapies utilizing pepducins to modulate G-protein receptors, thereby expanding treatments for cancer, diabetes, inflammation, and regenerative medicine
- Company 204 - Therapeutics for the treatment of post-operative and chronic pain
- Company 205 - Novel ophthalmic therapies to treat ocular diseases
- Company 206 - Third-generation transcatheter aortic valve prosthesis with increased safety, greater ease-of-use, and longer durability
- Company 207 - Ultrasonic devices for non-invasive fat removal from the chin, arm, and eye-bags and for skin tightening
- Company 208 - The Rx Timer Cap is a patented "smart cap" with a built-in LCD timer that fits common prescription vials and lets patients know exactly how long it has been since they last took their medication
- Company 209 - Sutureless, adjustable mitral annuloplasty toolset for surgical and robotic procedures
- Company 210 - A novel annuloplasty ring for heart valve repair. The Intra-annular Ring represents a unique solution for children allowing the valve to grow following implantation.
- Company 211 - The first home-based telemonitoring system for patients with age-related macular degeneration, the leading cause of blindness in people over age 50 in the western world
- Company 212 - A nanotechnology-enabled portfolio of therapeutic products for use in medical applications
- Company 213 - Proprietary technology for decellularizing biological organs/tissues to create an extra-cellular matrix retaining its original architecture, mechanical properties, and vascular network - suitable for scaffold transplantation or growing new functional organs/tissues by recellularization
- Company 214 - A battery-powered device which lifts and acquires a healthcare patient weighing up to 500 lbs. - without any caregiver's touching, logrolling, or lifting - and transports them to the next destination, then gently discharges them onto the desired horizontal surface
- Company 215 - The patented EXMI technology uses pulsed magnetic fields that penetrate up to 7,5 cm into the body, stimulating nerves (neuromodulation), contracting muscles (rehabilitation), treating pain/depression, and increasing blood flow
- Company 216 - Requiring only one drop of blood, the proprietary LBIdx(TM) Plasma Thermogram(TM) tests will significantly improve the clinical diagnosis and monitoring of autoimmune disease and cancer, vastly improving patient outcomes
- Company 217 - New gene-based medicines to treat "dominant" genetic diseases, particularly for the eye
- Company 218 - Technology that provides an immediate cardiovascular risk prediction for major chronic diseases, such as diabetes. The method is convenient, easy-to-use, and validated. It measures tissue accumulation of Advanced Glycation End products (AGEs) by means of fluorescence techniques. AGEs play a key role in the pathogenesis of many age-related diseases, such as diabetes and cardiovascular disease.
- Company 219 - An oral delivery platform for medications, food supplements, and other soluble substances that is easy-to-use, friendly, inexpensive, and requires no third-party assistance
- Company 220 - Ventritek 105 is a novel medical device that provides full treatment for Stroke/SAH/ICH patients by replacing the current long and risky procedure
- Company 221 - An inhaler with variable dosage of Asthma medicine, based on a built-in exhaling measurement of the airway obstruction level
- Company 222 - The RGS Vertex360(TM), which competes with the Gamma knife in the non-invasive treatment of brain tumors, is a highly precise cobalt 60 radiation system that utilizes the OsiriX(TM) based Explorer 4D(TM) treatment planning system, also developed by the company
- Company 223 - Innovative central nervous system therapies; Allon is proceeding in a fully enrolled pivotal Phase 2/3 clinical trial in an orphan indication, progressive supranuclear palsy (PSP)
- Company 224 - Vaccine platform technology for cancer and infectious diseases based on Listeria monocytogenes that has been engineered to be safe for use in humans and express specific disease antigens
- Company 225 - Real-time, non-contact, high resolution tissue temperature monitoring & mapping products that improve the safety and efficacy of ablation therapy by avoiding injury to surrounding tissue
- Company 226 - Oncology drugs that utilize novel mechanisms of action
- Company 227 - Electronic stimulation technologies that maintain muscle strength during recovery in the intensive care unit or other periods of inactivity
- Company 228 - The fentanyl iontophoretic transdermal system (IONSYS), an investigational, pre-programmed drug delivery system comprising a compact, needle-free, self-contained system that provides patient-controlled analgesia for adult inpatients requiring post-operative opioid therapy
- Company 229 - Two novel technologies that boost immune responses, including a synthetic toll-like receptor agonist for use as an adjuvant to vaccines , and a viral vector that targets immature dendritic cells
- Company 230 - A molecular diagnostics test that examines somatic alterations in cancer-related genes by applying massively parallel sequencing to routine clinical specimens, enabling targeted therapy
- Company 231 - Nanofibers designed for use in tissue engineering, drug delivery, and wound care
- Company 232 - Vascular closure device that seals the femoral artery following cardiac catherization
- Company 233 - An aerosolized long-acting muscarinic antagonist that treats chronic obstructive pulmonary disease (COPD)
- Company 234 - Novel metal abstraction peptide (MAP) platform technology that delivers platinum to cancer cells by incorporating it into cancer-targeting proteins, thereby improving treatment while limiting side effects and damage to healthy cells
- Company 235 - Long-acting, intravenous lipoglycopeptide used to treat acute bacterial skin and skin structure infections
- Company 236 - Innovative new topical therapies for dermatology applications, including photodynamic therapy for sebaceous gland disorders and small molecule therapeutics that treat acne, inflammatory skin diseases, and sebaceous gland hyperactivity
- Company 237 - Novel, minimally invasive surgical devices for the treatment of sinusitis
- Company 238 - Novel drugs that treat cancer by targeting cellular protein homeostasis pathways
- Company 239 - A next-generation eye drop medication that uses Rho-kinase inhibitors to treat glaucoma
- Company 240 - Minimally invasive spinal disc regeneration technologies (SRTs) with a goal of biologically regenerating the tissues of the disc to restore the natural visco-elastic, biomechanical, and fluid characteristics of the inner core and outer tensil ring
- Company 241 - MedApps' solutions utilize cloud computing to connect patients and professional care providers, enabling proactive healthcare delivery
- Company 242 - Novel 3D cell culture devices for stem cell, tissue engineering, cancer, and drug discovery applications
- Company 243 - Developing a whole-plant therapeutic, AMZ0026, that exhibits immunomodulator properties for the treatment of HIV/AIDS. Preliminary clinical studies in patients that are seropositive for HIV-1 have demonstrated a positive effect on CD4 and CD4/CD8 blood serum levels.
- Company 244 - A Leptin product as a novel hormone replacement therapy for Alzheimer's disease (AD) and/or as a preventative for those who are at risk
- Company 245 - EMMA (Electronic Medication Management Assistant) - a remote medication administration unit that is placed in a patient's residence to enable a healthcare professional (i.e., pharmacist or nurse) to remotely administer their oral medications
- Company 246 - A disruptive next-generation low profile (14 French), pre-mounted and pre-packaged "package-to-patient" percutaneous Transcatheter Heart Valve (THV)
- Company 247 - EPIFLO utilizes cutting-edge oxygen concentration technology to create tissue regenerative processes driving closure of delayed-healing acute or chronic wounds
- Company 248 - Drugs to treat dry Age Related Macular Degeneration (dAMD) and other vascular diseases of the eye, including Glaucoma, DME, and Diabetic Retinopathy
- Company 249 - Endoluminal device for incisionless treatment of obesity
- Company 250 - Software that can read and analyze the image stack of a CT scan and draft a report that includes major pathological findings, identification of key images, and quantitative measurements - provided to the radiologist at the customers site
- Company 251 - Developer of easy-to-use genetic tests (clinically validated DNA SNP patterns) that empower individuals to prevent certain chronic conditions and manage their existing health and wellness through actionable guidance
- Company 252 - A therapeutic for HIV that is divergent from current approaches, in that rather than fight against HIV's greatest strengths - mutation frequency & rate of replication - the drug exploits these "strengths" to cause viral population collapse
- Company 253 - A device that uses non-invasive ultrasound to disrupt the blood-brain barrier, for delivery of large molecule therapeutics to treat primary and metastatic brain tumors
- Company 254 - The company's testing services include cytogenetics, fluorescence in-situ hybridization (FISH), flow cytometry, morphology studies, anatomic pathology, and molecular genetic testing
- Company 255 - Developing healthier drugs from whole-plants. MAHDL, developed to elevate HDL-C, has undergone tests in man with positive results and has an IND from the FDA. Other whole-plant therapeutics are under development for dementia.
- Company 256 - ZeroFold, the lowest profile balloon available for improving deliverability and effectiveness of balloon angioplasty catheters
- Company 257 - A revolutionary technology to sterilize proteins in dehydrated formulations by irradiation (beta, gamma) or Ethylene Oxide
- Company 258 - Next-generation vaccines based on patented LAMP Technology that induce a strong and complete immune response, with applications in allergy, cancer, and infectious disease
- Company 259 - The world's first homozygous parthenogenetic stem cell lines that can provide therapeutic cells with the potential to be transplanted into hundreds of millions of individuals of differing ages and racial backgrounds with minimal risk of immune rejection
- Company 260 - A web-enabled, low level electromagnetic therapy system, that provides HealthCare providers in the Complementary and Alternative Medicine (CAM) marketplace with a device that improves both their Patients' Health and their Business
- Company 261 - Bioluminescent (light producing) proteins and related substrates that can: 1-be used as an adjunct to surgery, including laparoscopy, 2-track the progression of disease and evaluate the effectiveness of therapy, and 3-diagnosis a disease process before there are symptoms or anatomical features such as tumors
- Company 262 - A patented ultrasound miniaturization technology which has enabled the creation of iPod sized ultrasound pain therapy systems with unprecedented operation times of up to 6 hours on a single cell phone battery
- Company 263 - Miniaturized, hand-held, instrument-mounted optical measurement and navigation systems for surgical applications
- Company 264 - Turnkey SaaS software solution that dramatically reduces errors, turnaround times, and costs of MRI, CT, and PET-CT diagnostic reports
- Company 265 - Fast-track development of novel drugs for an unmet medical need - Alzheimer's disease - with rapid payback on investment
- Company 266 - Technology platforms that improve surgical efficiency in complex orthopedic procedures such as total joint replacement, spinal fusion, and trauma fixation: 1-For medical device manufacturers, RepAssist(TM) reduces training costs, dramatically compresses the time it takes for new reps to provide value in the OR, and enhances rep efficiency with existing accounts. 2-For hospitals/surgery centers, Virtual Backtable(TM) significantly enhances OR team proficiency in organizing and utilizing instrumentation, independent of the team's experience level with the implant system or surgeon, resulting in improved surgical efficiency and higher surgeon satisfaction.
- Company 267 - Implantable devices that allow surgeons to reduce the morbidity of spinal deformity surgery with a procedure that is quicker, safer, and more cost-effective than existing techniques
- Company 268 - Minimally invasive, joint preserving treatment option for chronic knee osteoarthritis (OA) pain; an alternative to total knee replacement (TKR)
- Company 269 - A broad platform of minimally invasive intramedullary devices to improve fracture fixation, reduce soft tissue trauma, and speed the patient's return to normal daily activities
- Company 270 - Intra-articular ion channel modulators for the treatment of osteoarthritis (OA) in all synovial joints
- Company 271 - A breakthrough platform technology that provides highly porous (>65%), load-bearing orthopedic implants in both surface active (metal, ceramic) and resorbable materials
- Company 272 - An easy-to-use, low-cost, point-of-care (POC) ELISA-based adjunctive screening kit, specifically for oral cancer
- Company 273 - A neurostimulation technology to improve function and independence after stroke
- Company 274 - Novel portable diagnostic tool to detect a wide variety of protein analytes and un-amplified DNA at point of care
- Company 275 - Hand-held smart drill with robotic technology that provides: safe depth control, accurate depth measurement, bone density measurement, and performance feedback for orthopedic and spine applications
- Company 276 - An affordable drug delivery pump/patch that is cost-competitive with pre-filled pen injectors and offers a superior end-user experience
- Company 277 - A disruptive, non-invasive, and long-term neuro-monitoring technology with the potential to reduce stroke and damage from aneurysms, tumors, and other neurologic trauma
- Company 278 - A minimally invasive stent platform that offers safe, simple, and accelerated healing for the treatment of endoluminal diseases
- Company 279 - MGI Medical's "Pulse Flowmeter" provides sensitive, early detection of hemodynamic instability through continuous, non-invasive assessment of peripheral blood flow. This permits early detection and management of blood loss and/or heart failure when there have been no changes in vital signs.
- Company 280 - An ultrasensitive hand-held probe that is capable of detecting specialized, subcutaneously injected magnetic materials and is used to locate lymph nodes to support the diagnosis and treatment of cancer
- Company 281 - A non-invasive, accurate, and easy-to-use female fertility monitor
- Company 282 - A low-cost incision guide that is applied with an adhesive sticker before a medical scan and leaves behind an ink imprint of locational markings (such as a grid or ruler) on the patient's skin so that the surgeon can accurately correlate target locations with the medical image
- Company 283 - Technology that enables and facilitates seamless stenting of all coronary bifurcation disease scenarios
- Company 284 - A biopharmaceutical company with an extensive library of structurally diverse bioactive peptides with broad applications in the health, beauty, and pharmaceutical industries
- Company 285 - 1-A spray drying technology to enable the storage of plasma in diverse environments by methods that are far simpler/less costly than those used currently and 2-A product to enable platelets to be stored in refrigerators rather than at room temperature to: (i) improve safety, (ii) extend shelf life, and (iii) significantly reduce costs
- Company 286 - A mechanical thrombectomy kit that will help restore blood flow and reduce hemorrhagic complications associated with acute ischemic stroke therapy
- Company 287 - Miniature infrared thermal imaging cameras combined with a spectroscopic infrared real-time in vivo analysis device for the early detection/accurate identification of internal lesions and tumors, as an add-on to existing endoscopes
- Company 288 - A unique lipid-soluble anti-oxidant heavy metal chelator that is safe and effective, for which the company is pursuing orphan drug approval
- Company 289 - ImplantLock, a device that enables a safe alternative to vertical bone augmentation or sinus lifting as well as immediate functional loading even after tooth extraction
- Company 290 - Advanced medical technology that combines CO2 laser capabilities with autologous stem cells to significantly improve cardiac output in patients with heart disease or heart failure
- Company 291 - A take-home conception aid system that is designed to address the growing unmet need of delayed/unsuccessful natural fertility that historically has had similar results to intrauterine insemination (IUI), yet can now be done in the privacy of the home
- Company 292 - Integrated molecular diagnostic system that is easy to use and requires little or no training
- Company 293 - Technologies that: 1-Temporarily plug body passageways with a thermo-transitioning gel that is delivered as a cold liquid, solidifies at body temperature, and is later flushed away and 2-Keep body passageways open with gentle passively dilating devices, as well with more rigid construction of an open design, to prevent eventual long-term blockage
- Company 294 - Non-invasive disposable device to automatically deliver a new therapy called *Remote Ischemic Preconditioning*, an adjunct to traditional treatments for heart attack and stroke that mitigates ischemia-reperfusion injury and has been clinically shown to reduce infarct size by 50%, without side effects
- Company 295 - Biologically compatible polymers that provide non-surgical regenerative therapies for treating chronic and acute episodes of pain
- Company 296 - The only device-based therapy, offering low-cost and non-invasive treatment for a wide range of antenatal conditions; thereby promising to prevent preterm birth
- Company 297 - The first miniature and highly accurate guide for brain surgery that is fully MRI-compatible and gives the possibility to perform simultaneous bilateral procedures, in addition to being easy-to-use and cost-effective
- Company 298 - A hand-held device with a touch-screen interface that identifies a patient's preferred language and then collects his/her information, medical history, symptoms, and complaints, which are then summarized into the caregiver's language and can be accessed on the device/through a facility's electronic health records (EHR) system
- Company 299 - Innovative single-use surgical retractors designed to manage all MIS exposure needs in gynecological, digestive, visceral, and vascular surgery
- Company 300 - Small, discrete, and disposable device to reduce food intake
- Company 301 - Cartilage repair using cell therapy - true, 100% hyaline cartilage tissue, in a single procedure, using an off-the-shelf product
- Company 302 - X-ray light valve device for use in conjunction with mammography screening and future imaging modalities
- Company 303 - Genetic test for expectant mothers that detects spina bifida
- Company 304 - Hand-held, disposable device that transdermally removes spider and reticular veins without a sclerotherapy agent
- Company 305 - Needle-free silicone patch for vaccine delivery
- Company 306 - Next-generation PCR system that can provide absolute quantification of nucleic acid molecules, at higher resolution and lower target levels than the current standard, thereby identifying diseases earlier in progression
- Company 307 - ClearRing is a minimally invasive prostatic reshaping implant for the treatment of lower urinary tract symptoms due to benign prostatic hyperplasia
- Company 308 - Immediate detection and identification of bacteria in bodily fluids through optical spectroscopy with low quantities of material without bacteria culturing
- Company 309 - Temporary implantable ventricular assist device (VAD) that wraps around the heart and squeezes it to help pump blood
- Company 310 - Non-invasive nitric oxide gas (gNO) technology and iontophoresis drug delivery for treating diseases of the skin and nails
- Company 311 - Immunomagnetic cell capture system which isolates and removes pathogens directly from the blood in under 30 minutes
- Company 312 - Synthetic 3D extracellular matrices to support tissue growth for use in a wide range of regenerative medicine
- Company 313 - Small molecule plasma kallikrein inhibitors for the treatment of diabetic macular edema (DME)
- Company 314 - Prefilled, easy-to-carry epinephrine auto-injection device for people with severe allergies
- Company 315 - Micro-needle skin patch for delivery of the influenza vaccine
- Company 316 - Hand-held device that sublingually monitors changes in carbon dioxide (CO2) levels for the prevention of septic shock
- Company 317 - Minimally invasive memory polymer devices for use in peripheral vascular, non-vascular, and neurovascular applications
- Company 318 - Energy-based thermal surgery device that provides better soft tissue cutting and coagulation
- Company 319 - Aerosol-based inhaled insulin delivery device
- Company 320 - A light-based medical device in the form of an LED patch with a proprietary, optimized formulation of light which triggers local, controllable, and safe Nitric Oxide (NO) production to treat diseases triggered by underlying vascular dysfunction
- Company 321 - Implantable, wireless, intracranial pressure monitor for use in patients with tumors, prior strokes, and traumatic brain injuries (TBI)
- Company 322 - Self-expanding, fully removable, temporary inferior vena cava (IVC) filter used in conjunction with the placement of a central line for the prevention of pulmonary embolism
- Company 323 - The BNX(TM) (Beacon-Needle-eXchange) needle delivery system for use in gastrointestinal endoscopic procedures including: Endoscopic Ultrasound (EUS), Endoscopic Bronchial Ultrasound (EBUS), and Endoscopic Retrograde Cholangio-Pancreatography (ERCP)
- Company 324 - Low-cost mobile device and software that adapts smartphones into ECG machines
- Company 325 - Next-generation prefilled drug delivery devices, including prefilled syringes, auto-injectors, and IV systems, offering improved product performance at lower costs
- Company 326 - Electrophysiological mapping device for the treatment of complex cardiac arrhythmias
- Company 327 - Hand-held, non-contact vein illumination device for imaging veins just below the surface of the skin
- Company 328 - Miniaturized, continuously adaptable, left ventricular assist device (LVAD) for the treatment of heart failure
- Company 329 - Drugs to treat breast and other cancers by targeting cancer stem cells
- Company 330 - Real-time vital signs monitoring with data collected from earbuds and streamed wirelessly to mobile devices or the web for viewing
- Company 331 - Drug therapy for the treatment of rare diseases such as hereditary inclusion body myopathy (HIBM)
- Company 332 - Compounds for oncology indications, including: 1-the prevention of A) chemotherapy-induced nausea and vomiting (CINV), B) post-operative nausea and vomiting (PONV), and C) chronic cough and 2-treatment for patients with non-small cell lung cancer (NSCLC) whose tumors express an Anaplastic Lymphoma Kinase (ALK) fusion protein
- Company 333 - Portable, self-contained system for the precise minimally invasive removal of diseased tissue, to restore natural tendon and soft tissue function in the elbow, knee, ankle, foot, and shoulder
- Company 334 - Thermal pulsation system for effective, in-office treatment of evaporative dry eye
- Company 335 - Non-invasive neuromodulation device that exposes the brain to an oscillating magnetic field, for the treatment of psychiatric and neurological disorders such as major depressive disorder and bipolar depression
- Company 336 - Real-time orthopedic surgery imaging system that will save valuable time for surgeons and hospitals, while improving surgery accuracy and patient safety
- Company 337 - An interactive, computer-assisted system utilizing image-guided robotics to enhance the quality of hair follicle harvesting during hair restoration surgery
- Company 338 - Wireless, non-invasive, and portable brainwave recording device for convenient at-home sleep monitoring and analysis to: 1-offer insight into the diagnosis and treatment of conditions such as Alzheimer's, autism, cancer, epilepsy, depression, and schizophrenia and 2-reveal how drugs affect the brain
- Company 339 - Implantable drug delivery device using nanochannel-based chip to control/modulate release
- Company 340 - Non-invasive device to alleviate the symptoms of subjective tinnitus that synchronously presents sound using headphones and tactile representations to an intra-oral array on the tongue
- Company 341 - A family of single-use devices that provide quantitative pressure measurements, while alleviating doubt and uncertainty during common medical procedures such as central line insertions, spinal taps, and epidurals
- Company 342 - Ozone injection system for multiple spinal applications, including herniated disc, to eliminate the need for multiple steroid injections and/or a surgical discectomy
- Company 343 - Bone anchorage technology for use in spine, trauma, and general orthopedics
- Company 344 - Non-systemically absorbed compounds for the treatment of diabetes and obesity, as an alternative to gastric bypass surgery
- Company 345 - Diagnostic tests that leverage the ability to extract clinically relevant information from maternal blood, including a non-invasive prenatal test to diagnose specific genetic and other inherited disorders
- Company 346 - Regenerative stem cell therapy to treat heart failure (HF), acute myocardial infarction (MI), angina, peripheral artery disease (PAD), and hard-to-heal wounds including burns, diabetic foot ulcers, venous stasis ulcers, and pressure ulcers
- Company 347 - A non-invasive hand-held system for accurately measuring circulating blood volume in real-time, to quickly identify and treat shock
- Company 348 - Device used to safely deliver epidural anesthesia during childbirth and other procedures
- Company 349 - Implantable neurostimulation device for the treatment of obstructive sleep apnea (OSA)
- Company 350 - Pressurized olfactory drug delivery device to bypass the blood brain barrier and deliver greater pharmaceutical concentrations
- Company 351 - Pancreatic islet cell transplantation as a potential cure for Type I diabetes
- Company 352 - Liver dialysis system that removes protein-bound toxins plus water-soluble toxins from blood and is more effective and cost-efficient than currently available therapies
- Company 353 - System that is capable of simultaneous quantitative and independent determination of up to 100 biomarkers in individual cells, not possible with existing technologies, for early disease diagnosis and monitoring of treatment efficacy
- Company 354 - Molecular testing that analyzes gene expression in airway epithelial cells to detect early signs of lung cancer
- Company 355 - Biocompatible surgical mesh with high tensile stiffness and strength, similar to native tendon, that is sutured over torn or degenerative tissue as a reinforcement to surgical repair to allow for rapid tissue in-growth
- Company 356 - Next-generation quantitative angiography
- Company 357 - A "smart shirt" that can count a patient's heartbeats through its sensors, record a medical quality electrocardiogram (ECG), and detect the respiration rate, body temperature, and position of the patient (standing, walking, lying, asleep, or fallen)
- Company 358 - Soft, flexible devices with tissue-like characteristics that can be used for health and wellness, cardiology, and neurology to make surgical diagnosis and treatment easier - based on a new generation of thin, conformal electronics technology that endures bending, twisting, and stretching without sacrificing performance
- Company 359 - Technology that manages the exit sites of central venous catheters by promoting the formation of a biological seal around the catheter that blocks the route for bacteria
- Company 360 - A non-invasive, optical brain monitor for monitoring hypnosis (depth of anesthesia) and level of sedation via direct non-invasive measurement of changes in deoxyhemoglobin (deoxy Hb)
- Company 361 - A disposable skin patch that provides diabetics with a painless, BLOODLESS, easy-to-use, and rapid method for monitoring glucose levels
- Company 362 - Interwoven biopolymer 3D-oriented matrices that more accurately mimic natural extra cellular matrix (ECM) for use in cell and tissue engineering applications
- Company 363 - Revolutionary HyperQ technology based on advanced signal processing of the high frequency ECG signal, enabling more accurate results in the initial diagnosis of coronary artery disease (CAD)
- Company 364 - Optical Ultrasound Tomography(R) (OUT) identifies brain injuries, brain hematomas, malignant breast cancers, and Inflammatory Breast Cancer safely and quickly and displays 3D images in "real time" and can transmit the images to waiting hospitals and surgeons. The cameras are lightweight and portable, and can be mounted on a bedside providing continuous monitoring of hemorrhages and the flow of blood. They can be used in an ambulance, on the battlefield, on the Little League field, and in the ER.
- Company 365 - A scalable molecular diagnostic chip platform that will allow for the diagnosis of diseases in five minutes as well as in-home monitoring of conditions such as: profound venous thrombosis, embolisms, and myocardial infarctions (MI)
- Company 366 - Transcutaneous vagus nerve stimulation to treat patients suffering from drug-resistant epilepsy or other difficult-to-treat neurological and psychiatric disorders
- Company 367 - Implantable device consisting of a series of miniature magnetic beads, linked together to form a "bracelet" around the Lower Esophageal Sphincter (LES) for the treatment of gastroesophageal reflux disease (GERD)
- Company 368 - Wireless 3G cellular-enabled blood glucose meter that instantly transmits glucose values to a care-management server and provides instant feedback and coaching to patients with diabetes
- Company 369 - Accurate, ultra-low-cost whole genome sequencing by way of a simple, single-molecule detection process
- Company 370 - Drug therapy focusing on the carotid body for the treatment of sleep-related breathing disorders
- Company 371 - Deep brain stimulation probe technology for advanced and personalized treatment of degenerative or functional brain disorders, such as Parkinson's disease and dystonia
- Company 372 - Versatile, easy-to-use, accurate, and cost effective aorto-ostial stent positioning system to facilitate precise stent implantation in coronary and renal arteries
- Company 373 - Device that increases the size of skin grafts without the use of chemicals, biologics, or enzymes
- Company 374 - Immediate and permanent contraception implant for women to use as an alternative to surgical tubal ligation
- Company 375 - Tissue expander technology that allows both diagnostic and therapeutic capabilities never before available during tissue expansion
- Company 376 - Tendon repair device that utilizes a simple and familiar technique to ingeniously join tissue together, with broad applications across a range of surgical sub-specialties
- Company 377 - Novel solutions for wound closure
- Company 378 - Sternal closure system that maintains rigid fixation of the sternum in multiple directions of force and eliminates the common causes of sternal dehiscence
- Company 379 - Bioseparation technology, for use outside of the research lab, with broad applications from molecular diagnostics to transplant therapies
- Company 380 - Non-invasive system for the treatment of acute ischemic stroke and other vascular disorders using externally applied ultrasound that can be rapidly and easily deployed by virtually any emergency room staff
- Company 381 - Genomics-based diagnostic tests for obstructive coronary artery disease (CAD), cardiac arrhythmias, and heart failure (HF)
- Company 382 - Nicotinic receptor agonist compounds for the treatment of asthma and other inflammatory respiratory and non-respiratory diseases
- Company 383 - Femoral vascular access catheter that uses a longer and shallower angle arteriotomy, providing better site closure WITHOUT vascular closure implants
- Company 384 - Surgical instruments, medical lasers, and other medical devices
- Company 385 - KeyHole Cup(R) is designed to provide a safer and efficient entry into the abdominal cavity during laparoscopic surgery. It allows for a more rapid insufflation than standard techniques, mitigating associated risks.
- Company 386 - Cost-effective lab-on-a-chip system that anyone can use to get laboratory quality results in any location, within minutes, and with minimal training
- Company 387 - ImagistxProstate(R), a breakthrough prostate imaging technology providing a diagnostic tool to identify prostate cancer via its 21 MhZ center frequency, 512 element array, and 3D ultrasound capabilities
- Company 388 - Proven patented technology platform that rapidly and accurately measures oxidative stress and oxidizability in blood and other biologic fluids, with multiple diagnostic applications
- Company 389 - Real-time pathology solution for cancer surgical guide, with microchip-based in vivo imaging systems
- Company 390 - A disposable, flexible conduit that provides a protective channel through which an endoscope is inserted for sinus surgery, to keep the introduction site open throughout the course of the procedure, thereby minimizing trauma along the nasal passageway
- Company 391 - Novel bilateral brain monitor with independent hemisphere indexing for the direct measurement of the effects of anesthetics and sedatives, which allows for patient-specific dosing
- Company 392 - Intelligent continuous glucose monitoring device utilizing recent innovations in microneedle and bluetooth technology, to provide a more accurate and pain-free method than what current devices offer
- Company 393 - Professional and home use devices for automated bladder assessment incorporating a novel, extremely compact, 3D ultrasound scan head and embedded image processing technology
- Company 394 - Ultrasound-based molecular imaging agents that can be used to: 1-diagnose and stage disease, 2-monitor response to therapy in the pharmaceutical research setting, and 3-elucidate the biology of disease processes in the basic science setting
- Company 395 - Portable brain sensing system to rapidly diagnose ischemic stroke at point-of-care; other indications include identification of brain trauma and cerebrovascular abnormalities and continuous monitoring of stroke patients
- Company 396 - Minimally invasive system for decompressing pinched nerves in the spine, based on highly maneuverable tools and a precise tissue-removal mechanism
- Company 397 - The Vortex ZDS(TM) catheter reduces Catheter Associated Urinary Tract Infections (CAUTIs) by at least 50% to replace Foley catheter as the indwelling urinary catheter of choice
- Company 398 - Non-invasive real-time diagnostic tools for early detection, prevention, and management of Acute Kidney Injury (AKI) in critical care environments
- Company 399 - A unique permanent injectable bulking agent for the endoscopic treatment of GERD (chronic heartburn)
- Company 400 - Therapies for the treatment of acute wounds, chronic wounds, scarring, abnormal scarring, inflammation and pain, fibrosis, surgical adhesions, and orthopedic procedures
- Company 401 - A Percutaneous Tracheostomy (PT) system that simplifies the traditional PT technique to be used by more physicians OUTSIDE of the Operating Room (OR) and in faster times than current devices
- Company 402 - Mammary Aspirate Specimen Cytology Test (MASCT System(TM)) that collects a small amount of nipple aspirate fluid (NAF) in 10 minutes, using no radiation and is painless
- Company 403 - Cardiac mapping catheters to analyze electrical heart activity for the diagnosis of cardiac arrhythmias
- Company 404 - Thermal infusion fluid warmer device that enables surgeons to manage and warm up to five fluids at once
- Company 405 - Next-generation insulin analogs for both the rapid-acting and long-acting insulin markets
- Company 406 - New embolotherapy catheter that minimizes reflux when administering medication
- Company 407 - Non-surgical, removable hearing device that transmits sound through the teeth for the treatment of single-sided deafness
- Company 408 - Medical devices for the treatment of neurovascular conditions
- Company 409 - Next generation X-ray scintillator device that provides high resolution imaging
- Company 410 - Permeable, micro-porous, flexible, and user-friendly implants in tubular or patch shape for bone reconstruction and fracture repair in surgical procedures
- Company 411 - Flexible endoscopy and endoluminal surgery device
- Company 412 - Drug therapy for the treatment of inner and middle ear disorders
- Company 413 - In vivo optical imaging devices for real-time diagnosis in a broad range of applications
- Company 414 - Headset that detects and records brainwaves for the diagnosis of Alzheimer's disease and other neurological disorders
- Company 415 - Drug therapy by way of modulating the N-methyl-D-aspartic acid receptor for the treatment of depression and other central nervous system disorders
- Company 416 - Smart-phone based ultrasound imaging system
- Company 417 - Minimally invasive devices using radiofrequency (RF) energy for the treatment of gastroesophageal reflux disease (GERD) and fecal incontinence (FI)
- Company 418 - Portable, non-invasive device designed to offer transcutaneous pulsed electro-magnetic field stimulation therapy for treating post-operative pain and inflammation in superficial soft tissue
- Company 419 - Implantable electronic gastric stimulation device for the treatment of obesity
- Company 420 - High-intensity ultrasound energy for non-invasive reduction of arterial plaque
- Company 421 - Catheter-based technologies aimed at restoring blood flow for patients with obstructed vessels
- Company 422 - The VortxRX delivers non-invasive Histotripsy with image guidance to treat benign prostatic hyperplasia (BPH). Histotripsy homogenizes prostatic tissue non-thermally as it is monitored in real time with ultrasound imaging.
- Company 423 - Robotic and manual endoscopy devices for increased ergonomics during laparoscopic surgery
- Company 424 - Eye-tracking device for earlier diagnosis of Parkinson's disease and other neurological diseases
- Company 425 - Device that uses localized vibrations to reduce pain during injections
- Company 426 - The first non-invasive, prep-free imaging test for colon cancer
- Company 427 - Biologically-active plastic surgical patch for rotator cuff and tendon injuries, designed to promote healing and formation of new bone
- Company 428 - Catheter-based drug delivery system for the treatment of vascular disease and restenosis
- Company 429 - Anti-infectives for the treatment of severe infectious diseases
- Company 430 - Device for the intraocular delivery of photoactive nanoparticles for the treatment of retinitis pigmentosa, macular degeneration, and diabetic retinopathy
- Company 431 - Venous stenting device and ablation technology for the treatment of chronic venous disease
- Company 432 - Devices that facilitate minimally invasive access to a beating human heart and the delivery of therapeutic options intended to treat complex cardiovascular diseases
- Company 433 - Customized Sound Therapy (CST) system for tinnitus therapy
- Company 434 - Artificial sphincter device for use in ostomy and stoma care
- Company 435 - Microcatheters for treating and preventing acute ischemic stroke
- Company 436 - Spinal probe that uses radiofrequency (RF) ablation on nerves thought to be the cause of chronic back pain
- Company 437 - Disposable device for the prevention of catheter-related infections from hemodialysis
- Company 438 - Single-use needle-free injection system for liquid medications
- Company 439 - Non-invasive Auto-Targeting Neurostimulation (ATN) device for high-stimulation pinpoint treatment of lower back pain
- Company 440 - Portable, patch-based device that delivers "slow release" ultrasound to treat localized pain and induce soft tissue healing
- Company 441 - Shape memory implants that restore motion and eliminate pain for patients requiring soft tissue repair, fracture fixation, or joint fusion
- Company 442 - Removable adhesion barriers for spinal, tendon, and nerve-related surgery to reduce post-operative scarring, pain, numbness, muscles weakness or limited motion
- Company 443 - Orthopedic implants for limb lengthening/correction/reconstruction
- Company 444 - Neurocatheter for the removal of blood clots in the brain
- Company 445 - Portable/mobile nuclear cardiology imaging system
- Company 446 - The first and only wire-independent embolic protection that uses any single guide wire of choice for the entire procedure and seamlessly integrates with standard workflow
- Company 447 - Single-use devices that will address epicardial access, protection, and treatment facilitating the electrophysiologist's ability to perform cardiac ablations more efficiently and with a higher degree of safety and effectiveness
- Company 448 - Irrigation devices for improved visualization during upper and lower gastrointestinal (GI) procedures
- Company 449 - DNA-testing platform that enables results from a wide variety of gene signatures to be delivered quickly, simply, and cost-effectively at the point-of-care (POC) within an hour
- Company 450 - A market leading non-invasive hypoglycemic symptom detection device that protects diabetics from emergency low-blood sugar events. Hypoglycemia healthcare costs average $7,000 per episode and can result in death to the patient.
- Company 451 - High-stability, short-length expandable implants that eliminate the need for complex bone augmentation - shortening overall time to implantation and significantly lowering treatment costs
- Company 452 - System that cools cerebral spinal fluid to reduce injuries associated with spinal and cerebral ischemia
- Company 453 - Infection control technology that does something no other product can - protect and disinfect BOTH the needleless injection site and the end of the IV tubing male luer
- Company 454 - Biodegradable, inflatable balloon device which separates healthy organs from adjacent tumors receiving radiation therapy
- Company 455 - The first passive fetal movement monitor (detector, analyzer, and data logger) for expectant mothers to use at home
- Company 456 - A minimally invasive implantable pulse generator (IPG) to treat obese and type II diabetics by applying electrical stimulation to the duodenum
- Company 457 - Implantable artificial pancreas for the treatment of patients with Type I & Type II diabetes
- Company 458 - Non-invasive hand-held device that detects abnormal heart sounds and uses a smart-phone interface for the diagnosis of coronary artery disease (CAD)
- Company 459 - Aerosol technology which efficiently delivers therapeutics into the abdominal cavity of patients during surgery to combat post-surgical complications such as pain and adhesions
- Company 460 - Self-powered miniature pacemaker and leadless electrodes implantable through minimally invasive procedures; used to treat arrhythmia
- Company 461 - Innovative sutureless technology for blood vessel anastomosis
- Company 462 - Incubator with 12 fully owned portfolio companies and 20+ fully owned pipeline technologies, driven by unmet market need
- Company 463 - The only device enabling simultaneous, non-invasive, and continuous measurement of blood flow and oxygen saturation
- Company 464 - Functional optical imaging technology for the early diagnosis and guided treatment of blinding retinal diseases and diseases of other organs of the body; it is the only optical imaging approach that allows visualization of the capillaries, non-invasively (without any contrast agent)
- Company 465 - A point-of-care diagnostic system for rapid, sensitive, quantitative biomarker panels that delivers laboratory-quality results in a clinic or doctor's office, within minutes
- Company 466 - Next-generation, cost-effective ophthalmic implants made from STAR(R) biomaterial that will help patients suffering from glaucoma and corneal blindness
- Company 467 - Continuous glucose monitoring system using an intravascular, optical fluorescence-based sensor to support clinical implementation of tight glycemic control (TGC) in the intensive care unit (ICU)
- Company 468 - Non-invasive devices for continuous real-time evaluation of hemodynamic changes
- Company 469 - Grafts for small diameter (less than 5mm) artificial blood vessels in both peripheral and coronary applications
- Company 470 - 1-Deep brain stimulator (DBS) to treat movement disorders, 2-A hybrid auditory implant (HAI) to treat severe hearing loss
- Company 471 - Innovative hydrogel technology for tissue repair including cartilage, bone, and dermal of the knee, wrist, elbow, shoulder, and ankle
- Company 472 - An ophthalmic device company delivering Navigated Retinal Laser Therapy to address the unmet need for durable and cost-effective outcomes in the treatment of major vision-threatening retina diseases, primarily caused by a complication of diabetes
- Company 473 - Best-in-class platform to optimize genes and proteins in human therapeutics
- Company 474 - Cloud/web-based medical imaging data management software and infrastructure as services - to replace picture archiving communication system (PACS) at a significantly reduced cost
- Company 475 - Incubator with over 100 highly novel medical technology inventions spanning most medical markets
- Company 476 - The only minimally invasive cure for spinal stenosis that maintains the natural dynamics of the spine
- Company 477 - Technology to embed Nitric Oxide (NO), part of the innate immune system, into polymer medical devices to make them antimicrobial without the issues of antibiotic resistance
- Company 478 - Minimally invasive catheter-based system that safely, rapidly, and effectively removes thrombus and restores blood flow in the peripheral vasculature utilizing ultrasound energy to destroy clots, without harming adjacent healthy tissue or generating dangerous emboli
- Company 479 - 1-Effective cryosurgical tool that is simple and safe to use without cryogenic gasses or liquids for all medical office skin lesion removal needs, 2-Cervical freeze attachment for gynecology use, 3-Third-generation technology to accommodate cryosurgical treatments for prostate, liver & renal cancers and cardiac aberrant foci ablation
- Company 480 - Remote (wireless) continuous EEG (cEEG) brain monitoring of critical care patients that significantly reduces mortality rates, improves patient outcomes, and saves millions of dollars in patient care expense
- Company 481 - Atherosclerotic plaque dissolution through chemical means for treating occlusive and non-occlusive atherosclerotic disease that may reduce the need for permanent implants like drug-eluting stents (DES), while also potentially addressing plaque instability
- Company 482 - Revolutionary raman-spectroscopy based platform technology licensed from the BC Cancer Agency to aid in the early detection of cancer
- Company 483 - 1-Non-invasive in vitro diagnostic (IVD) blood test for the detection and/or monitoring of 14 different types of cancer, 2-Combination Immunogene Therapy (CIT) technology that could lead to a vaccine or possibly treat those already diagnosed with cancer
- Company 484 - A low-cost, clip-on eye-piece for mobile phones that mimics and replaces the expensive laser-based Shack-Hartmann wavefront aberrometers to diagnose the most common refractive eye disorders: myopia (nearsightedness), hypermetropia (farsightedness), astigmatism, and presbyopia (age-related visual impairment)
- Company 485 - Non-invasive, rapid assessment of dP/dt in Cardiac Resynchronization Therapy (CRT) for lead placement, lead optimization, and monitoring
- Company 486 - Unique, patented, activated collagen, CellerateRX(R) for the expanding diabetes and greater wound care markets
- Company 487 - A medical implant surface technology company focused on the design and manufacturing of proprietary and cellular-friendly interbody fusion devices for the spine
- Company 488 - Anatomically appropriate orthopedic implants, unique instrumentation, and biologics for pediatric and small stature patients
- Company 489 - Proprietary medical devices and patient interfaces for the enhancement of patient safety through capnography monitoring
- Company 490 - 1-Adult stem cell collection and storage, 2-VSEL(TM) (very small embryonic-like) stem cells for tissue regeneration, 3-Contract cell manufacturing for clients around the world, Progenitor Cell Therapy, 4-Therapeutics such as a T-cell regulatory technology to treat disorders of the immune system, 5-A wound healing technology that uses autologous bone marrow-derived stem cells, 6-An autologous bone marrow-derived cell line selected to treat damaged heart muscle following AMI
- Company 491 - A business and technology research & development platform, dedicated to delivering innovative solutions for the musculoskeletal disorders industry
- Company 492 - Ellanse, the first dermal filler family offering a complete customized solution in medical aesthetics
- Company 493 - A Peripheral Nerve Stimulation (PNS) system for patients suffering from severe, intractable pain
- Company 494 - Portable, disposable, non-powered suction device for negative pressure wound therapy (NPWT)
- Company 495 - Device that prepares 10 million micro-droplets per hour for use in drug discovery, genomics, molecular epidemiology, and proteomics
- Company 496 - Non-invasive imaging system for the early detection of pre-cancerous tissue and to guide early treatment intervention
- Company 497 - A handheld breath analyzer for the measurement of fat metabolism
- Company 498 - Portable pediatric vision-screening device for early diagnosis of serious vision abnormalities
- Company 499 - Minimially invasive percutaneous implantable cardioverter defibrillator (PICD) for the treatment of cardiac arrhythmias
- Company 500 - A non-invasive, automatic analyzer that uses measurements of sweat gland activity to determine whether a patient is at risk for diabetes
- Company 501 - Compact, home-based device for male fertility assessment
- Company 502 - Device for the early detection, assessment, and monitoring of mild perceptual impairment (MPI), an early indicator of mild cognitive impairment
- Company 503 - Device providing sustained intravesical drug delivery for the treatment of Overactive Bladder (OAB), Interstitial Cystitis (IC), and other bladder conditions
- Company 504 - Percutaneously-inserted interspinous process fusion cages that provide for stabilization of the spine
- Company 505 - Implantable neurostimulation system for the treatment of obstructive sleep apnea (OSA)
- Company 506 - Physical and chemical resurfacing of orthopedic implants and stents which allows for drug elution without the use of a binding polymer
- Company 507 - Wireless, implantable heart device that allows Congestive Heart Failure (CHF) patients to monitor data using a handheld instrument
- Company 508 - Percutaneous vertebral augmentation (PVA) system for controlling bone cement delivery and leakage during spinal surgery
- Company 509 - Remotely controlled percutaneous catheter system for use in a wide range of interventional applications
- Company 510 - Novel and clinically-validated percutaneous approach for the treatment of functional mitral regurgitation in the heart failure population
- Company 511 - Sutureless, anastomotic connectors to provide a controlled method of joining vessels
- Company 512 - Minimally invasive orthopedic device for the treatment of hip pain
- Company 513 - Handheld device for monitoring chronic disease home-care patients using a single drop of blood
- Company 514 - 1-Novel 510(k)-cleared XCOIL(TM) mechanical thrombectomy device initially targeting DVT and stroke patients and 2-Novel 510(k)-cleared EViTAR(TM) double-lumen, coaxial neurocatheters for intracranial delivery of small molecules, biologics, stem cells/gene-based therapies, and smart sensor enhancements
- Company 515 - Microwave-based soft tissue ablation
- Company 516 - Implantable device to treat epilepsy by anticipating seizures and delivering intracranial drugs
- Company 517 - Injectable, synthetic bone subsitutes
- Company 518 - Device that delivers iron transdermally for patients with iron-deficiency anemia
- Company 519 - Implantable pacing and defibrillation device that detects the early onset of atrial fibrillation and chronic heart failure and delivers targeted medications
- Company 520 - Device for dry powder pulmonary delivery to treat patients with Parkinson's disease
- Company 521 - A thrombectomy catheter for peripheral artery disease (PAD) that features a rotating, extending tip
- Company 522 - A unique, non-invasive tool for the analysis of muscle function to assist in the evaluation and treatment of neck and back injuries and illnesses
- Company 523 - Vital signs monitoring device for use as an early congestive heart failure (CHF) crisis indicator at home, to avoid acute/expensive hospitalizations
- Company 524 - Novel bioresorbable regenerative scaffolds that provide 3D architecture for enhanced tissue repair
- Company 525 - Novel implantable ultrasound flow-measuring devices with flow data wirelessly transmitted from within the body
- Company 526 - Technology for nurses/pharmacy technicians/emergency responders to more safely and effectively vaccinate the public in the event of a biological or viral pandemic
- Company 527 - Modular, powered, proprietary articulating technology for endoscopes and laparoscopes, enabling surgical safety, flexibility, and procedural innovations
- Company 528 - Medical image viewing solution that enables physicians to access/view critical patient images/information from anywhere, without compromising the security/privacy of the data
- Company 529 - An elegant, user-friendly alternative to traditional eye dropper bottles that will allow multi-dose of preservative-free ophthalmic formulations
- Company 530 - The d-OSAB platform technology, used to treat ischemic stroke by delivering a precise, measured dose of oxidative stressor and comprising a monitoring system that determines the amount of stressor absorbed as well as a disposable device that maximizes contact with the fluid or blood
- Company 531 - Novel micro-texture pattern applied to surfaces and medical devices to inhibit bacterial colonization and reduce infection by producing an unsuitable environment for growth; this no-kill approach without the use of biocides does not contribute to antimicrobial resistance
- Company 532 - StimBrace addresses osteoarthritic knee pain by intelligently strengthening leg muscles to stabilize and brace the knee during real-world use
- Company 533 - Image-guided interventional endoscopy products
- Company 534 - An expandable, funnel-shaped cannula for the removal of intravascular material during extracorporeal circulation
- Company 535 - Teraherz-based, real-time, video-rate imaging system
- Company 536 - A wearable product that uses Touch Activated Phlebotomy (TAP) technology to reduce the inconvenience of blood sampling and facilitate simpler diagnoses
- Company 537 - Radiofrequency (RF)-based detection systems to reduce the risk of retained surgical sponges
- Company 538 - A removable surgical implant to improve vision loss resulting from presbyopia
- Company 539 - A minimally invasive, green, laser-based technology for the treatment of benign prostatic hyperplasia (BPH), as an alternative to traditional TURP surgery
- Company 540 - An artificial silicone microchip, which stimulates retinal cones and rods to restore retinal function
- Company 541 - An automated, continuous glucose monitor for bedside use in intensive and critical care
- Company 542 - A small, injectable ophthalmic implant containing multiple, laser-activated reservoirs designed for the on-demand, physician-controlled release of ocular drug therapies to the back of the eye
- Company 543 - A non-invasive, portable device that treats glioblastomas with electrical fields
- Company 544 - A bionic retina designed to restore sight to millions blinded by retinal degenerative diseases
- Company 545 - 1-Biochemical sensing technologies for continuous glucose monitoring and 2-Drug-delivery devices for osteoporosis management
- Company 546 - Less invasive technologies and a more effective option for Primary Open Angle Glaucoma patients
- Company 547 - 1-A long-term cardiac rhythm monitor and 2-A disposable electrocardiography (ECG) monitor for use for up to 30 days
- Company 548 - Devices for arthroscopy, hip, knee, and spine surgery, in addition to radiofrequency identification (RFID) tracking technology
- Company 549 - A percutaneous implant for mitral valve repair
- Company 550 - Capsule-based hydrogels to reduce food intake in obese patients
- Company 551 - Novel, implantable cardiovascular device for the treatment of a prevalent cardiovascular condition
- Company 552 - Whole-body imaging technology for orthopedic applications
- Company 553 - Advanced surgical devices for ear, nose, and throat (ENT) surgery
- Company 554 - 3D full-breast ultrasound imaging device for the detection of benign or malignant masses
- Company 555 - Radiofrequency (RF)-based device for the treatment of congestive heart failure (CHF)
- Company 556 - A wireless, touch-screen insulin pump featuring a blood glucose meter, food library, and an activity monitor
- Company 557 - Synthetic cartilage technology for joint repair
- Company 558 - A vertebral restoration system that uses spine-specific osteogenic biomaterials to restore vertebral stability
- Company 559 - Advanced long-term hemodialysis and peritoneal dialysis catheters
- Company 560 - Portable and advanced point-of-care diagnostics equipment
- Company 561 - Endovascular device targeting the treatment of abdominal aortic aneurysms (AAAs)
- Company 562 - A wireless, remote-controlled unit targeting tissue expansion for breast reconstruction
- Company 563 - User-friendly, simple, and needle-free transdermal delivery system that can deliver a broad range of compounds, including: peptides, proteins, small molecules, and vaccines
- Company 564 - Brachytherapy device for gynecological cancers
- Company 565 - Ophthalmic implant for improved vision in patients with end-stage age-related macular degeneration (AMD)
- Company 566 - Small, disposable, discreet, and very convenient alternative to CPAP for obstructive sleep apnea (OSA) patients
- Company 567 - A wearable, battery-operated, bionic leg - used as a robotic aid during therapy sessions, until the patient recovers their gait so they can walk/continue to improve without it
- Company 568 - Surgical films, meshes, sutures, and other products constructed from a new class of absorbable biomaterials
- Company 569 - Advanced sealants and anti-adhesion agents for use in vascular and general surgery
- Company 570 - Devices to treat diseases and injuries of the foot and ankle, resulting in faster ambulation, superior cosmesis, and less pain
- Company 571 - Benchtop-based positron emission tomography (PET) imaging system
- Company 572 - System that features an intramedullary implant for fusion or fixation of the sacroiliac (SI) joint using a small incision
- Company 573 - Magnetic technology used to destroy blood clots
- Company 574 - P.L.E.A.S.E.(R) (Precise Laser Epidermal System) - a novel transdermal delivery device for high molecular weight drugs, that can be used by medical personnel or the patient
- Company 575 - Technology platform that uses physical vapor deposition, thin film technology, and thin film metals to produce stents and other implants that feature greater biocompatibility
- Company 576 - Laparoscopic devices for single-port surgery and natural orifice transluminal endoscopic surgery (NOTES)
- Company 577 - Device that stimulates the urinary bladder electrically in order to modulate key renal functions, thus, breaking the vicious cycle of cardio-renal interaction in congestive heart failure (CHF) patients
- Company 578 - Endometrial ablation system that uses a low-profile insertion diameter, automatic power settings, an atraumatic tip, and an ergonomic handle, to provide therapy quickly and comprehensively
- Company 579 - A two-step treatment for ischemic stroke patients that provides rapid reperfusion as well clot capture and retrieval
- Company 580 - Transcatheter cardiac valve replacement technology
- Company 581 - Laser system that uses an integrated ocular measurement technology and short-pulse laser to perform surgical incisions for refractive cataract surgery
- Company 582 - Advanced surgical field illumination technologies to improve surgeon visualization and reduce surgeon fatigue in less invasive surgery
- Company 583 - Home dialysis system that integrates multiple, advanced micro-technologies
- Company 584 - Deep brain stimulation (DBS) technology for the treatment of Alzheimer's disease (AD) and Mild Cognitive Impairment (MCI)
- Company 585 - External fixation system that uses specialty clamps to: reduce the construct weight, enable greater flexibility for the surgeon, and reduce operating times
- Company 586 - Ablation system that uses a specialty catheter to deliver low-pressure liquid nitrogen for tissue ablation during endoscopy
- Company 587 - Disposable device to provide fast, objective measurement of vaginal cervical length, which assists in the determination of whether the patient is undergoing preterm labor
- Company 588 - Optical sensing technology for non-invasive pH monitoring of stored platelets
- Company 589 - Software allowing physicians to remotely monitor vital signs using smartphones and hybrid tablet devices such as the iPhone, BlackBerry, Android, Windows Mobile devices, and iPad/Android-based tablets
- Company 590 - Patch-based technology that delivers a weekly, low-dose contraceptive to women
- Company 591 - Integrated system that monitors the activity of patients and caregivers in long-term care environments and features a proprietary fiberoptic sensor to detect patient movement, thereby detecting falls and helping to prevent pressure ulcers
- Company 592 - Remotely-operated, in vivo, miniature robotic products for laparoscopic surgery
- Company 593 - Angioplasty stenting system intended to reduce procedure times
- Company 594 - Integrated system comprising reusable and disposable devices, components, and software to enable magnetic resonance imaging (MRI)-guided neurological procedures
- Company 595 - Devices used to assist in the introduction and advancement of endoscopes in the upper and lower gastrointestinal (GI) tract
- Company 596 - The ViSi Mobile System, a comprehensive vital signs monitoring platform for bedside, ambulatory, or transport applications
- Company 597 - 510(k) cleared device using acoustic reflectometry to continuously monitor breathing tubes for placement, movement, and obstruction, enabling adverse event prevention
- Company 598 - Platform of technologies used to lower intraocular pressure (IOP) for glaucoma patients, including the Gold Shunt implant, the 790 laser for trabeculoplasty, and a sensor to continuously monitor IOP
- Company 599 - Paddle that measures the mechanical properties of breast tissue during mammography, reducing pain and discomfort
- Company 600 - Implantable neurostimulation device to treat inflammation
- Company 601 - Repositionable transcatheter aortic valve replacement system
- Company 602 - Technology to treat cardiac arrhythmias
- Company 603 - Diagnostic system for hematology and HIV-immune monitoring in developing countries
- Company 604 - Bronchoscopically-placed nitinol coil for lung volume reduction
- Company 605 - Controlled electrical pulses delivered to nerve clusters to improve swallowing function and control in patients with acute dysphagia
- Company 606 - Hand-held device intended for use in facial rejuvenation
- Company 607 - Hand-held device that deactivates the axillary glands using electromagnetic energy, thereby eliminating the problem of massive underarm sweating
- Company 608 - Hand-held point-of-care and home-based testing devices that measure blood viscosity for patients taking Warfarin
- Company 609 - 3D scanning technology that measures ear canal shape and tissue compliance
- Company 610 - Bioabsorbable drug-eluting stent for chronic sinusitis patients
- Company 611 - Catheter securement system that features a small anchor placed subcutaneously
- Company 612 - Wireless systems to enable remote safety and wellness monitoring for geriatric patients
- Company 613 - An intravascular continuous glucose monitor comprising a single-use catheter and sensor system that enables direct measurement of plasma glucose in flowing blood
- Company 614 - Non-invasive meters for continuous glucose monitoring
- Company 615 - The DISTALOCK Intramedullary Nail and Drill System uses an innovative approach to facilitate the accurate placement of locking screws used to stabilize the rod-like implants, or nails, used for long bone fractures
- Company 616 - Drug-eluting balloon product for cardiac and peripheral arteries
- Company 617 - Advanced vascular closure device designed to reduce the time to hemostasis
- Company 618 - Low-energy, pain-free atrial cardioverters for atrial fibrillation (AF)
- Company 619 - Combines imaging technology and advanced algorithms to assess early embryo viability at the 4-cell stage
- Company 620 - Radiofrequency-based ablation catheter for atrial fibrillation (AF) that features integrated microwave radiometry technology
- Company 621 - Non-surgical procedure to reverse some of the physical effects of vaginal childbirth
- Company 622 - Intravenous (IV) catheter system which substantially increases successful IV insertions and provides top-of-class passive needle safety; also applicable to many other vascular access applications where higher success rates and less vessel trauma are important
- Company 623 - Spine implant system that stabilizes and restores the spinal anatomy of persons that have suffered a vertebral compression facture (VCF)
- Company 624 - 1-Trans-nasal catheter for real-time imaging of atrial fibrillation (AF) ablation procedures; 2-Intra-cardiac catheter for real-time image guidance of percutaneous valve and other structural heart repair procedures; 3-High-definition intravascular ultrasound (IVUS) system, with near-OCT image resolution; and 4-Image-guided, endoventricular injection catheter for stem cell and/or biological agent therapy for congestive heart failure (CHF)
- Company 625 - Next-generation solution for patent foramen ovale (PFO) closure that directly treats the pocket of the PFO (in-tunnel closure), while minimizing the impact to the atrial spaces
- Company 626 - Hydrogel-based ocular bandage to protect clear corneal incisions following cataract and intraocular lens placement surgery, covering vulnerable tissue as the incision heals, and reducing pain and discomfort in the days following surgery
- Company 627 - Hand-held intra-operative surgical probe used in diagnosing, staging, and treating breast cancer, to reduce residual cancer/repeat surgery after breast cancer lumpectomies
- Company 628 - Effective antimicrobial coatings and compounds that are broad-spectrum and fast-acting against clinically relevant pathogens, including multi-drug resistant strains such as MRSA
- Company 629 - Next-generation drugs with better efficacy and safety, plus longer duration of action, for rheumatoid arthritis, anemia, organ transplants, and blood diseases
- Company 630 - Next-generation extracellular matrix (ECM) products for advanced wound healing and tissue regeneration, with improved handling, strength, resorbability, and infection control over existing products
- Company 631 - Low-cost disposable devices that enable efficient and patient-friendly delivery of colonoscopy and colon prep services at convenient care settings on a walk-in basis
- Company 632 - System that provides a new direction in dialysis, through a new mode of access through two implantable ports that allow safe repeated access into arteries and veins, so that the dialysis process works with the natural direction of blood flow
- Company 633 - Polymer-based liquid bandage with antimicrobial properties to: cover intact skin or minor cuts, scrapes, burns, and minor irritations of the skin; help keep them clean and dry; and help protect them from infection
- Company 634 - Disruptive diagnostic platform, using an innovative multi-modality approach, to advance cardiovascular health assessment for the prevention of heart attack and stroke
- Company 635 - Fixation with compression technology that offers significant improvement over existing products with applications in small & long bone, spine, and the sternum
- Company 636 - First spinal instrumentation system developed specifically to restore healthy kinematics in lumbar flexion for the treatment of lumbar spinal stenosis with or without degenerative spondylolisthesis
- Company 637 - A portable pneumatic compression system for the treatment of venous and arterial insufficiency, to be used in the hospital, secondary care facility, and home
- Company 638 - Revolutionary portable device to provide easy and efficient screening methods for early detection of age-related macular degeneration, diabetic maculopathy, and other types of retinal disease in the human eye
- Company 639 - A proprietary drug delivery platform that uses human Alpha-Fetoprotein (AFP) to deliver selective chemotherapy, avoiding damage to normal cells
- Company 640 - Orthopedic implants for the reconstruction of distal extremities
- Company 641 - Implant fault detection and monitoring technology
- Company 642 - Leak-proof, rupture-proof breast implant technology, with the potential to replace all existing saline and gel implants
- Company 643 - Next-generation non-invasive portable ultrasound system for the treatment of fat, skin, and other plastic surgery and dermatology applications at all anatomical sites - without anesthesia and surgery
- Company 644 - Highly multiplexed real-time PCR-based assays for the accurate detection of hospital-acquired antibiotic resistant bacteria such as MRSA, MSSA, and pathogens causing Sepsis and gastrointestinal infections
- Company 645 - 24-hour intraocular pressure monitoring of glaucoma patients by a telemetric, implantable micro sensor
- Company 646 - Electrochemical biosensors for the in-hospital diagnostics, home health care, and consumer diabetes markets
- Company 647 - New medical grade preservative that is non-toxic and capable of preserving urine, blood, plasma, and serum at room temperature; designed and used by the space program
- Company 648 - Molecular diagnostics and therapeutics for back-related and joint-related pain
- Company 649 - Technology that can detect in real time an acute myocardial infarction and derive a 12-22 lead ECG with only 3 leads or 5 electrodes
- Company 650 - Minimally invasive surgical suturing devices, using standard type curved needles and all standard sutures, for conventional and single-port laparoscopy, urogynecology, cardiac surgery, and endoscopic interventional therapies, including NOTES
- Company 651 - IVC filter utilizing unique anchoring technology that allows for optimal placement during implantation, superior migration resistance in vivo, and easy retrieval after the threat of PE has been eliminated
- Company 652 - Effective, reliable use of autologous adult stem cells (ASCs) to enhance fusion in spine and orthopedic surgery
- Company 653 - Fail-safe and inexpensive system that employs a technology to prevent errors in the intravenous administration of drugs and blood transfusion
- Company 654 - Device that applies gentle pulsing forces, in combination with standard orthodontics, to move teeth faster through accelerated bone remodeling
- Company 655 - Forward-looking intravascular ultrasound (FLIVUS) catheters that can determine correct stent size and placement through a field of view which extends beyond the catheter tip
- Company 656 - Lightweight and portable system with unsurpassed fluid balance accuracy for blood purification and fluid management
- Company 657 - Single-use, disposable "sensing embedded" surgical glove 1-to accurately map cervical length/dilatation during pre-term/full-term labor, 2-as a tool in general surgery, and 3-as a tool in telemedicine
- Company 658 - Reagents for use in non-invasive MRI, PET, and optical imaging
- Company 659 - Non-invasive device that acts as a robotic physical therapist for treating chronic head and neck pain
- Company 660 - A genomics diagnostic tool company, with a transformative technology that integrates sample preparation and sequencing on a chip, delivering actionable data in the doctor's office; supported by a $30 million large grant project with access to 15 million samples associated with cradle to grave electronic medical records established a decade ago
- Company 661 - Patient monitoring system providing real-time continuous information via four physiological parameters - sensed at the tissue level, reflecting the patient's systemic metabolic state
- Company 662 - Prevention and treatment of osteoporosis-related fractures
- Company 663 - A unique, simple-to-use, single-use inhaler device to address major unmet needs in the respiratory and drug-delivery fields; specifically, the acute treatment of asthma and COPD
- Company 664 - Growth factor, stem cell, scaffold, and bioadhesive technologies that improve the body's ability to regenerate healthy cartilage, improve joint function, and prevent degenerative disease
- Company 665 - Bioceramics for the treatment of post-myocardial infarction (MI), mitral valve regurgitation, applications to coronary and peripheral stents, and other technologies
- Company 666 - Cost-effective, laser-based antimicrobial treatments for Chronic Rhinosinusitis (CRS)
- Company 667 - Modular, 3D, real-time, stereoscopic vision and recording systems to change the surgical paradigm from 2D to 3D-HD stereoscopic vision for minimally invasive surgery (MIS)
- Company 668 - Next-generation infusion pump platform to bring new standards of accuracy and ease-of-use to the hospital and homecare markets
- Company 669 - Non-hormonal, one-size-fits-all intravaginal contraceptive ring
- Company 670 - Single-use high-definition (HD) surgical camera that will provide high-quality HD imaging at a fraction of the price of current market leading HD cameras
- Company 671 - Endoscopic accessory devices that fill unmet needs in the field of gastrointestinal (GI) endoscopy
- Company 672 - Needle technology that reveals visible blood flow at the instant of vein penetration without activation or additional instruction
- Company 673 - Non-invasive method for detecting the presence of a right-to-left cardiac shunt (i.e., PFO) to enable medical treatment and/or closure before the occurrence of a debilitating or life-threatening stroke or heart attack
- Company 674 - Patent-protected, FDA-approved, gentler power-assisted liposuction devices offering more controlled and faster fat removal, with less trauma to the doctor and patient
- Company 675 - Technology for: 1-prophylactic treatment of allergic asthma and 2-infection control in surgical theatres
- Company 676 - Non-invasive, controlled, and sustained release back-of-the-eye therapeutics for sight-threatening diseases such as: severe uveitis, diabetic macular edema, and age-related macular degeneration (AMD)
- Company 677 - Technology that can regenerate nerves
- Company 678 - Compound that can regenerate new blood vessels and has a biodegradable stent
- Company 679 - Tissue-engineered, autologous heart valves for the replacement of malformed or malfunctioning heart valves
- Company 680 - The first robotic system capable of offering full force-reflection to laparoscopic surgeons in any surgical practice
- Company 681 - An intraocular lens, customized to the patient's vision needs and adjustable throughout the patient's life, for greater quality of vision
- Company 682 - Minimally invasive stents to treat patients suffering from dysfunctional uterine bleeding (DUB), urinary tract obstruction, prostate enlargement (BPH), or prostate cancer
- Company 683 - 1-Real-time device navigation and positioning system for cardiovascular interventions and 2-Real-time angiography-based system, designed to assist in delivery of a transcatheter heart valve (THV)
- Company 684 - Biomimetic prosthetic vascular grafts that are transformed in the body into bioartificial arteries which resemble "healthy" arteries in form and function
- Company 685 - Novel neurovascular clot retrieval device for acute ischemic stroke intervention
- Company 686 - Flexible endoscopic tools for interventional gastroenterologists to perform therapeutic procedures
- Company 687 - Modern, sophisticated system to ensure a proper blood match is obtained and the patient gets the correct cord blood unit in a timely manner
- Company 688 - Implantable device to treat patients with left ventricular dilation following a Myocardial Infarction (MI) heart attack
- Company 689 - Blood glucose monitoring system designed to integrate test strips, the lancing device, and lancets into one compact glucose meter
- Company 690 - A wound dressing constructed from a biocompatible matrix and coagulating agents
- Company 691 - PediGuard is the world's first and only hand-held device capable of alerting surgeons to potential pedicular or vertebral breaches. Real-time feedback is provided via audio and visual signals.
- Company 692 - Hand-held, battery-powered product using intense therapeutic ultrasound (ITU) technology for skin care
- Company 693 - Bone cement for cranial defect repair
- Company 694 - A vascular robotic system designed to place coronary guidewires, stents, and balloon catheters during percutaneous coronary interventions
- Company 695 - An integrated system featuring sensors and software to enable the monitoring of seniors in multiple care settings
- Company 696 - Minimally invasive therapy for enlarged prostate
- Company 697 - Controlled Deployment Technology (CDT), which uses a low-profile access sheath that may be increased to provide a wider working diameter
- Company 698 - A portable device that provides therapeutic hypothermia in emergency care settings
- Company 699 - Hand-held, disposable nerve stimulator for use during surgeries
- Company 700 - An absorbable skin stapler for skin closure that eliminates the need for removing staples after surgery
- Company 701 - Esophageal cardiac monitoring device for use in surgery and critical care
- Company 702 - Proprietary devices for obtaining, shaping, and implanting ankle and knee cartilage grafts from foot joints
- Company 703 - Quantitative and qualitative cardiac assays to assist in the diagnosis of cardiovascular diseases at the point of care
- Company 704 - Advanced, portable and easy-to-use noninvasive devices for the assessment of traumatic brain injury (TBI) at the point of care
- Company 705 - Next-generation wellness program with sophisticated physical and mental health diagnostic software
- Company 706 - Combination of a proprietary ELISA substrate with Raman spectroscopy to dramatically increase the performance of immunoassays for diagnostics, research, and drug discovery
- Company 707 - Surgical instruments to reduce the trauma of full access surgery
- Company 708 - Non-ablative skin rejuvenation technology which produces immediate and visible aesthetic improvement together with long-term skin remodeling effects
- Company 709 - Implantable medical device that helps diabetic patients control their eating habits, lowering their blood glucose and body weight, by applying electrical stimulation to the stomach during meals
- Company 710 - Ophthalmic devices for minimally invasive treatment of corneal blindness and vision correction using proprietary corneal implants and microsurgical instrumentation
- Company 711 - Device that measures the presence, progression, and severity of any disease condition and the effectiveness of treatment and timing of non-acute death
- Company 712 - Non-obtrusive CPAP mask that uses the natural oral cavity anatomy to create the seal required for effective CPAP treatment
- Company 713 - rEEG(R) technology for the assessment of neurophysiological abnormalities and determination of psychiatric treatment
- Company 714 - Miniaturized wireless telemetry, physiological monitoring, and rehabilitation devices including applications in electrophysiology, sleep disorders, and movement disorders
- Company 715 - Dedicated Diabetic Machine (DDM) insulin regulation therapy for type 2 diabetes
- Company 716 - Non-invasive glucose monitoring device targeting the eye
- Company 717 - Universal oncology, cardiology, stroke and diabetes molecular imaging agents
- Company 718 - Implantable hearing device that provides extraordinary acoustic performance in a completely invisible device
- Company 719 - Surgical sponge detection using radiofrequency identification
- Company 720 - Home monitoring technologies with automatic fall detection capabilities
- Company 721 - Implantable neuromodulation devices for epilepsy and other neurological disorders
- Company 722 - Unique non-invasive blood pressure and cardiac output monitor, offering a precise hemodynamic profile with real-time data posted within a minute
- Company 723 - Single-port, multi-channel laparoscopic surgical platform
- Company 724 - Advanced over-the-wire vascular access device
- Company 725 - Technologies that improve visualization during laparoscopic surgery, permit laparoscopic suturing, and enable simpler removal of ureteral stones
- Company 726 - Portable hyperthermic perfusion system for raising the core temperature of the thoracic or peritoneal cavity
- Company 727 - Optical guidance systems for computed tomography (CT), fluoroscopy, and magnetic resonance imaging (MRI) procedures
- Company 728 - Liposome-encased nanoparticles for computed tomography (CT) contrast imaging
- Company 729 - Cartridge-based portable hemodialysis machine
- Company 730 - Capillary force vaporizer technology
- Company 731 - Home-based diagnosis of sleep disorders
- Company 732 - Office-based, minimally-invasive ablation device for enlarged prostate
- Company 733 - Medical imaging technologies for clinical and pre-clinical applications
- Company 734 - Ultrasound systems powered by the Scan Engine, a device that may be interchanged with any of the company's 3 carts, promoting efficiency and cost-effectiveness
- Company 735 - A drug-eluting stent coated with bioabsorbable polymers
- Company 736 - Parts and services for new and refurbished imaging and patient monitoring technologies
- Company 737 - Inhalation delivery technologies
- Company 738 - Synthetic bone substitutes
- Company 739 - Organ-specific molecular imaging
- Company 740 - Image analysis for the diagnosis of Alzheimer's and other diseases
- Company 741 - High-speed, disposable dental drill
- Company 742 - Software systems for cardiology
- Company 743 - Spinal implant for remote-controlled spine deformity and trauma correction
- Company 744 - Endoluminal treatment for morbid obesity
- Company 745 - A non-invasive diagnostic medical device that replaces the current traumatic procedure used to detect pediatric VUR (urinary reflux) and prevent kidney damage in 4M children annually
- Company 746 - Highly differentiated aorto-ostial stent and delivery platform for both peripheral and coronary applications
- Company 747 - Medical records application on a simple USB flash drive for patients, providers, and insurers
- Company 748 - Intelligent orthopedic devices that will address the growing clinical and economic cost of orthopedic implant failure and osteoporosis
- Company 749 - Pro-Vas is a novel less-invasive alternative to vasectomy for men seeking permanent contraception
- Company 750 - Minimally invasive lumbar annular repair technologies to prevent disc re-herniation and interrupt disc degeneration
- Company 751 - Innovative imaging that provides real time and wide field visualization of cancer margins during surgery to increase tissue conservation and comprehensive removal of cancerous areas, specifically for the treatment of breast cancer
- Company 752 - Device to non-invasively detect and monitor blood borne diseases in vivo, without taking blood
- Company 753 - Products ranging from needleless injection site connectors, to safety syringes, and biodiagnostic sampling devices
- Company 754 - Products for the urinary incontinence market
- Company 755 - New medical diagnostic system for the early detection of lung cancer
- Company 756 - Non-invasive ultrasound device for the treatment of glaucoma
- Company 757 - Technology that will impact the way surgeons perform laparoscopic surgery, making it possible for one surgeon to do what now requires two, and to reduce the number of surgical incisions for most all procedures
- Company 758 - Varicose vein stripping under direct vision for ablation of the diseased saphenous vein in a kit that reduces trauma, minimizes bleeding, and expects improved clinical outcomes
- Company 759 - Advanced biofeedback stimulator with diagnose and treatment modes
- Company 760 - Device for treating diseases in patients with acute renal failure (ARF) and acute inflammation induced by cardio pulmonary bypass (CPB) surgery, to produce improvement in survival rates and reduce costs
- Company 761 - Technology that bridges the gap between low-tech aspiration and complex electromechanical aspiration systems for use in thrombus removal, rotational vacuum assisted biopsy, tissue resection, and spinal disc decompression
- Company 762 - A handheld device for the as-needed treatment of allergic rhinitis
- Company 763 - Non-compressible hemostatic fibrin sealant for high-volume bleeding in intraoperative surgery and trauma
- Company 764 - Minimally invasive device for midface lift and other lift procedures
- Company 765 - Robotic ankle and foot prosthesis
- Company 766 - Handheld CD4 cell counter
- Company 767 - Auto-adjusting portable oxygen system
- Company 768 - Magnetically-guided enteral feeding tube
- Company 769 - Wireless electrocardiography
- Company 770 - Human fibrinogen-based tissue sealant
- Company 771 - Gastrointestinal endoscopy products
- Company 772 - Interventional cardiology devices for chronic total occlusions
- Company 773 - Dental imaging
- Company 774 - Type 1 Diabetes medication delivery
- Company 775 - Innovative neuroscience solutions for diseases of the central nervous system including neurological and psychiatric disorders such as migraine, Parkinson's disease, schizophrenia, and bipolar disorder
- Company 776 - In-situ formed hydrogels for radiation oncology and oncologic surgery
- Company 777 - Protein signature-based diagnostic tests for prostate, lung, and breast cancers
- Company 778 - Synthetic polymer for osteoarthritis therapy
- Company 779 - Controlled warm air delivery device for human head lice removal
- Company 780 - Polymolecular system for the treatment of inflammatory disease
- Company 781 - Critical care monitoring technologies
- Company 782 - Advanced feeding tube technology which can be placed using ultrathin endoscopes
- Company 783 - An accurate, low-cost home healthcare device for use by patients to self-measure Intraocular Pressure (IOP)
- Company 784 - Ultrasonic technologies and related techniques for aesthetic surgery
- Company 785 - Therapeutic ultrasound to treat hypertension
- Company 786 - Breast imaging system for early breast cancer detection
- Company 787 - RFID technology and software systems for medical device manufacturers, distributors, and hospitals
- Company 788 - Smart card platform that identifies and authenticates a patient to the healthcare provider and matches the patient to his or her medical record
- Company 789 - "Lap-Pak" is a flexible, one-piece, device contoured to enable the rapid and secure re-positioning of the bowels to expose the surgical site while eliminating the need for re-positioning during surgery
- Company 790 - Enhanced meter dose inhalers and spacer devices for the treatment of Asthma and COPD
- Company 791 - Sensor-based, video-monitored, automatic/semi-automatic laryngoscope that makes intubation easy, safe, and fast
- Company 792 - The first point-of-care device able to give a rapid determination of platelet quality through a multi-dimensional test, thus, avoiding the use of poor quality platelets and improving transfusion outcome
- Company 793 - Portable diagnostic device used to determine the presence and level of Myocardial Ischemia (MI)
- Company 794 - Suite of diagnostic imaging products using near-field and forced-resonance principles targeting several specialties including cardiology, oncology, orthopedics, and neurology
- Company 795 - Rapid endovascular vessel occlusion and blood flow interruption
- Company 796 - Flat panel x-ray sources for use in sterilization systems, compact CT systems, and a non-radioactive blood irradiator
- Company 797 - Non-invasive, easy-to-use device that uses pulsed radio frequency energy (PRFE) for tissue growth, wound healing, and pain relief
- Company 798 - Robotic assistance device for CT-guided soft tissue interventions
- Company 799 - Fatigue-resistant/fiber-reinforced bone cement for orthopedic joint replacement
- Company 800 - Full line of products specifically dedicated to avoiding a total joint replacement and preserving the shoulder, hip, knee, or ankle joints
- Company 801 - Single-use, disposable silver ion delivery device to treat Osteomyelitis (OM)
- Company 802 - Micro-format, CMOS-based, imaging technology for minimally-invasive, disposable endoscopic medical procedures
- Company 803 - Fish-skin-derived tissue regeneration technology for chronic wounds and hernia repair that improves upon current human and porcine technologies through improved economics & clinical performance, reduced disease transfer risk, and absence of cultural constraints on usage
- Company 804 - Hand-held ultrasound tool that displays a see-through image in the medical practitioner's line of sight, at the patient's skin surface
- Company 805 - Minimally invasive ultrasound-guided RF ablation system to treat symptomatic uterine fibroids through a transcervical approach
- Company 806 - Products for minimally invasive bypass surgery
- Company 807 - Rapid/sensitive/cost-effective diagnostic products for detecting microbes causing hospital associated infections
- Company 808 - Diagnostic products for rapid infection determination at the point-of-care (POC) for professional and consumer markets
- Company 809 - Cancer immunotherapy device, which selectively removes specific blood-borne inhibitors of the immune system
- Company 810 - POC/PST device to directly detect clot formation and do it in real time
- Company 811 - 1-Low-cost, disposable point-of-care (POC) Pap smear replacement requiring no lab or technician; 2-Disposable, woman-controlled, cervical cap embedded with an anti-HIV drug to provide contraception and help prevent infection from HIV
- Company 812 - Small/wearable/all-mechanical insulin delivery device containing a 3-day supply of insulin
- Company 813 - The next major step in the treatment of early breast cancer: replacing lumpectomy with a percutaneous, minimally invasive outpatient procedure under local anesthesia that not only eradicates the cancer, but is not disfiguring and leaves no scar
- Company 814 - Stand-alone/rapid/autologous cell harvesting processing and delivery technology
- Company 815 - System that measures airway inflammation to determine asthma severity for improved treatment
- Company 816 - Minimally invasive, image-guided therapies to treat back pain
- Company 817 - Products enhancing focally-delivered radiation and drug therapies for patients with spinal metastatic disease or bone tumors
- Company 818 - Needle-free drug delivery for migraine attacks and cluster headache episodes
- Company 819 - Image-guided ultrasound for prostate cancer tissue ablation
- Company 820 - Obstetric position tracker and ultrasound technology
- Company 821 - Compact ultrasound devices
- Company 822 - Continuous blood glucose measurement devices
- Company 823 - Radiosurgical therapy for neurovascular and inflammatory ocular conditions
- Company 824 - Wound closure technology
- Company 825 - Neurosurgical tumor removal
- Company 826 - Surgical device for treating benign prostatic hyperplasia (BPH) and other conditions
- Company 827 - Radiofrequency balloon catheter technology
- Company 828 - The TOPS(TM) System is an implantable device that allows axial rotation, lateral bending, extension, and flexion. The implant facilitates bending, straightening and twisting movements at the affected segment of the spine while blocking excessive posterior and anterior sagittal translation.
- Company 829 - Implants for sensorineural hearing loss
- Company 830 - Medical textiles for hemostasis
- Company 831 - 1-System for use in spinal surgical procedures such as vertebroplasty, 2-System to provide immediate vascular access through the intraosseous space for the delivery of essential drugs and fluids, 3-System for aspirations, biopsies, and stem cell collections
- Company 832 - Pressure cycling technology (PCT) to safely, conveniently, and reproducibly control the actions of molecules in biological samples
- Company 833 - Low-cost technology to survey the genome in its native state, in context, and at ultra-high resolution, without the need for DNA amplification
- Company 834 - Temperature management technology to treat hyperthermia and hypothermia, prevent damage from stroke, and enhance cancer therapies
- Company 835 - Unique solutions for ophthalmic conditions such as: presbyopia, myopic progression using contact lenses, intraocular lenses and lasik, or other corneal surgeries
- Company 836 - Non-invasive radiofrequency (RF) energy-based system to treat vaginal stretching caused by childbirth
- Company 837 - High-quality, cost-efficient, single-room proton beam radiotherapy (PBRT) system as an alternative to conventional high-energy x-rays
- Company 838 - Controlled, targeted deep-tissue therapeutic warming system to promote pain relief, reduce joint stiffness, and enhance recovery/rehabilitation programs
- Company 839 - 1-Artificial larynx, 2-Ear, nose, and throat (ENT) prostheses/implants
- Company 840 - microRNA-based tests to diagnose various cancers and gastrointestinal diseases
- Company 841 - Brain training software aimed at enabling individuals to strengthen cognitive function using the concept of neuroplasticity
- Company 842 - Non-invasive near-infrared (NIR) laser energy for the treatment of: acute ischemic stroke, spinal cord injury, traumatic brain injury, global cerebral ischemia, spinal cord injury, Alzheimer's disease, Parkinson's disease, and sepsis
- Company 843 - Hydrogel materials that can be fabricated into devices, nanogels, and polymer solutions with applications in ophthalmology as well as cardiology, urology, and tissue engineering
- Company 844 - Advanced polymer-based biomaterials for applications in cardiology, dentistry, orthopedics, surgery, and urology
- Company 845 - Neurostimulation device to block residual limb pain caused by complications of amputations, as well as chronic pain after surgery, and migraine pain
- Company 846 - Joint, spine, and trauma implants
- Company 847 - "Minimally invasive" gene repair
- Company 848 - Implantable device for the surgical treatment of obesity without reliance on sutures, staples, or other mechanisms that puncture the stomach wall
- Company 849 - Microdermabrasion system with polyester/nylon bristle tips and variable vacuum levels for particle-free/crystal-free performance
- Company 850 - Elastic, self-expanding devices to specifically improve left ventricle relaxation and diastolic function
- Company 851 - Point-of-care handheld immunoassay system providing high-performance quantitative laboratory blood test results in an inexpensive, portable, and easy-to-use configuration
- Company 852 - Routine serum DNA blood tests for early cancer diagnosis and management
- Company 853 - Minimally invasive alternative to the surgical treatment of obesity
- Company 854 - Drug-eluting balloons that allow for controlled release of different and even multiple substances, for the treatment of coronary (CAD) and peripheral artery disease (PAD)
- Company 855 - Cancer prognostic tests for predicting specific individual patient clinical outcomes
- Company 856 - Genomics-based in vitro diagnostic (IVD) tests developed from FFPE tissue for personalized medicine
- Company 857 - Needleless/transdermal delivery system for insulin, analgesics, or vaccines with on/off control of dosing
- Company 858 - MRI-compatible ultrasound applicator to deliver controlled thermal therapy to the cancerous regions of the prostate gland
- Company 859 - Non-invasive (needle-free), wireless, transdermal continuous glucose monitoring (tCGM) system
- Company 860 - Antimicrobial solutions to reduce the incidence of Surgical Site Infections (SSIs) in spinal surgeries
- Company 861 - Tissue repair platform that obviates the need for sutures, stapes, glues, or other foreign bodies and instead allows the body to repair and heal itself
- Company 862 - Catheter-based system to treat large vessel acute ischemic strokes
- Company 863 - Next-generation remote patient monitoring (RPM) to continuously monitor vital life-sign functions such as: heart rate, respiratory rate, body position, activity level, and skin temperature
- Company 864 - Total Artificial Heart (TAH) to replace both ventricles of a failed heart, thus, restoring the circulatory system to normalcy
- Company 865 - Antalgic-Trak(R) (A-T) is the only non-surgical spinal decompression system in the world engineered with a series of multi-axis articulating sections that provide and create spinal "Range-Of-Motion" (ROM) therapy
- Company 866 - Portable DNA analyzers for on-demand, non-batched testing, with real-time polymerase chain reaction (PCR) results in 30-60 minutes
- Company 867 - Novel biomimetic shape memory hydrogel implants for minimally invasive vessel protection following surgical treatment of degenerative conditions of the anterior spine
- Company 868 - System designed to prevent contrast-induced nephropathy (CIN)
- Company 869 - A novel suite of workflow tools that automate the viewing, analysis, and interpretation of x-rays for musculoskeletal disease
- Company 870 - Technology to preserve the normal, healthy tissue of patients that today is damaged as a by-product of current treatments
- Company 871 - Ventricular Assist Device (VAD) that can be inserted above the diaphragm
- Company 872 - Handheld, non-invasive, real-time Central Venous Pressure (CVP) monitor for cardiology and nephrology diagnostic applications
- Company 873 - Next-generation stent platform with: significantly thin walls for reduced restenosis, ease-of-use, superior deliverability, and improved radiopacity for accurate placement
- Company 874 - In-line, battery-powered, disposable, lightweight, and completely portable blood and IV fluid warming device, capable of intravenous application and irrigation warming
- Company 875 - Next-generation endovascular devices that incorporate advanced fiber optics technology into currently used products/procedures to improve patient outcomes without adding to procedure time/cost
- Company 876 - Digital fluorescence scanners for molecular pathology research, biomarker development, and clinical molecular diagnostics (MDx) for personalized medicine
- Company 877 - Software for efficiently coordinating the delivery of patient care outside of hospitals; it optimizes home care operations and can turn a medical practice into an ACO
- Company 878 - Polymer technologies for drug delivery and regenerative medicine with applications in orthopedics and spine
- Company 879 - A-FX(TM) is a minimally invasive platform technology for creating an orthopedic implant in-situ which provides superior fixation in osteoporotic bone
- Company 880 - Non-invasive device designed to offer transcutaneous pulsed electro-magnetic field stimulation therapy for treating postoperative pain and edema in superficial soft tissue
- Company 881 - Non-invasive reverse thermal gradient technology to treat conditions of tendons, ligaments, muscles, fasciae, and joints
- Company 882 - Automatic screw delivery system for cranial maxillo-facial bone fasteners
- Company 883 - Non-invasive brain physiological measurement technologies
- Company 884 - Smallest/passive/implantable tag using RFID (radio-frequency identification) technology
- Company 885 - Diabetic pain relief via topical dermal administration and controlled release of pure Nitric Oxide (NO)
- Company 886 - A percutaneous, catheter based system for the temporary isolation of the liver from the systemic blood circulation and local administration of chemotherapy drugs at high concentrations, directly into the liver without systemic side effects - under optimal drug conditions
- Company 887 - Vacuum-based clean surface nanotechnology for faster and larger osseointegration
- Company 888 - Technology for: 1-Glaucoma diagnosis and 2-Real-time homecare monitoring of intraocular pressure (IOP)
- Company 889 - Precision stapling devices enabling minimally invasive vascular connections, especially for Coronary Artery Bypass Graft (CABG) surgery
- Company 890 - The technology, based on growth factor extract from reindeer bones, improves bone formation in bone healing problems
- Company 891 - A range of injectable gels made from hyaluronic acid for applications in Aesthetic Dermatology, Ophthalmology, and Orthopaedics
- Company 892 - Mobile air purification unit that captures and destroys airborne pathogens
- Company 893 - Therapy delivery platform for the upper airway with applications to initially target chronic sinusitis, nasal allergies, cystic fibrosis, and CPAP users
- Company 894 - 1-Multi-generational devices using hybrid technologies for Natural Orifice Translumenal Endoscopic Surgery (NOTES) procedures, 2-Low profile single-patient-use tissue retractor, 3-Range of 7Fr intra aortic balloon catheters with fluid-filled technology that plugs into current hardware
- Company 895 - Percutaneous anastomosis device to improve long-term vascular access for dialysis and cancer patients
- Company 896 - Intelligent 3DHD visualization and guidance platform for ophthalmic, cranial, and spine surgeries
- Company 897 - Wireless/battery-less antenna on a chip (tag) for continuous tracking of blood samples
- Company 898 - Permanently implanted electrical neural stimulators to treat balance/hearing/perceptual disorders
- Company 899 - Real-time advanced fluid sensing with smart solutions for safe preparation and delivery of IV medications
- Company 900 - Electrical stimulators via electrode garments for the treatment of pain related to chronic/acute soft tissue injuries
- Company 901 - Non-invasive neuromodulation technology platform to therapeutically address several major areas of disease; the Company's lead indication is Parkinson's Disease (PD)
- Company 902 - Surgical instrument designed to solve recurrent problems in managing sutures, tissue reattachment, and visualization during surgical procedures
- Company 903 - Nanolayer surface technology to improve the osteoconductive/bio-resistant/anti-infective attributes of implants
- Company 904 - Ultrasound-guided cryothermally enhanced devices used to facilitate the site-specific C(2) (Cryo-Chemo) Cancer Ablation Procedure, which delivers newly developed proprietary therapies to cancer sites while avoiding toxic side effects
- Company 905 - The NuLens(TM) Dynacurve IOL is an implantable, flexible lens that changes it curvature in response with the movements of the eyes accommodative muscle system
- Company 906 - Systems to diagnose neurological and sleep disorders
- Company 907 - Technology that precisely eliminates irregularly shaped/invasive solid tumors while avoiding significant damage to surrounding healthy tissue and is non-toxic
- Company 908 - Extracellular matrix (ECM) implant that is completely integrated, remodeled, and replaced by the patient's native tissue over time
- Company 909 - Non-surgical/injectable tissue revitalization and stabilization to address lower back pain (LBP) and the underlying problem of mechanical insufficiency
- Company 910 - 1-System for remote home patient monitoring of glucose, blood pressure, and thermal weight, 2-Glucose meter cell phone
- Company 911 - 1-A proprietary non-invasive ophthalmic diagnostic device designed to quickly detect elevated advanced glycosolated end products (AGEs) for very early detection of diabetes and 2-A rapid non-invasive, ophthalmic-based glucometer for painless and convenient measurement of glucose levels
- Company 912 - Implantable replacement valve to treat incompetent deep vein valves causing degenerative pain, swelling, and non-healing ulcers associated with chronic venous insufficiency (CVI)
- Company 913 - Advanced blood purification to reduce cytokine storm and inflammation that leads to multi-organ failure in sepsis and other critical care diseases
- Company 914 - Next-generation anatomic pathology (AP) with improved speed, automation, and ease-of-use
- Company 915 - Injectable biopolymer for the direct treatment of acute myocardial infarction (AMI)
- Company 916 - Endoear(R) is the world's first implantable hearing device of its kind, created for the treatment of mild to moderate hearing loss
- Company 917 - Wireless device for the treatment of stress/urge/mixed urinary incontinence (UI)
- Company 918 - Communication device that acquires neurological signals from the brain and translates them into speech
- Company 919 - Visually guided catheter ablation for atrial fibrillation
- Company 920 - Next-generation vessel closure
- Company 921 - Pneumatic compression devices targeted to the lymphedema, venous insufficiency, and sports medicine markets
- Company 922 - Technology that enables the "packaging" of chronic therapies/biologics in an easy-to-use, disposable patch-like device
- Company 923 - Instrumentation that provides surgeons with real-time sensing/feedback from the operative site
- Company 924 - Lab-free salt intake monitor for hypertension/congestive heart failure (CHF) patients
- Company 925 - Endoscopically placed device for the treatment of obesity
- Company 926 - Minimally invasive radiofrequency (RF) device to treat aging skin
- Company 927 - Optical biopsy needle that will accurately diagnose prostate cancer, yet eliminate random prostate biopsies
- Company 928 - New holding company for various orthopaedic device companies, such as Enztec and OMNI life science
- Company 929 - Catheters for dissolving/removing cerebral blood clots then delivering therapeutics to the diseased site
- Company 930 - Targeted molecular assays for onco-diagnostics/personalized medicine
- Company 931 - Biomarker discovery platform for detecting Type 2 Diabetes, Prostate Cancer, and Amyotrophic Lateral Sclerosis (ALS, aka Lou Gehrig's disease)
- Company 932 - Molecular diagnostic technologies for organ transplantation and various complex genetic disorders
- Company 933 - Non-invasive breast cancer diagnostic test via breast fluid analysis
- Company 934 - Non-invasive vascular disease detection that combines the advantages of MRI with the temporal resolution and ease-of-use of ultrasound
- Company 935 - Endoscopic/removable device that mimics the effects of gastric bypass surgery on a patient's metabolism
- Company 936 - "Smart" cells than can determine the type of disease/injury present in the body and repair/regenerate tissue accordingly
- Company 937 - Imaging systems for the non-invasive, in vivo detection of cancerous and pre-cancerous lesions
- Company 938 - Microarray-based technology enabling targeted next-generation sequencing of genomic regions of interest
- Company 939 - Minimally invasive therapy for Emphysema
- Company 940 - Comfortable, soft, and pliable cloth mask for the treatment of obstructive sleep apnea
- Company 941 - Wearable neuroimaging cap for mapping brain function
- Company 942 - Computer-controlled rehabilitation table for the management of lower back pain
- Company 943 - 1-Bioactive/conductive polymer materials and coatings for implantable biomedical devices and 2-Next-generation all-polymer leads that may be grown in the body
- Company 944 - Non-invasive tests to detect fetal chromosomal abnormalities
- Company 945 - Devices to treat low back pain
- Company 946 - Wearable sensor technology that safely and accurately measures individual sleep patterns
- Company 947 - Vascular navigation system designed to more accurately and rapidly position venous catheters (CVC and PICC)
- Company 948 - Minimally invasive breast tumor diagnosis and treatment
- Company 949 - Lightweight, waterproof, medical alert pendant for seniors - to avoid the dangers of missed medications
- Company 950 - Non-invasive DNA-based prenatal diagnostic test
- Company 951 - Heart pump technologies
- Company 952 - DNA sequencing technology for the detection of biomarkers for infectious and other diseases
- Company 953 - Computer-assisted surgical devices for total joint replacement
- Company 954 - Diagnostic and therapeutic ophthalmic devices
- Company 955 - Nanomaterials for angiogenesis/anti-angiogenesis/diagnostic applications
- Company 956 - Non-invasive neurostimulation device to restore vision to patients suffering from stroke, traumatic brain injury (TBI), dry age-related macular degeneration (AMD), and glaucoma
- Company 957 - Surgical/restorative dental implants
- Company 958 - Molecular diagnostic/prognostic tests for cancer
- Company 959 - Device to treat osteoarthritis
- Company 960 - Minimally invasive implant for treating spinal stenosis
- Company 961 - Non-polymeric drug-eluting stent (DES)
- Company 962 - Variety of diagnostic tests for infectious diseases, cardiology, hepatology, and various cancers
- Company 963 - Non-woven fabric with extended shelf-life to restore/repair tissue function
- Company 964 - Device for removing uterine fibroids without hysterectomy
- Company 965 - ALIVIOS Intelligent Eyewear enables people challenged with low vision to do more, including the ability to zoom in and out, improve brightness and contrast of whatever they are looking at, and even quickly store visual information for a closer look later
- Company 966 - Diagnostic retinal imaging system for use in the primary care setting
- Company 967 - The Unyvero(TM) System is a novel high-multiplex MDx/IVD platform for severe infectious disease (Pneumonia Application has 39 analytes: 17 pathogens, 22 antibiotic resistance markers)
- Company 968 - Inferior vena cava (IVC) filter that includes: 1-automatic self-centering, 2-bi-directional deployment and retrieval, 3 -atraumatic design, and 4-total transluminal filtration
- Company 969 - Compliant balloon platform technology for use in neuroradiology, cardiovascular, and peripheral vascular applications
- Company 970 - Mechanical thrombectomy device to treat ischemic stroke
- Company 971 - Artificial heart technologies
- Company 972 - Cancer diagnostic test which enables the development of personalized therapeutics
- Company 973 - Bone graft material that is: 1- synthetic, 2-non-immunogenic, 3-inclusive of all bone regenerative properties of an autograft, and 4-cost-effective
- Company 974 - Portable/rapid cooling technologies via the nasal cavity to improve patient outcomes after cardiac arrest, stroke, or traumatic brain injury (TBI)
- Company 975 - Tests for the diagnosis/prognosis of cardiovascular disease
- Company 976 - Cost-effective solutions for the improved detection and prevention of cancer in the gastrointestinal (GI) tract
- Company 977 - Neuromodulation for hypertension/heart failure
- Company 978 - System to repair abdominal aortic aneurysms (AAA)
- Company 979 - Endoscopic device to treat sinusitis
- Company 980 - Drug delivery platform that releases a cocktail of therapeutic proteins in response to a variety of local and systemic inflammatory and ischemic diseases
- Company 981 - Aortic embolic protection device for acute and long-term use
- Company 982 - Autologous adult stem cell technology, cultured from the nasal passageway, to repair damage resulting from spinal cord injury
- Company 983 - 1-Minimally invasive treatment of spinal compression, 2-Minimally invasive treatment of long bone factures, 3-Neuromodulation catheter that can be introduced into the spinal canal to treat pain
- Company 984 - Next-generation needleless drug delivery
- Company 985 - Minimally invasive neurosurgical and orthopedic instruments and implants
- Company 986 - Tissue fusion via infrared laser to replace sutures
- Company 987 - Ultrasound system that can measure true tissue elasticity in a reproducible/quantifiable/user-independent manner
- Company 988 - Next-generation nanostructured capacitors for: 1-implantable cardiac defibrillators (ICD) and 2-microsteerable cardiac ablation and related catheters
- Company 989 - Minimally invasive spine implant (facet versus pedicle screw)
- Company 990 - Spine implant that allows for post-operative adjustment of the implant size via radio control
- Company 991 - Spine fusion implant for motion preservation/dynamic stabilization
- Company 992 - Next-generation medical devices with anti-fouling surface modifications that reduce the risk of complications over long durations
- Company 993 - Device for the treatment of benign prostate hypertrophy (BPH), prostatitis, erectile dysfunction (ED), lower urinary tract symptoms, and infertility
- Company 994 - Andara technology for the treatment of acute spinal cord injury
- Company 995 - Polymer implant to repair meniscal tears via tissue regeneration
- Company 996 - Electrodes/neural interface products for functional neurosurgery and neurostimulation
- Company 997 - Non-systemic/non-invasive system that delivers magnetic versus electrical pulses for the treatment of depression
- Company 998 - Implantable neuromodulation device designed to electrically alter the pain signal pathways
- Company 999 - Next-generation implants, stem cell enabling technology, and other minimally invasive surgical instruments
- Company 1000 - Invisible hearing device
- Company 1001 - Cooling and compression therapy for the relief of pain/swelling after orthopedic/other surgery
- Company 1002 - Catheter insertion systems, designed for extended IV dwell time, to eliminate the risk of related bloodstream infections
- Company 1003 - A rapid, monthly test that uses glycated albumin to monitor gestational and type 2 diabetes more effectively
- Company 1004 - Products for surgical RF ablation, valve replacement or repair, and coronary artery bypass (CABG) grafting
- Company 1005 - Biomaterial with exceptional hardness/low friction/bio-inertness that also prevents the leaching of metallic ions into the body
- Company 1006 - Disposable and needleless patch that can be placed on the body inconspicuously for insulin delivery - an alternative to daily insulin injections
- Company 1007 - Small shunt-like device implanted into the bloodstream to modify, collect, or eliminate a broad range of Target Cells
- Company 1008 - Artificial heart made of biosynthetic tissues, with two-pumps
- Company 1009 - Permanently implantable/wireless/miniature sensors to transmit cardiac output, blood pressure, and heart rate data
- Company 1010 - Fully implantable device for the treatment of central sleep apnea in heart failure patients
- Company 1011 - Heart valve implant
- Company 1012 - AdaptDx - A novel diagnostic instrument that can detect and track age-related macular degeneration (AMD) from its beginning stages, allowing for early intervention
- Company 1013 - Nanotechnology-based liquid that absorbs energy on a near-molecular scale versus relying on the mechanical properties of solid materials
- Company 1014 - Cyanoacrylate-based products for wound care and infection prevention
- Company 1015 - Femtosecond pulse laser system for various ophthalmic applications
- Company 1016 - Technology that uses the patient's own blood to make either: 1-A surgical sealant to prevent/stop bleedings or 2-A gel to stimulate the healing of chronic wounds
- Company 1017 - Real-time/multi-user image communication/collaboration system that consolidates images and text records into a single point of access
- Company 1018 - Polymer-based/biodegradable/drug-eluting peripheral vascular stent for tibial and infrapopliteal arteries
- Company 1019 - Ultrasound-based diagnostic biosensor that enables blood analysis at the molecular level for the patient self-testing market
- Company 1020 - Non-invasive biomechanical diagnostic system that records/analyzes range of motion (ROM) in a full 3-D environment for musculoskeletal diagnostics/therapeutics
- Company 1021 - Full Sense(TM) Bariatric Device which is implanted and extracted via endoscopy and causes satiety leading to weight loss
- Company 1022 - Continuous glucose monitoring specifically for use in the Intensive Care Unit (ICU)
- Company 1023 - Real-time interactive training visualization system, specifically for the task of training any designated personnel in successfully accomplishing a limited "focused assessment with sonography for trauma" (FAST) examination
- Company 1024 - Molecular diagnostic tests to: 1-Differentiate between squamous and non-squamous non-small-cell lung cancer, 2-Differentiate between mesothelioma and adenocarcinoma, 3-Identify more than 20 types of cancer
- Company 1025 - Nasal stent to treat obstructive sleep apnea
- Company 1026 - 1-Pacing/sensor-enabled device for Cardiac Resynchronization Therapy (CRT), 2-Real-time modality to quantify cardiac performance, 3-System that adds ingestible microchips to drugs
- Company 1027 - Pocket-sized, affordable, and easy-to-use resuscitation devices that can be effectively deployed by both trained professionals and laymen
- Company 1028 - Wearable health monitoring system for potential diabetes, heart disease, and sleep apnea applications
- Company 1029 - Biomarkers for the screening and diagnosis of cervical and other cancers
- Company 1030 - Implantable vagus nerve stimulation system for the treatment of tinnitus and post-stroke motor rehabilitation
- Company 1031 - Smart, accurate guiding device based on image technology for orthopedic trauma procedures such internal fixation with intramedullary (IM) nails, osteotomy, and others
- Company 1032 - Non-invasive molecular diagnostics for autism, chronic obstructive pulmonary disease (COPD), multiple sclerosis, and diseases with a genetic susceptibility
- Company 1033 - Natural polymer technology that mimics the physiological clotting cascade without reliance on blood-derived proteins - to stop severe bleeding, reinforce staple and suture lines, and repair tissues
- Company 1034 - Effective and convenient phototherapy system available for in-home treatment of scalp/small-area psoriasis and other photo-responsive skin diseases
- Company 1035 - Electroporation-delivered/DNA-based vaccines against cancers and infectious diseases
- Company 1036 - Next-generation computer-assisted laparoscopic tool composed of multiple rigid elements with intervening controllable joints
- Company 1037 - Novel, POC diagnostic instrument that rapidly diagnoses blood coagulation defects based on sonorheometry - a patented ultrasound-based technology that is faster, easier to operate and interpret, and cheaper than competing technologies
- Company 1038 - Fluorescent markers/optical sensors that provide an accurate and rapid determination of kidney function
- Company 1039 - Ready-to-market medical device for assessing - via the eye - exposure to neurotoxins, cyanide, and low level radiation. Future products include assessment of mild TBI and other health conditions, including diabetic diseases of the eye.
- Company 1040 - The SatiSphere System is a non-invasive obesity device that safely and effectively uses the body's natural physiology to treat obesity by regulating satiation mechanisms, slowing digestion, and discouraging excessive eating
- Company 1041 - Catheter ablation for the treatment of cardiac arrhythmias
- Company 1042 - Monitoring products/clinical services for advanced ambulatory cardiac monitoring
- Company 1043 - Technology used in: 1-Finished products designed for micro-surgical/microscopy procedures and robotics and 2-Biosensors with applications in gene expression, neuroscience, and nanotechnology
- Company 1044 - Resorbable hydrogel that 1-Seals annular tears in the intervertebral disc and 2-Provides an environment for nucleus regeneration
- Company 1045 - Non-invasive/fast/easy-to-use/reliable medical devices that test for neuro-visual disorders
- Company 1046 - High-dose drug delivery system for the minimally invasive and repeatable treatment of liver cancers, colorectal cancer, and hepatitis
- Company 1047 - Technologies that integrate bone and cartilage forming peptide and small molecule therapies with osteostimulating matrices
- Company 1048 - A non-invasive, safe cardiac diagnostic system that in a 10-minute test reliably detects existence or absence of ischemia and monitors treatment efficacy
- Company 1049 - Injectable porous scaffolds/spheres/composites with fully interconnected pores, for multiple applications
- Company 1050 - Compact, remote, wireless, real-time device for biomedical monitoring such as cardiac, neurological, sleep disorder, obstetrics, orthopedic, and other vital signs outside the hospital/clinic
- Company 1051 - Permanent implant to address mitral regurgitation directly
- Company 1052 - Portable/lab-quality diagnostics for the ER/ambulance/physician's office/home/field
- Company 1053 - Percutaneous injection treatment for patients with internal disc derangement (IDD) who have failed conservative care/are not yet candidates for total disc replacement (TDR)/spinal fusion
- Company 1054 - Technology that allows surgeons to rapidly treat tissue at the surgical site/reduce blood loss
- Company 1055 - A1c diabetes testing at the point of care, with results in under 4 minutes
- Company 1056 - Next- generation/predictive blood tests to help warn of potential future health problems
- Company 1057 - Vertebral compression fracture treatment
- Company 1058 - Orthopedic imaging
- Company 1059 - 1-Artificial vascular graft with self-sealing, non-woven, synthetic fiber structure, 2-Ventral hernia mesh
- Company 1060 - 1-Prohealing coronary stent as an alternative to drug-eluting stents (DES), 2-Balloon -expandable/crush-resistant nitinol peripheral stent, 3-Nano-based transcatheter, 4-Anatomy-specific combination embolic protection and stent delivery systems, 5-Localiz
- Company 1061 - Early detection of Alzheimer's disease via an eye drop and laser eye scan
- Company 1062 - Drug-coated balloon angioplasty technology
- Company 1063 - Behavioral remote patient monitoring system that uses wireless sensors to non-intrusively track and report on the daily patterns of seniors' activities
- Company 1064 - System that assesses, then provides therapy to develop infant feeding skills
- Company 1065 - Painless, continuous glucose monitoring
- Company 1066 - Wireless/wearable/ultra-compact device that automatically tracks/wirelessly uploads data about a person's activities (exercise intensity levels, calories burned, sleep quality, steps, distance)
- Company 1067 - Joint reconstruction device that ideally/anatomically matches the size/shape of the facet joint
- Company 1068 - Platforms for: 1- Pedicle screw fixation (even with poor bone quality), 2-Vertebral compression fractures, 3-Simple- to-use trauma products
- Company 1069 - Implantable device for maintaining adequate blood flow to the brain in patients experiencing a buildup of excess cerebral spinal fluid (CSF) due to trauma
- Company 1070 - 1- Straightforward knotless suture anchor, 2-Instrumentation for percutaneous suture management, 3- Endotendonous repair system, 4-Shape memory staples
- Company 1071 - Coagulation analyzer to eliminate unnecessary blood transfusions
- Company 1072 - Simple, rapid, blood-based cancer tests to provide accurate and individualized clinical information on disease status/treatment selection/treatment response
- Company 1073 - Neurostimulator for cardiac contractility
- Company 1074 - Endoscopically delivered devices focused on slowing gastric emptying, to treat all stages of obesity
- Company 1075 - Autonomic nervous system stimulation for pulmonary and headache disorders
- Company 1076 - Optimization of T cell receptors (TCRs) for use in adoptive T cell therapy - to target and destroy cancerous/infected cells
- Company 1077 - Technology for wound care and slow release drug delivery, by both transdermal and subcutaneous routes
- Company 1078 - Intraoperative wavefront aberrometer for use in intraocular lens replacement surgeries
- Company 1079 - Technology to treat atrial fibrillation that allows doctors to perform radiofrequency ablation under direct visualization
- Company 1080 - Tests to "predict" chronic diseases/conditions, such as diabetes/osteoporotic bone fracture/a major cardiac event
- Company 1081 - Disposable/miniature/minimally invasive surgical devices including reusable endoscopes for visualization, initially for use in spinal surgeries
- Company 1082 - Dental implant that can be placed into a multi-rooted molar extraction site "immediately"
- Company 1083 - Biocompatible and biodegradable synthetic scaffold to aid soft tissue regeneration of the anterior cruciate ligament (ACL) of the knee
- Company 1084 - Ingestible/wireless capsule with sensor technology to measure pH, pressure and temperature from within the entire GI tract
- Company 1085 - Counter-stimulation technology to treat Restless Legs Syndrome (RLS)
- Company 1086 - Minimally invasive device to treat emphysema
- Company 1087 - Gene expression test for the diagnosis of ambiguous tumors
- Company 1088 - Non-invasive, rapid, quantitative measurement of metabolic health of the retina using a novel spectroscopic biomarker
- Company 1089 - Implantable neuromodulation device for the treatment of chronic pain and future applications
- Company 1090 - Home-use devices for hair removal/acne/skin rejuvenation
- Company 1091 - Technology that restores natural physiologic outflow as a foundation of significant/steady/sustained glaucoma management
- Company 1092 - Minimally invasive surgery system for simpler and safer soft-tissue suturing/fastening
- Company 1093 - Effective/consistent/non-invasive neuromodulation for the treatment of urinary incontinence and future applications
- Company 1094 - 1-Needleless mesotherapy to treat cellulite, 2-Non-invasive/non-thermal treatment for skin laxity/hypertrophic scars/striae
- Company 1095 - Laparoscopic instruments that articulate/rotate/lock for single port access/"scar-less" surgery
- Company 1096 - Miniature implantable sensors to accurately/continuously pinpoint the location of tumors in real-time, during radiation therapy delivery
- Company 1097 - Manual rongeur and access tools for use in spinal decompression procedures
- Company 1098 - Convenient/improved continuous glucose monitoring system
- Company 1099 - Coating that triggers the body to generate nitric oxide (NO) at the device surface, by using naturally circulating blood substances
- Company 1100 - Real-time/in vivo/cellular-level/3-D imaging for: image-guided surgery; early cancer diagnosis without a biopsy
- Company 1101 - In vivo transdifferentiation to regenerate ischemic/diseased organs
- Company 1102 - Technology that has demonstrated its usefulness in tracking all facets of in vivo oxygen metabolism using normally installed MRI scanners
- Company 1103 - True seizure "prediction" - up to an hour before the event
- Company 1104 - Wearable mobile device to accurately measure real-time energy (calorie) expenditure/combat obesity
- Company 1105 - 1-Non-embryonic cell technology that creates cells/tissues/organs for virtually anyone needing a transplant, 2-Non-toxic cancer vaccine that uses the body's natural immune response to fight cancer, 3-Cell separation system to diagnose/monitor cancer
- Company 1106 - Custom miniaturized mechanical components/devices for a broad range of medical device applications
- Company 1107 - Wireless/disposable sleep-monitoring device
- Company 1108 - 1-Next-generation, natural fibrin sealant, 2-Human thrombin
- Company 1109 - In vivo smart sensor to help women get pregnant, automatically detecting pregnancy and any early pregnancy loss, and screening for cervical cancer and other STDs, with additional uses central to women's health & lifestyle
- Company 1110 - Technologies that focus on wound diagnostics, infection control, and wound therapy
- Company 1111 - Wireless/MEMS-fabricated/nano-processed/dermal/percutaneous continuous glucose monitoring device
- Company 1112 - Diagnostic instrument to measure the material properties of bone
- Company 1113 - Electronic Brachytherapy (eBx) systems based upon miniaturized x-ray tube technology for the practice of radiation oncology in virtually any clinical setting, eliminating the need for heavily shielded environments
- Company 1114 - Minimally invasive method for lumbar spine decompression to treat patients with lumbar spinal stenosis (LSS), which may be performed in conventional operating rooms or interventional radiology suites with fluoroscopic imaging
- Company 1115 - Next-generation respiratory device that delivers synchronization of flow/temperature/humidity/oxygen percentage, without discomfort, via nasal cannula
- Company 1116 - Minimally invasive system to treat emphysema and resolve prolonged air leaks following lung surgery
- Company 1117 - 3-D mesh pouches that are implanted empty, positioned, filled, then deployed to their full size for spinal/orthopedic applications
- Company 1118 - Painless photo-pulsation technology for diminishing fine lines/wrinkles/age spots on the face/neck/hands
- Company 1119 - Plastic surgery implantable devices for cosmetic and reconstructive surgery
- Company 1120 - The SENSIMED Triggerfish(R) "eye-Holter" is a paradigm-changing technology consisting of a disposable contact lens telemetric sensor, which for the first time provides ophthalmologists with the full ambulatory 24-hour IOP profile, conveniently and during uninterrupted daily activities and sleep
- Company 1121 - Technology for the non-fusion treatment of scoliosis
- Company 1122 - Atraumatic injectable plugs for 1-Temporary occlusion of blood vessels, 2-Kidney stone removal, and 3-future applications
- Company 1123 - Percutaneously deliverable endograft to treat Abdominal Aortic Aneurysms (AAA) and Thoracic Aortic Aneurysms (TAA)
- Company 1124 - Optical Coherence Tomography (OCT) for sub-surface biological tissue imaging at much greater resolution than ultrasound/MRI/CT scanners
- Company 1125 - Next-generation femtosecond laser that can operate inside the eye to make cataract surgery safer/more effective
- Company 1126 - Totally implantable pumps delivering targeted medications directly to the spinal cord
- Company 1127 - Point-of-care diagnostic tests for infectious diseases capable of detecting virulence markers produced only during ACTIVE infections
- Company 1128 - Therapeutic gene delivery
- Company 1129 - 1-Vertebral augmentation system and 2-On-demand ultra-high viscosity cement injection, for spinal applications
- Company 1130 - Miniature implantable neurostimulator for treating central nervous system disorders
- Company 1131 - Simple, point-of-care blood test for the detection/monitoring of traumatic brain injury (TBI)
- Company 1132 - Resurfacing system to treat lesions/defects in the body's weight bearing, non-weight bearing, and extremity joints
- Company 1133 - Molecular imaging of apoptosis (programmed cell death) for disease detection/monitoring
- Company 1134 - Technology to close incisions made during Natural Orifice Transluminal Endoscopic Surgery (NOTES) procedures
- Company 1135 - Transitional in vivo imaging
- Company 1136 - Collapsible titanium-alloy implant for spinal fusion
- Company 1137 - Non-invasive type 2 diabetes and pre-diabetes screening with no blood draw/no fasting/no waiting for a lab result
- Company 1138 - Devices for the destruction of pathogens responsible for: heart/blood/respiratory/gastrointestinal/periodontal/otological diseases, pancreatic cancer, and toe nail fungus
- Company 1139 - Device that delivers a low-level/precisely controlled heat for the treatment of acne
- Company 1140 - Nanomaterial-based MRI coil for higher image quality/faster scan times
- Company 1141 - Handheld/at-home hair removal via laser
- Company 1142 - Enhanced diabetes insulin pump
- Company 1143 - Transpedicular/minimally invasive approach to vertebral body reconstruction/anterior spinal column support
- Company 1144 - Next-generation Spinal Cord Stimulation (SCS) technology to treat chronic back/lower extremity pain
- Company 1145 - Dynamic and intelligent optics for use in spectacle lenses for the correction of presbyopia
- Company 1146 - Blood screening tests for breast and ovarian cancers
- Company 1147 - Implantable/battery-less diagnostic system to allow orthopedic surgeons to monitor spinal fusion progress
- Company 1148 - Next-generation coatings/advanced drug-delivery systems for cardiovascular stents and other implantable medical devices
- Company 1149 - Pressure-controlled Intermittent Coronary Sinus Occlusion (PICSO) device for acute coronary syndrome (ACS) and heart failure patients
- Company 1150 - Ultra-thin/personalized/single-use/flexible/transdermal drug delivery patch
- Company 1151 - DNA-based diagnostic tests for early identification/management of cancer/acute diseases
- Company 1152 - Device with bio-active formulae to rapidly/painlessly treat/control the wound environment
- Company 1153 - Less invasive treatment for chronic sinusitis delivered via non-nasal access
- Company 1154 - Leadless/implantable pacing device for left ventricular stimulation/the treatment of heart failure
- Company 1155 - Technologies to acquire/process/visualize data from 3-D breast imaging
- Company 1156 - Mental stimulation system to help maintain mental acuity/quality of life
- Company 1157 - Implantable device to treat high blood pressure that cannot be controlled with medications/lifestyle modifications
- Company 1158 - Polymer technologies for cardiac/cranio-maxillofacial/orthopedic surgery applications
- Company 1159 - Leadless/subcutaneously implantable cardiac defibrillator (ICD)
- Company 1160 - 1-Handheld intelligent bone sculpting tool, 2-X-ray vision that appears "within" the patient
- Company 1161 - Synthetic peptides for tissue regeneration for the treatment of musculoskeletal/vascular/chronic wound diseases
- Company 1162 - Radiofrequency (RF) energy to reshape the cornea without incision
- Company 1163 - Endovascular treatment of peripheral arterial blood vessels that require re-vascularization
- Company 1164 - Cells derived from bone marrow which can be used in an allogeneic/off-the-shelf setting to treat kidney/other difficult to treat diseases
- Company 1165 - Thin-walled/removable/entirely covered stents designed to match the site to be treated and the surrounding anatomy
- Company 1166 - Technologies to: 1-Treat the progression of age-related macular degeneration (AMD) and retinitis pigmentosa (RP), 2-Stop/reverse some of the vision loss from Glaucoma, 3-Prevent diabetic retinopathy, 4-Greatly enhance pars plana vitrectomy surgery
- Company 1167 - Single device for high-frequency ultrasound imaging/therapeutic treatment
- Company 1168 - Low-level laser technology for aesthetics, bone healing, neck/shoulder pain, and wound healing
- Company 1169 - Light-based aesthetic systems that are pain-free/seven times faster than existing systems
- Company 1170 - 1-Image analysis technology for virus detection/analysis, 2-Antiviral drugs
- Company 1171 - Simultaneous testing of sobriety and identy that is simple/rapid/non-invasive, requiring no bodily fluids
- Company 1172 - Technology for diagnosing breast and ovarian cancers and determining responsiveness to new therapeutics
- Company 1173 - Synthetic graft/stent technology that reduces neo-intimal hyperplasia (NIH) and occurrence/rate of restenosis
- Company 1174 - Disposable endoscopic assist device that can be used with existing equipment to significantly improve flexible endoscopy procedures
- Company 1175 - Systems using radiofrequency (RF) energy for the treatment of GERD and fecal incontinence (FI)
- Company 1176 - Sutureless anastomosis systems to reduce/eliminate cross clamping time and suturing during minimally invasive surgery (MIS)
- Company 1177 - Anti-infective compounds designed to mimic host defense proteins, but with completely synthetic/non-peptide backbones, for serious, life-threatening, acute disorders
- Company 1178 - Minimally invasive interstitial laser therapy (ILT) as an alternative to lumpectomy
- Company 1179 - Less invasive approach for mitral valve repair, on a beating heart
- Company 1180 - High-resolution dermoscopy imaging technology to identify melanoma at an earlier stage/reduce the number of unnecessary excisions
- Company 1181 - Nanotechnology surface treatments for combination medical devices that address nosocomial (in-hospital) infections and thrombus
- Company 1182 - Non-invasive, fully automated system for the accurate assessment of: cardiovascular/diabetic autonomic neuropathy, effectiveness of beta-blocker therapy, and risk stratification of sudden cardiac death
- Company 1183 - Wireless/motorized orthopedic lengthening implants for applications in deformity correction/cosmetic limb lengthening/bone fractures
- Company 1184 - 3-D scaffold that enhances the biointegration of percutaneous/fully implanted current and next-generation devices
- Company 1185 - Injectable gels for localized and controlled release of biologicals
- Company 1186 - Portable/palm-held endoscopic imaging with a mobile platform for recording/sharing/archiving images
- Company 1187 - Hand-held ultrasound device to quantify strain and stiffness of tendons/ligaments
- Company 1188 - Lightweight brace support suit that restores mobility function for paraplegics/lower limb paralysis patients
- Company 1189 - Non-invasive gene expression-based tests for the monitoring of transplant rejection/autoimmune diseases
- Company 1190 - Cobalt-chromium, balloon-expandable stent, which marries with approved DES to treat the entire spectrum of coronary artery bifurcation lesions
- Company 1191 - Non-invasive intracranial pressure monitor to diagnose/treat head injury
- Company 1192 - Temperature-controlled/multi-functional next-generation cutting/sealing product
- Company 1193 - Interspinous/interlaminar functionally dynamic stabilization device and other non-fusion scoliosis technologies
- Company 1194 - CO2 lasers through flexible/rigid endoscopes for use in minimally invasive surgery and soft tissue procedures in otolaryngology/head and neck surgery/pulmonology
- Company 1195 - Real-time/PCR-based molecular diagnostic tests for life-threatening respiratory fungal infections
- Company 1196 - Ultra-lightweight/soft/non-palpable mesh technology to treat urinary stress incontinence/pelvic organ prolapse
- Company 1197 - Medipacs first-ever, solid-state polymer pump platform is the "end-game" for low cost, high precision drug delivery solutions and it will spawn electronic syringe products that reformulate markets
- Company 1198 - Surgical implants and biological products for spinal surgery
- Company 1199 - In situ formed hydrogels designed/indicated for ophthalmic surgery
- Company 1200 - Light-activated glue system to stabilize shattered bone
- Company 1201 - Non-contact imaging system that provides local anatomical and oxygenation information
- Company 1202 - Affordable/good quality standard-of-care surgical devices
- Company 1203 - Low-dose-rate brachytherapy that will replace individual seeds and provide more uniform/consistent radiation delivery to patients
- Company 1204 - Recombinant adeno-associated viral (AAV)-based gene therapy as a treatment for congestive heart failure (CHF)
- Company 1205 - Aortic valve bypass graft system for use as a minimally invasive, beating heart alternative to traditional aortic valve replacement therapy
- Company 1206 - Single-use catheter device w/controller that delivers radiofrequency energy during outpatient bronchial thermoplasty for the treatment of asthma
- Company 1207 - Ultrasonic energy for the selective dissection/fragmentation/debridement/cleansing of tissues
- Company 1208 - Percutaneous soft tissue lifts for the breast/neck/other soft tissue structures
- Company 1209 - Bioresorbable polymer surgical implants designed to prevent/reduce the formation of post-operative adhesions
- Company 1210 - Implanted electronic subretinal device to restore vision to those who are blind due to retinitis pigmentosa (RP) or age-related macular degeneration (AMD)
- Company 1211 - Noninvasive tests for the risk assessment of cardiovascular disease and the detection of early-stage lung/breast/colorectal cancer
- Company 1212 - Guidewire system intended to safely/quickly cross occluded peripheral and coronary vessels
- Company 1213 - Matrix therapy based technology that treats skin ulcers/reduces amputation
- Company 1214 - Artificial muscle technology for the treatment of sphincter dysfunction and urinary incontinence (UI)
- Company 1215 - Technology that selectively treats only cancer cells and avoids destruction of normal cells
- Company 1216 - Full line of precision-crafted/disposable/ultra-minimally invasive surgical instruments
- Company 1217 - Beam steering/target tracking/treatment planning solutions to the external beam radiation therapy market
- Company 1218 - Device that uses combined electric field and low-intensity, noninvasive ultrasound for the treatment of solid tumors without the need for chemotherapy
- Company 1219 - 1. Vascular staplers for open surgery of abdominal aortic aneurysms (AAAs) or aorto-biliac/femoral bypasses 2. Endovascular staplers for fixation of any current stent-grafts 3. Staplers for Critical Limb Ischemia surgery, aiming to replace Femoro-Popliteal bypasses
- Company 1220 - Stent to treat cerebral/aortic aneurysms by modulating hemodynamic flow
- Company 1221 - Biomotion sensors that enable easy/non-contact capture of high-quality physiological data - remotely/wirelessly
- Company 1222 - Flexible/single-use/sterile video-endoscopes which may be used at the patient bedside and which avoid all cross-contamination risks
- Company 1223 - Therapeutic gene delivery to treat diabetes/obesity/intestinal disorders/hemophilia/anemia
- Company 1224 - Non-invasive technique for sampling the surface layers of the skin to generate individual genetic profiles for diagnostic/prognostics
- Company 1225 - Non-invasive method designed to only kill fat cells and not harm the skin or other tissue
- Company 1226 - 3-D/single-piece/dual optic accommodating intraocular lens (IOL)
- Company 1227 - Cellular therapy to act directly at the level of the cause of autoimmune disorders, the dysregulated immune regulation
- Company 1228 - Next-generation transluminally placed endovascular grafts for the treatment of aneurysmal disease in the AAA/TAA
- Company 1229 - The first tomographic, real-time, high-resolution imaging system for pulmonary disease management. The Tomophase OCTIS(TM) is being deployed in major hospitals worldwide.
- Company 1230 - Very strong/customizable/biomimetic/easily revisable artificial disc implant, requiring no assembly in situ
- Company 1231 - Diagnostic and therapeutic catheter-based devices for prevention/treatment of heart attacks caused by soft plaque
- Company 1232 - Advanced method of photocoagulation to provide more rapid, precise, and safe treatment for a variety of retinal conditions
- Company 1233 - Next-generation personal diagnostics for hematological malignancies/autoimmune disorders
- Company 1234 - Soft tissue repair/replacement, using proprietary chemistry and organic collagen matrices
- Company 1235 - Sirolimus-based product as a next-generation therapeutic for the treatment/prevention of wet AMD and the treatment of diabetic macular edema
- Company 1236 - Phototherapy/ultraviolet light to inactivate the organisms that cause nail infections
- Company 1237 - Technology enabling detection and monitoring wirelessly, remotely, and with no contact to the subjects; also through clothing/barriers
- Company 1238 - Biochips to identify gene expression patterns
- Company 1239 - Automated blood analysis at point-of-care
- Company 1240 - Applicator for breast brachytherapy that delivers targeted dose of radiation
- Company 1241 - MRI contrast agents to monitor the position/quantity of transplanted cells non-invasively in vivo
- Company 1242 - A soft tissue aperture fixation system for anterior cruciate ligament (ACL) reconstruction using the hamstring/other soft tissue grafts
- Company 1243 - Non-invasive/convenient measurement and monitoring of human hydration status, using saliva as a sample
- Company 1244 - Cryotherapy to ablate diseased tissue
- Company 1245 - Reliable/accurate/solid-state laser system for customized treatment of many vision disorders
- Company 1246 - Non-invasive/iontophoretic drug delivery system with broad applicability for treating serious ocular diseases
- Company 1247 - Electrical stimulation technology, along with single-use disposables, to restore continence control to individuals with abdominal ostomies and eliminate the need for traditional ostomy pouching systems
- Company 1248 - MRI-guided laser ablation system for targeted, minimally invasive, focal tumor therapy
- Company 1249 - Medical devices that enable earlier detection/minimally invasive treatment of lung cancer
- Company 1250 - Non-invasive devices for the treatment of superficial venous disease
- Company 1251 - High-quality low-cost spine implants
- Company 1252 - The CoolTools family of products, which target support/microcatheterization, local vascular drug delivery, and selective hypothermia for the treatment of ischemic brain injury (e.g., stroke, cardiac arrest, trauma)
- Company 1253 - Cardiac assist device for patients in moderate/severe long-term heart failure
- Company 1254 - Digital image acquisition, coupled with proprietary CAD decision-making algorithms, to provide an immediate/automated colposcopic evaluation
- Company 1255 - Robotic system for fabrication of nano-material based wound dressings, delivered on-demand, at the POC
- Company 1256 - Unique spine functional testing that delivers improved surgical outcomes
- Company 1257 - Electromagnetic thermal therapy to relieve pain/improve function in patients suffering from osteoarthritis
- Company 1258 - System to inactivate pathogens in all three major blood components: platelets/plasma/red cells
- Company 1259 - Therapeutic approaches to prevent the abnormal tissue growth that inhibits recovery from surgical procedures/impairs normal wound healing
- Company 1260 - Biocompatible shape memory polymers which can be programmed to change shapes/rigidity when an initiating stimulus is applied
- Company 1261 - A fully integrated, affordable, sample-to-result platform for rapid, accurate PCR-based detection/differentiation of infectious disease
- Company 1262 - Technologies that will prevent infection for many large patient populations
- Company 1263 - Light-activated drug therapy to transform cancer into a treatable chronic disease
- Company 1264 - 1-Percutaneous venous valve, 2-Inferior vena cava filter, 3-Multi-purpose/disposable laparoscopic scissor grasper, 4-Multi-sized/multi-stiffness guidewire
- Company 1265 - Non-invasive infrared imaging system for the early detection of breast cancer
- Company 1266 - Device for the treatment of sudden cardiac arrest for both in- and out-of-hospital markets
- Company 1267 - Line of antimicrobial coatings to prevent microbial colonization/biofilm formation of endotracheal tubes/other indwelling medical devices
- Company 1268 - 3-D tracking devices for use in surgical navigation and MIS
- Company 1269 - Implantable patient alerting system for the detection and prevention of heart attacks
- Company 1270 - Minimally invasive/RF nerve ablation to reduce of migraine headache pain
- Company 1271 - Less invasive devices for the treatment of glaucoma, intended to replace current therapies
- Company 1272 - Natural cell-based technologies to restore normal neuron function in the central nervous system
- Company 1273 - Non-invasive/urine-based diagnostic assays for specific cancer types
- Company 1274 - Fluid-controlled accommodating intraocular lens (IOL) to restore vision of youth to middle-aged/elderly individuals
- Company 1275 - Single, multi-cannula laparoscopic port and specially designed curved instrumentation
- Company 1276 - Technology that provides the precision of a scalpel and the bleeding control of traditional electrosurgery, without extensive collateral tissue damage
- Company 1277 - More viable/cost-effective method for treating intracranial aneurysms
- Company 1278 - System that enables consistent tissue contact/complete lesions during cardiac surgery for the treatment of arrhythmias
- Company 1279 - Non-invasive neurorehabilitation system
- Company 1280 - Cerebral protection system to prevent embolic strokes
- Company 1281 - Catheter-based drug delivery using high-frequency/low-power ultrasound
- Company 1282 - Technology for real-time identification/localization of cancer cell clusters to enable complete/residual-free therapeutic excisions
- Company 1283 - Third-generation cancer-associated biomarkers using proteomics
- Company 1284 - Cardiac mapping system that is non-invasive, maps the entire heart in one beat, and provides catheter localization
- Company 1285 - Repair and regeneration technology platforms designed to mend and regrow hard tissue (such as bone) and soft tissue (such as cartilage)
- Company 1286 - Minimally invasive/flexible spinal implant technology to treat vertebral compression fractures and degenerative disc disease
- Company 1287 - Catheter-based drug delivery system designed to dissolve blood clots in a single/rapid/one-step procedure
- Company 1288 - Rapid DNA-based point-of-care diagnostics
- Company 1289 - Joint prostheses as an adjunct to laminectomy/laminotomy/neural decompression/facetectomy, in lieu of fusion
- Company 1290 - Advanced trilobal pericardial valve technologies
- Company 1291 - Protective coatings for medical instrumentation to combat bacterial biofilms
- Company 1292 - Wireless ECG monitoring
- Company 1293 - De-cellularized biological scaffolds meant to function like native tissue
- Company 1294 - Non-invasive, wearable, watch-sized metabolism measurement system that employs the use of a low-cost proprietary disposable sensor using direct-calorimetry, to accurately measure minute-by-minute caloric expenditures
- Company 1295 - Advanced, intuitive real-time imaging for abdominal minimally invasive surgery
- Company 1296 - Technology that improves vascular access accuracy and visualization of veins and arteries as well as related vascular events such as rolled veins, bifurcations, vasospasm, and extravasation
- Company 1297 - Regenerative medicine company developing novel treatments from hair growth to cancer therapies based on the products of cells grown under simulated embryonic conditions
- Company 1298 - Next-generation cell-based/tissue-engineered products
- Company 1299 - Mesh wrap for permanent implantation around the heart to prevent/reverse the progression of heart failure
- Company 1300 - Handheld/breath-based blood glucose monitor
- Company 1301 - More targeted/accurate radiation of cancer cells with significantly fewer side-effects
- Company 1302 - Bioactive glass-ceramic material that offers whiter and less-sensitive teeth while protecting from tooth decay
- Company 1303 - Membrane optimization, coatings technologies, and development of polymers for biomedical applications
- Company 1304 - System to process/concentrate cellular components from autologous bone marrow, including adult stem cells, at the point-of-care and in just 15 minutes
- Company 1305 - Devices to control bleeding post-hysterectomy/in other cases of pelvic area trauma
- Company 1306 - Safe, non-invasive body shaping technologies
- Company 1307 - Non-invasive/fast/accurate diagnostic kits for: fertility, hormones, infectious agents, auto-antibodies, and tumor markers
- Company 1308 - Gene therapy products for the treatment of inherited/acquired diseases.
- Company 1309 - Stent technology for the treatment of atherosclerotic disease at/near bifurcations
- Company 1310 - Neo-organs/tissues derived from the patient's own (autologous) cells
- Company 1311 - Computer-controlled pressure garments for the effective treatment of lymphedema/chronic wound healing
- Company 1312 - Small/portable/disposable infusion pump kit to treat post-operative pain more effectively than narcotics
- Company 1313 - Pulsatile perfusion generator technology to greatly enhance the preservation time window and organ transplant quality
- Company 1314 - The Argus II Retinal Prosthesis System is the world's first and only CE marked retinal prosthesis that utilizes electrical stimulation to partially restore sight in patients blinded by outer retinal degeneration
- Company 1315 - Device to improve drainage following heart, lung, and trauma surgery, as well as other procedures where drainage is critical
- Company 1316 - Next-generation/fully-automated/electronically-controlled/self-contained blood glucose system
- Company 1317 - Minimally invasive system for treating long-bone fractures using an intermedullary stent/cement
- Company 1318 - Non-invasive measurement of magnetic fields to diagnose functional brain disorders
- Company 1319 - Products to diagnose/treat dry and wet age-related macular degeneration (AMD) and other chronic diseases involving the alternative complement system
- Company 1320 - Wearable artificial kidney device
- Company 1321 - Multi-generational devices using hybrid technologies for Natural Orifice Translumenal Endoscopic Surgery (NOTES) procedures
- Company 1322 - Miniature patch that dispenses insulin
- Company 1323 - Microcatheter and imaging technologies for interventional ophthalmology
- Company 1324 - Easy, safe, and convenient injection of drugs and vaccines in a solid dosage form using the Glide SDI(R) (Solid Dose Injector)
- Company 1325 - Non-epigenetic cell reprogramming technology that enables the generation of patient-identical replacement tissue/organs on an as-needed basis
- Company 1326 - Device to percutaneously repair the mitral valve
- Company 1327 - Miniature intravascular flow augmentation device for every organ that needs temporary change of flow
- Company 1328 - Minimally invasive surgical procedure intended to reduce the incidence of stroke/thromboembolism associated with atrial fibrillation
- Company 1329 - Plaque vulnerability biomarkers to detect patients at risk for the development of stroke, myocardial infarction or claudication
- Company 1330 - A platform for minimally-invasive cardiac surgery (MICS) via single-port, subxiphoid access, and an endoscope that reaches any anatomical location, including complex paths, from one single access port
- Company 1331 - Percutaneous mitral valve replacement (PMVR) for Mitral Regurgitation (MR)
- Company 1332 - Medical devices for the osteoarthritis/rhinosinusitis markets
- Company 1333 - Miniaturized ultrasound probe that is easier-to-use/more flexible
- Company 1334 - Resonating sensor made out of piezoelectric ceramics that can be miniaturized and is suitable for use in diagnostic equipment
- Company 1335 - Bioresorbable peripheral/coronary polymer stents that promote the natural remodeling of an injured artery after angioplasty
- Company 1336 - Disposable devices for Natural Orifice Translumenal Endoscopic Surgery (NOTES) procedures
- Company 1337 - True 3-D imaging to improve evaluation/planning of radiation treatments
- Company 1338 - Next-generation spinal implants
- Company 1339 - New unilateral posterior fusion technology
- Company 1340 - Products for nuclear replacement/augmentation, vertebral compression fracture repair, and spinal fusion
- Company 1341 - Second-generation, metal-on-metal cervical/lumbar artificial discs
- Company 1342 - Artificial cervical disc with controlled range of motion in all six degrees of freedom
- Company 1343 - Next-generation of biomaterials for spinal implants
- Company 1344 - Intradiscal arthroplasty device utilizing articulating PEEK-on-PEEK material
- Company 1345 - Hydrogel matrix with applications across multiple specialties
- Company 1346 - Intelligent microgels as injectable scaffolds for intervertebral disc repair
- Company 1347 - Minimally invasive disc augmentation system to repair/rehabilitate an intervertebral disc
- Company 1348 - Implant designed to retain motion following the removal of diseased disc and/or bone material in the upper spine
- Company 1349 - Tissue repair/surgical mesh systems for soft tissue repair
- Company 1350 - Silicon nitride implants with 3-D structured cancellous ceramic for strong capillary action
- Company 1351 - Tibial knee implant for stable fixation to the medial tibial plateau without bone cuts/cement/screws
- Company 1352 - Technologies to treat obstructive sleep apnea and snoring
- Company 1353 - The Superion Interspinous Spacer system is the most advanced and least invasive spacer system and is delivered through a percutaneous midline approach for the treatment of lumbar spinal stenosis
- Company 1354 - Tissue engineering technologies for orthopedic/sports medicine patients
- Company 1355 - Real-time imaging/image guidance for the operating room
- Company 1356 - Stent that provides protection from embolic showers during/post-procedure
- Company 1357 - Minimally invasive vapor technology to treat emphysema
- Company 1358 - Human-based tissue scaffolds
- Company 1359 - Simple, low-cost infusion pump that contains the IV bag within it
- Company 1360 - Non-intrusive patient-monitoring systems that facilitate timely intervention for cardiac/respiratory deterioration
- Company 1361 - Bifurcated stenting
- Company 1362 - Bioabsorbable implants for accurate soft tissue fixation either to apposing soft tissue/to bone
- Company 1363 - Drug delivery vehicles that can easily be targeted to specific cell types/disease state tissues
- Company 1364 - Minimally invasive therapies for interventional neuroradiology
- Company 1365 - Treatment for ischemia via stem cell-based therapies
- Company 1366 - Cellular therapy device to treat liver disease
- Company 1367 - Customizable vibration therapy devices to stimulate bone/muscle tissue
- Company 1368 - Deep brain stimulation (DBS) guidance system
- Company 1369 - Cellular imaging technology, using the Internet to transfer real-time/secure/accurate cellular resolution images
- Company 1370 - Minimally-invasive percutaneous aortic valve replacement systems
- Company 1371 - Off-the-shelf implantable allograft tissue to support peripheral nerve repair and regeneration
- Company 1372 - Advanced detection, staging, endoscopic treatment and follow-up care for acute and chronic lung disease
- Company 1373 - Minimally invasive therapy for the treatment of chronic disc pain
- Company 1374 - A minimally invasive device for stomach-reduction surgery consisting of a stapling tool that can be passed down the throat into the stomach
- Company 1375 - Kidney stone management device and urethral dilating introducer
- Company 1376 - Ventricular elastic support therapy for heart failure
- Company 1377 - Plastic medical devices for gynecological exams and surgeries
- Company 1378 - Inferior vena cava filters
- Company 1379 - Neuromodulation system for both traumatic brain injury (TBI) and stroke
- Company 1380 - Minimally traumatic, bone- and cartilage-preserving knee implants and instrumentation
- Company 1381 - Radio-frequency (RF)-based tissue sealing and cutting instruments with a long jaw sealing length and high quality seal to greatly reduce procedure time and surgeon fatigue
- Company 1382 - Fast, accurate, and easy-to-use in vitro molecular diagnostic products that rapidly identify infectious pathogens
- Company 1383 - Unique spinal implant designed to promote rapid fusion
- Company 1384 - Devices for Natural Orifice Translumenal Endoscopic Surgery (NOTES) procedures
- Company 1385 - Unique transcranial magnetic stimulation system that allows direct non-invasive activation of deep brain structures
- Company 1386 - Dynamic "shape memory" platform to optimize mitral/tricuspid valve repair
- Company 1387 - Single molecule DNA analysis system, with no requirement for prior sequence information/PCR/cloning/probes
- Company 1388 - Biomaterials-based medical devices focusing on cardiovascular, metabolic, inflammatory, and fibrotic diseases
- Company 1389 - Transdermal/wound dressing/mucosal drug delivery
- Company 1390 - A unique solution similar to ring annuloplasty/edge-to-edge repair, all in one modality, for mitral valve repair
- Company 1391 - Minimally invasive devices that improve oxygenation for patients with COPD
- Company 1392 - Hands-free internal retractor/internally-anchored laparoscope camera cleaner
- Company 1393 - Particle technologies for the treatment/prevention of chronic respiratory disorders
- Company 1394 - Minimally invasive, single-procedure approach for the repair of cartilage damage/osteoarthritis
- Company 1395 - Biodegradable synthetic hydrogels for general and specialty surgery use
- Company 1396 - Silk-based biomaterial platforms for tissue rejuvenation/connective tissue repair
- Company 1397 - Ankle replacement implant for patients with chronic pain/arthritis
- Company 1398 - Biomarker assays for the early detection of cancer
- Company 1399 - 1-Painless intradermal drug delivery, 2-GERD diagnostic device, 3-Non-invasive continuous glucose monitoring
- Company 1400 - Detection products for viral/bacterial infections, genetic diseases, mutations, cancers, etc.
- Company 1401 - Video integration and equipment management system to enhance the MIS market
- Company 1402 - Multi-pixel x-ray source for enhanced system performance/new capabilities
- Company 1403 - Combination ultrasound/electrical stimulation device for skin rejuvenation
- Company 1404 - Bioprosthetic two-piece tissue valve system for minimally invasive valve replacement utilizing a transapical approach
- Company 1405 - Advanced suturing technology for minimally invasive/NOTES/bariatric/cardiac/other surgical specialties
- Company 1406 - A minimally invasive electromagnetic navigation system for early detection of lung cancer
- Company 1407 - Patient-centric data system and analysis tools for translational medicine and research
- Company 1408 - Hand-held device to monitor post-operative/trauma patients for early warning signs of sepsis or infection in the bloodstream
- Company 1409 - Spinal cage with dynamic stabilization/MIS placement (3mm access) and easily revisable
- Company 1410 - Fully modular total hip replacement systems to reduce wear/add longevity
- Company 1411 - A "plug & play" system for treating non-invasive, curative, and palliative cancers and precursors
- Company 1412 - Products for the early detection of lung and oral cancers
- Company 1413 - System that performs a non-invasive, 30-second test to identify the risk of heart disease
- Company 1414 - Non-molecular bacterial screening, identification, and antibiotic susceptibility testing
- Company 1415 - Optical coherence tomography for evaluation of human tissue microstructure with real-time depth visualization
- Company 1416 - Wireless electronic skin patch sensors for the real-time measurement/monitoring/diagnosis/clinical management of cardiac arrhythmias
- Company 1417 - Non-fusion spinal solutions that control segmental motion/maintain the neutral zone simultaneously
- Company 1418 - Optical cell sorters used in stem cell/cell therapy treatments for cancer, autoimmune disease, and regenerative medicine applications
- Company 1419 - BQT®, a non-invasive point-of-care diagnostic test for osteoporosis and bone fracture risk
- Company 1420 - Low-mass PFO closure system capable of repairing the defect from within the tunnel
- Company 1421 - Third-generation biodegradable annuloplasty rings
- Company 1422 - Easy-to-use, instrument-free, disposable molecular diagnostic tests
- Company 1423 - 1-Bone cement to replace PMMA-based materials, 2-A liquid hydrogel wound dressing able to cure rapidly and in situ
- Company 1424 - Monitoring system to replace the manual assessment of labor progress with real-time/continuous information
- Company 1425 - Delivery of proteins and peptide drugs without burst, with near-zero order release, and with high bioavailability
- Company 1426 - Contrast agents/molecular imaging for detection using a modified porous Silicon (mpSi™) platform
- Company 1427 - Aerolase cosmetic lasers have user-validated superiority on key attributes: efficacy and safety, particularly on hard to treat darker complexions; unique multi-purpose function and portability; yet industry-low cost
- Company 1428 - SutureCross™: Knotless Anatomic Fixation System for double row arthroscopic rotator cuff repair
- Company 1429 - Biodegradable surgical adhesive for seroma reduction in plastic surgery
- Company 1430 - Miniature blood pump, designed to be placed superficially like a pacemaker, for the long-term treatment of chronic heart failure (CHF)
- Company 1431 - Devices that use bio-electric stimulation therapy (bio-current) to treat hard-to-heal wounds
- Company 1432 - Minimally invasive catheter-based ablation technologies to treat atrial fibrillation and other cardiac arrhythmias
- Company 1433 - Transvaginal, ultrasound image-guided HIFU device, capable of real-time guidance and monitoring of therapy
- Company 1434 - A portable breath collection apparatus (BCA) which can collect breath samples virtually anywhere, for highly sensitive laboratory analysis
- Company 1435 - Automatic tools to support image visualization, lesion detection and quantification, temporal evolution assessment, and automatic reporting in chest and abdominal CT scans
- Company 1436 - RNA-based therapeutics
- Company 1437 - Wireless seizure alarm systems for people with epilepsy
- Company 1438 - Arm training device to restore arm movement in stroke patients who have experienced arm paralysis
- Company 1439 - Ophthalmic formulation of mitomycin-C in a single-use kit, for use in the surgical treatment of glaucoma
- Company 1440 - Products to diagnose the risk for heart attacks by means of assessing endothelial function
- Company 1441 - Minimally invasive medical devices for patients who are at risk for or have suffered a stroke
- Company 1442 - AOKit™-bio: an adaptive optics kit for biologists which enhances microscopic imaging
- Company 1443 - Neowater®, a water-based nanotechnology which has physical properties that mimic intracellular water
- Company 1444 - Metabolomic profiling of biomarkers for the diagnosis of early forms of dementia and neurodegenerative diseases
- Company 1445 - A portable oxygen delivery and ventilation system
- Company 1446 - Interventional bronchoscopy devices for lung diseases
- Company 1447 - Advanced endotracheal tube for intubation, fitted with advanced fiberoptic visualization technology
- Company 1448 - Modular hip stem technology and total knee replacement systems
- Company 1449 - First viable intracellular genetic protein therapy for the treatment of Chronic Heart Failure (CHF)
- Company 1450 - Fusion and non-fusion spinal implants
- Company 1451 - A device that seals blood vessels after hemodialysis as an alternative to central venous catheters for kidney-dialysis patients
- Company 1452 - Non-invasive ultrasound body contouring
- Company 1453 - Non-invasive, painless, Navigated Brain Stimulation (NBS) for brain diagnostics and therapy
- Company 1454 - Noninvasive breast cancer risk assessment device
- Company 1455 - Low cost, easy-to-use, credit-card-sized devices which will allow on-the-spot quantitative diagnosis
- Company 1456 - Telemedicine paired with state-of-the-art ophthalmologic imaging
- Company 1457 - Devices for treating cardiovascular disease
- Company 1458 - Precision surgical systems for computer-assisted 3D planning, surgical navigation, and surgeon-controlled robotic surgery
- Company 1459 - Female sterilization technology
- Company 1460 - Electromedical/electrotherapeutic equipment
- Company 1461 - Products for the minimally invasive repair of long bone fractures
- Company 1462 - Molecular diagnostic products for laboratories that are intended to enhance medical care by providing early diagnostic information rapidly
- Company 1463 - New pulmonary drug delivery system
- Company 1464 - Next-generation laser therapy
- Company 1465 - Devices for the in-office polypectomy/myomectomy market
- Company 1466 - Low-cost, fast, and accurate molecular diagnostic products
- Company 1467 - EXPANSE Vertebral Body Replacement Device for use in the thoracolumbar spine
- Company 1468 - An oncology visualization system that integrates advanced graphics processing capabilities with proprietary software algorithms to register multiple CT image sets in real-time
- Company 1469 - Minimally invasive, single-use, disposable devices that enable incisionless, transoral procedures for the treatment of a number of upper gastrointestinal problems, including gastrointestinal reflux disease (GERD) and failed bariatric surgery
- Company 1470 - Mobile phone-based data collection for chronic disease management
- Company 1471 - Advanced gene expression and DNA quantification products and services
- Company 1472 - Optical backscatter technology to improve the way cancer is detected and diagnosed
- Company 1473 - Laser, light-based, and radiofrequency devices for aesthetic and medical applications
- Company 1474 - Diagnostic methods using microarray gene expression profiling to determine specific properties of tumors
- Company 1475 - Catheter-based devices which rapidly provide quantitative data to the physician about vessel and stent size, suitable for peripheral and cardiac applications
- Company 1476 - Advanced wheelchair technologies
- Company 1477 - Human bionic devices that can instantaneously interact with the human body to replace or restore biomechanical or physiological functions
- Company 1478 - Cell-based epicardial patch designed to promote blood vessel growth in ischemic cardiac tissue
- Company 1479 - Methods for treating human tissue based on volumetric bipolar radio frequency ablation (RFA), and surface ablation of tissue
- Company 1480 - Infusing normothermic fluids from 10mL/hour-1200mL/minute with 30-second setup through a disposable cassette
- Company 1481 - Technology using opto-acoustics for functional imaging/cancer diagnosis
- Company 1482 - High-intensity focused ultrasound in a catheter to treat atrial fibrillation
- Company 1483 - 1-Alternative to instrument-based viscosity testing; 2-A disposable blood to plasma device for use in micro-fluidic assays; 3-A home-use test for clotting time
- Company 1484 - Portable, easy-to-use consumer device that allows for easy, safe and green disposal of used insulin syringes, lancets and pen needles by vaporizing the sharp
- Company 1485 - Site-specific catheter-guided system to deliver drugs and biologics directly to the adventitia
- Company 1486 - Device based therapy targeting ischemic brain stroke and chronic heart failure
- Company 1487 - Integrated wireless monitoring
- Company 1488 - Non-invasive robotic radiosurgery system for cardiac ablation
- Company 1489 - Ceramic components for spine, orthopaedic, and other implant needs
- Company 1490 - Target-specific recombinant human protein focused on spinal fusion surgery
- Company 1491 - Patient controlled analgesia device for pain management
- Company 1492 - Less invasive orthopaedic implant solutions employing advanced pliable structured materials and innovative designs
- Company 1493 - Dual function, automatic, handheld sinus irrigator and aspirator for OTC consumer use
- Company 1494 - Computer-integrated robotic instrumentation/navigation tools for orthopedic surgery
- Company 1495 - Next-generation disposable colonoscope incorporating diagnostic/therapeutic capabilities allowing for a potentially sedation-less treatment
- Company 1496 - Total hip replacement system that addresses resistance to wear and resistance to dislocation with ceramic and double mobility
- Company 1497 - Percutaneous mitral valve replacement system for treatment of mitral regurgitation
- Company 1498 - Non-invasive continuous glucose monitoring device, for patients with diabetes, based on a multi-sensor platform
- Company 1499 - Growth factor and biomaterial addressing the needs of spinal fusion, osteochondral defects, osteoarthritis, dental medicine, and other indications
- Company 1500 - Open-sky, cryogen-free, superconductive MRI scanner that uses a U-shaped magnet with no barriers in between the patient and the environment for orthopaedic, general purpose, and interventional applications
- Company 1501 - Minimally invasive retractors for pelvic surgery to optimize pneumoperitoneum pressure and patient position (OP5)
- Company 1502 - Handheld device which measures the amount of calories a person requires to maintain body weight
- Company 1503 - Intelligent nasal drug delivery devices for topical, systemic and nose-to-brain applications
- Company 1504 - Developing a fully implantable extra-aortic counterpulsation device designed to provide long-term, cost-effective treatment and significantly improve quality of life for heart failure patients
- Company 1505 - An absolutely non-invasive, radiation- and side-effect free electro physiological high speed cardiac diagnostic system to identify upcoming heart attacks and sudden cardiac deaths
- Company 1506 - DART is utilizing an interstitial radiation source that by nuclear decay recoil mechanism emits high-energy alpha particles widely dispersed by diffusion and by convection in the tumor mass
- Company 1507 - Producer of surgical devices including a self-attaching hernia patch, anti-clog surgical drain, and cavity implosion device
- Company 1508 - Non-surgical serum based cure, proven effective for PAD, Diabetic and Cardiovascular disorders
- Company 1509 - Portable and networked medical devices such as handheld ultrasounds
- Company 1510 - Single-use rigid endoscopes, with superior image quality, at a reduced per-use cost
- Company 1511 - Providing private and hospital-based OB/GYNs, Perinatologists, and Radiologists with integrated reporting and image management systems
- Company 1512 - Minimally invasive ophthalmic device therapy for Dry Macular Degeneration and other blindness causing diseases
- Company 1513 - Minimally invasive surgical technology that uses ionizing radiation to treat wet age-related macular degeneration (AMD)
- Company 1514 - An automated blood glucose monitor for the intensive care unit using near infra-red spectroscopy
- Company 1515 - Human Globin, a biopolymer to replace animal collagens in dermal fillers and create biomaterials for tissue repair
- Company 1516 - Indigo Orb, Inc is a technology leader in "Automatic Detection of Epidural Cavity"
- Company 1517 - Developing and marketing EEG systems, tools and services for Neurologists, Neurosurgeons, and Neuroscience Researchers
- Company 1518 - Orthopedic products, specifically for upper and lower extremity small bone applications
- Company 1519 - Lumbar system for dynamic stabilization without fusion, artificial discs, and minimally invasive surgery systems
- Company 1520 - Reintroducing CHYMOPAPAIN, the only proven minimally-invasive therapy for herniated discs; it allows nuclear regeneration.
- Company 1521 - 1-Lumbar cage with integrated fixation screws, 2-Pedicle screw product line, 3-Access systems and implants for use in minimally invasive surgery (MIS)
- Company 1522 - Surgical adhesives that serve to augment or replace sutures and staples/tacks
- Company 1523 - Revisable cervical and lumbar total disc replacement that can be converted to fusion
- Company 1524 - Proprietary, non-fusion spinal motion preservative total disc replacement technology (ErgoFlex) that provides permanent solutions for lower back (lumbar) area disc problems. The technology is easily adaptable to the entire spine and the company's next target area is the neck (cervical).
- Company 1525 - Two clinically proven lumbar, motion-preservation spinal implants that offer surgeons: 1-a lumbar joint replacement that has provided superior treatment over fusion and disc replacement, for patients with degenerative lumbar joint disease and 2-a posterior dynamic stabilization system used to restabilize the spine after surgery for spinal stenosis, as an alternative to lumbar fusion
- Company 1526 - Building on an exclusive intellectual property platform for both fusion and non-fusion products
- Company 1527 - Tumor necrosis factor alpha (TNF-a) inhibitor therapy for treatment of chronic persistent radiculopathy (including sciatica) related to disc herniation.
- Company 1528 - Spinal implants, cervical, thoracolumbar, interbody, bone substitutes, motion preservation
- Company 1529 - Biocellulose technology that eliminates the risks/complications/limitations inherent in animal, human, and synthetic biomaterials
- Company 1530 - Wireless patient vital signs monitoring
- Company 1531 - Disease management system for early detection of heart failure using a noninvasive cardiovascular-sleep prognostic marker
- Company 1532 - 1-Soft tissue attachment nanotechnology, 2-Bioactive/biocompatible/osteoconductive synthetic bone filler, 3-Biodegradable fiberglass fiber & composites
- Company 1533 - Noninvasive blood glucose monitor that will measure glucose in sweat in a disposable dermal patch
- Company 1534 - Affordable thermal systems that are portable, easy-to-use, and comfortable to wear
- Company 1535 - High Intensity Focused Ultrasound for incisionless male surgical sterilization
- Company 1536 - Ambulatory infusion pumps and disposables that require no programming and use pre-filled solution containers
- Company 1537 - ViaDerm - home use transdermal drug delivery system creating microscopic passageways in the top skin layer
- Company 1538 - Tools for enabling adult stem cell based regenerative medicine
- Company 1539 - Lectin-based cell adhesion technology which enables stents that traffic cells in the bloodstream
- Company 1540 - Programmable lab-on-a-chip platform for applications ranging from drug discovery to consumer diagnostics
- Company 1541 - Technology that enables real-time tracking of the position and orientation of any interventional tool - biopsy device, catheter, endoscope, ablation probe, marker dispenser, etc.
- Company 1542 - Blood tests for the early detection of breast cancer, ovarian cancer, lung cancer, Alzheimer's, and other serious diseases where significant unmet clinical needs exist
- Company 1543 - Spinal implants utilizing elastomeric polymers for non-fusion treatment of disc degeneration
- Company 1544 - ECG software for assessing acute ischemia and cardiac safety surrogates in clinical trials
- Company 1545 - Resorbable pegylated hydrogel for surgical wound sealing/adhesion prevention/sustained and targeted drug delivery
- Company 1546 - The Sensation
- Company 1547 - Robot-assisted stroke therapy devices
- Company 1548 - Endothelial management - less trauma combined with new agents for improved healing in vascular interventions
- Company 1549 - Digital Pulse Analyzer - provides early detection of arterial wall stiffness and biological age of arteries
- Company 1550 - Diagnostic platform with a test for measuring unbound Bilirubin for the management of newborn jaundice
- Company 1551 - Percutaneous light activation reduces intra-abdominal fat, returning Type 2 diabetic patients towards normoglycemia
- Company 1552 - 1-Cartilage implant for the knee, 2-Injectable cell therapy for the spinal disc/nucleus, 3-Bone graft extender to treat spinal deformities
- Company 1553 - Protein free induction of endochondral ossification, no human origin, not contagious, no soft tissue ossification
- Company 1554 - 1-Instant-on/instant-off proximal occlusion funnel catheter, 2-Scoring balloon with drug delivery capability
- Company 1555 - An internal adhesive biotechnology designed for strength, biocompatibility, and ease-of-use with applications in cardiovascular surgery
- Company 1556 - Technology that prepares the spinal disc for a nucleus replacement/minimally invasive fusion device
- Company 1557 - Tissue repair devices exploiting shear force transfer and large-interface substrates for adherent new tissue formation
- Company 1558 - Advanced skin biopsy and wound healing solutions to dermatology, cosmetic, primary care, and oncology clinicians
- Company 1559 - Advanced optical systems/services that are changing the way doctors evaluate and treat the eye
- Company 1560 - Non-invasive cardiac output monitoring to assess stroke volume, contractility, cardiac output, cardiac index, and thoracic fluid content
- Company 1561 - 1-Cardiovascular-directed growth factor therapeutics; 2-Endovascular catheter-based system to rapidly and controllably cool the body in order to reduce cell death and damage following acute ischemic events
- Company 1562 - A drug delivery platform that approaches the endovascular bifurcation challenge from a completely different angle
- Company 1563 - A bioactive ceramic that delivers better/faster spine fusion and bone repair
- Company 1564 - Percutaneously delivered implantable system to treat mitral valve regurgitation and improve congestive heart failure
- Company 1565 - Electro-grafting coating technology for implantable biomedical applications; used for the fast healing post drug-eluting-stent (DES) implantation (avoiding late stage thrombosis)
- Company 1566 - Noninvasive medical device for the treatment and prevention of obesity using controlled hypoxia
- Company 1567 - An implantable ophthalmic device to treat vision correction associated with Age-Related Macular Degeneration (AMD)
- Company 1568 - Accommodating and multifocal phakic IOLs, CE-approved for $ billion refractive IOL market
- Company 1569 - Biocompatible polymer implant to prevent or reverse the progression of chronic heart failure and mitral valve regurgitation
- Company 1570 - Noninvasive device used in the differential diagnosis of disc or facet mediated low back pain
- Company 1571 - Surgical stapling devices for open and laparoscopic procedures developed for the growing China market
- Company 1572 - The first-and-only, fully self-contained, low-cost, and market-proven disposable iontophoretic patch - topical drug delivery platform for enhanced penetration and efficacy
- Company 1573 - IBraces - 100% customized, invisible orthodontic braces designed for efficient, effective treatment of teens and adults
- Company 1574 - Flash Ultrasound
- Company 1575 - Free-floating optical probe with multiple LD scanning and magnetic stabilization for noninvasive blood glucose monitoring
- Company 1576 - Repositionable/removable percutaneous heart valve, precision controlled delivery device, and calcified valve encapsulation system
- Company 1577 - Next-generation estrogen-based drug-eluting coronary stent and an orthopedics/sports injury pain management device
- Company 1578 - Heart pump that achieves superior flow and pressure performance, mimicking the physiological performance of the human heart, and reducing post-surgery kidney failure, mortality, and complications cost by 50%
- Company 1579 - Porcine-derived tissue devices for ligament, cartilage, bone, and soft tissue replacement and augmentation
- Company 1580 - MIS platform technologies for creating cavities in tissue and partially molding an orthopedic implant in situ
- Company 1581 - Orbital atherectomy for the treatment of peripheral vascular disease
- Company 1582 - Functional brain imaging centers that identify Alzheimer's, brain injury, stroke, ADHD, bipolar, depression, anxiety, OCD
- Company 1583 - A protein therapeutic biotreatment that regresses solid tumors and protects against relapses
- Company 1584 - Analyze, search, store, mine, share and unlock the power of digital tissue images
- Company 1585 - Smart devices to harness human physiology for health care, industrial safety, and law enforcement applications
- Company 1586 - Naturally-derived/non-crosslinked/collagen-based extracellular matrix to repair/remodel damaged tissues
- Company 1587 - Facet fixation system that is a less-invasive/faster alternative to pedicle screw fixation
- Company 1588 - The Extremity Compartment Syndrome (ECS) System is being launched as the only FDA-cleared continuous monitoring device that assists physicians with diagnosing a limb-threatening complication
- Company 1589 - Shielded reciprocating tissue sculpturing instrument, able to navigate into neural foramen to relieve nerve compression
- Company 1590 - 1-LIFEBACK® Spine Programs for non-operative and post-operative spine patients and 2-the LTX 3000® Rehabilitation System
- Company 1591 - Stable and extractable self locking intramedullary nails and proximal femoral fixation
- Company 1592 - Emperor Mobile Spinal Disc, P.E.E.K Cages, Pedicle Screw System, and Saturn Hip Resurfacing
- Company 1593 - Rapid table-mounted retraction/surgical site access for MIS placement of hip/knee/shoulder/spine implants
- Company 1594 - Lumbar dynamic stabilization with MIS compatibility and pedicle screws
- Company 1595 - Real-time image-guidance technology with an FDA-accepted accuracy claim of +/-1mm at 1 meter
- Company 1596 - Noninvasive, ambulatory, portable, 3-D traction technology providing an effective and unique therapy for spinal disorders
- Company 1597 - Fusion technology platforms and second-generation artificial discs for the lumbar and cervical spine
- Company 1598 - A biological and mechanical solution to annular repair and spine fusion
- Company 1599 - Low-profile implants/less invasive surgical instruments to treat spinal disorders utilizing fusion and non-fusion technologies
- Company 1600 - A CE-marked resorbable plating system for cervical fusions allowing for load sharing
- Company 1601 - Biomaterials-based product that augments or replaces the diseased nucleus pulposus of the spinal disc
- Company 1602 - Nitric oxide-based therapies to accelerate healing of tendon, bone, and other musculoskeletal tissue
- Company 1603 - Drug product for the treatment of acute spinal cord injury, cancer, macular degeneration, and glaucoma
- Company 1604 - Synthetic bone that duplicates the microstructure, composition, and performance of human bone
- Company 1605 - Implanted oscillating field stimulation device which regenerates acute and sub-acute damaged spinal cord nerve tissue
- Company 1606 - PuraMatrix injectable synthetic nanofibrous hydrogels for bone, cartilage and soft tissue regeneration, and drug delivery
- Company 1607 - Noninvasive device providing substitute vestibular sensory information through the tongue for treatment of balance disorders
- Company 1608 - Naturally occurring neuropeptide to treat ischemia associated with myocardial infarction, heart failure, and angina
- Company 1609 - Miniature/patient-controllable/valved catheter to improve quality of life/decrease urinary tract infections in patients suffering urinary retention
- Company 1610 - Phase-shifting technology for Contrast Ultrasound imaging
- Company 1611 - Innovative, implantable, combination drug+device products that utilize novel biomaterials. TYRX's first commercially available products include the AIGISRx(R) Antibacterial Envelope & Flat Sheet technologies, designed to reduce surgical-site infections associated with Cardiac Implantable Electronic Devices (CIEDs).
- Company 1612 - Laparoscopic surgical access technology based on a No-Seal platform
- Company 1613 - Theramers
- Company 1614 - Respiratory diagnostics for noninvasive assessment of airway acidification in Asthma, COPD, and GERD
- Company 1615 - A "preventative" vaccine for HIV-AIDs
- Company 1616 - Post-proteomics multiplexed MS-based diagnostics/theranostics linked to drug development and personalized medicine
- Company 1617 - Image-guided therapy for metastatic liver disease
- Company 1618 - Biomaterial that regulates resorbability and enhances bone regeneration
- Company 1619 - Drug/device products for post-operative pain and orthopedic drug delivery indications using syntinate synthetic absorbables
- Company 1620 - Ultrasonic medical devices for minimally invasive therapeutic procedures for treatment of cancer/other healthcare purposes
- Company 1621 - Multi-channel implantable microelectrodes for deep brain stimulation and recording, enabling enhanced neuromodulation therapies
- Company 1622 - Aesthetic treatment device using collimated high-energy light and laser, delivered simultaneously by fiber delivery system
- Company 1623 - A remotely controlled, wireless-powered implantable 230-channel nerve stimulator built on a 15
- Company 1624 - Real-time, noninvasive monitoring of blood loss, anemia, and other vital blood measurements
- Company 1625 - Small/portable/handheld device for diagnosing brain hematomas
- Company 1626 - Fiber-optic, catheter-based, near-infrared (NIR) spectroscopy system to identify lipid rich plaques in the coronary arteries
- Company 1627 - Laparoscopic surgeons maintain direct control of the laparoscope movement/placement with GMP's Laparocision
- Company 1628 - Rapid testing systems led by the Growth Direct
- Company 1629 - World's smallest leg compression device for the prevention of deep vein thrombosis (DVT) in surgical patients, as a safe and effective alternative to Lovenox, for a significantly reduced price
- Company 1630 - Ultraviolet light technologies for the inactivation of RNA viruses in/out of the body
- Company 1631 - Minimally invasive percutaneous neuromodulation pain therapy
- Company 1632 - The Axya Shoulder Fixation System generates ultrasonic energy for knotless suture welding in shoulder surgery
- Company 1633 - Gene-based products for the diagnosis and treatment of spinal disorders
- Company 1634 - A platform aerosol drug delivery nebulizer device for multiple- and single-use applications with disposables
- Company 1635 - Non-invasive continuous measurement of tissue oxygenation for various intraoperative and post-operative applications
- Company 1636 - Vascular stents and grafts with increased patency by improved flow dynamics, reducing stenosis and restenosis
- Company 1637 - 1-Next-generation liquid embolic for treating cerebral aneurysms and arteriovenous malformations (AVMs); 2-Two wound management products that will be out-licensed
- Company 1638 - SurfLink
- Company 1639 - Bifurcated coronary stent
- Company 1640 - Monitoring products based on microsensor technology allowing minimally invasive, real-time measurement of clinical chemistry parameters and therapeutic drug concentrations
- Company 1641 - Noninvasive, outpatient bariatric device for overweight/obesity
- Company 1642 - A suite of tools for automated CT Angiography (CTA) diagnostics for Coronary Artery Disease
- Company 1643 - Magnetically actuated telescopic intramedullary (IM) nail activated by an induced low power directional magnetic field
- Company 1644 - Transdermal delivery system of levodopa (L-DOPA) for the treatment of Parkinson's Disease
- Company 1645 - Immediate, active, device-less, and painless topical drug delivery, of small/macromolecules, for local/systemic indications
- Company 1646 - Endotracheal tube with video, self-locking orthopedic implants, structured TPN lipids, cell therapy for cancer, etc.
- Company 1647 - Products that digitize manual breast examination tissue elastic properties into objective computerized visual maps/reports
- Company 1648 - Technology for the manipulation of adult stem cells to repopulate chronically diseased liver tissue
- Company 1649 - Non-invasive airway clearance in ICU patients to prevent ventilator associated pneumonia
- Company 1650 - Unique add on and removable needle safety product that fits to standard glass/plastic syringes
- Company 1651 - Medical devices utilizing radiofrequency and microwave energy which are cost-effective and clinically relevant
- Company 1652 - Non-invasive screening of Peripheral Arterial Disease (PAD), combining postural/infrared blood volume testing
- Company 1653 - Tissue fixation implants, injectable bone grafting biomaterials, and tissue scaffolds with drug releasing properties
- Company 1654 - Miniature implantable, continuous blood glucose sensor for diabetics, incorporating noninvasive wireless monitoring
- Company 1655 - Coronary guidewire, to provide real-time ultrasonic measurement of coronary arteries to determine stent size and apposition without exchange of catheters
- Company 1656 - Bioabsorbable, bioactive, and drug-releasing medical device products for various fields of surgery
- Company 1657 - 1- Interventional single-use cardiac support device and drug delivery platform, 2- Implants for use in/with magnetic resonance imaging (MRI) systems
- Company 1658 - A tubular valve implanted through the mouth during an ambulatory procedure for the treatment of gastroesophageal reflux disease (GERD), although future applications for the technology include obesity and irritable bowel syndrome
- Company 1659 - Cellular implants for orthopedic, trauma, and spinal applications based on a biological form stable matrix
- Company 1660 - SmartStep
- Company 1661 - Dynamic optimization of pacing intervals according to hemodynamic sensors for CRT devices
- Company 1662 - Neuro-monitoring systems for brain protection and stroke acute care in stroke units, cardiovascular ORs, during stenting, and in the ICU
- Company 1663 - Medical devices that enable diabetes disease management and the prevention of lower extremity amputations
- Company 1664 - Customized miniature disposable stereoscopic cameras that provide 3D vision, measurements, and image fusion in real-time
- Company 1665 - Infusion catheter for treatment of tumors which are unresponsive to systemic chemotherapy by the local delivery of drugs and other agents
- Company 1666 - Non-invasive imaging tool designed to provide automated, 3-D ultrasound images of the breast
- Company 1667 - RFID hardware and software platform for test tubes/ apheresis device for blood component separation
- Company 1668 - Saliva-based consumer diagnostic systems, which enable the development of personalized therapeutics
- Company 1669 - Disposable, noninvasive, pump-less, and valve-less automatic blood pressure monitor "on-a-chip"
- Company 1670 - Noninvasive neural vision enhancement
- Company 1671 - Nanotechnologies for use in orthopedic implants, dental implants, and stents
- Company 1672 - Specialty and standard electrophysiology catheters that have superior performance, advantageous features, and are affordable
- Company 1673 - Dedicated angioplasty and stent systems for the treatment of arterial bifurcations
- Company 1674 - System to ablate cardiac tissue as a means to potentially treat atrial fibrillation
- Company 1675 - Point-of-care IVD platform that provides rapid, accurate, automated laboratory testing using low cost, disposable biochips
- Company 1676 - Interventional MRI technology for cardiovascular imaging including detection/treatment of vulnerable plaque
- Company 1677 - System analyzes a patient's susceptibility to cardiac arrest and consequent need for implantable defibrillator
- Company 1678 - Patient recovery system for cosmetic and reconstructive surgery
- Company 1679 - Microscope slide scanners and information management software that enable the digitization of pathology
- Company 1680 - SutureLock - a versatile suture-securing knot-replacement device for endoscopic wound approximation
- Company 1681 - Multi-Sensing Wireless Catheter platform attached along the GI-Uro tract detecting GERD, incontinence, and other abnormalities
- Company 1682 - Noninvasive medical device providing low-risk hypoxic treatment that induces appetite suppression and weight loss
- Company 1683 - Minimally invasive telemetric and continuous measurement of left atrial blood pressure at heart failure
- Company 1684 - Catheter-based photoreactive treatment system for endovascular intervention in coronary and peripheral atherosclerotic disease
- Company 1685 - Transcatheter mitral valve repair technology offering minimally invasive treatment option for mitral regurgitation/congestive heart failure
- Company 1686 - A platelet reactivity test to measure the effect of anti-platelet drugs, particularly aspirin and Plavix
- Company 1687 - OmniWave(R) catheter-based technology that delivers transverse ultrasonic energy to targeted thrombus in a diseased blood vessel, without damaging the surrounding vessel walls
- Company 1688 - A portable laseroptical system for noninvasive differentiation between ischemic stroke and spontaneous intracerebral hemorrhages
- Company 1689 - Alginate-based embolic material designed to fill blood vessel defects thereby displacing blood pressure effects and preventing vessel rupture
- Company 1690 - A wearable continuous ultrafiltration device that removes fluid overload in patients with Congestive Heart Failure
- Company 1691 - Minimally-invasive cardiac implantable devices for treating mitral valve regurgitation without atriotomy or cardiopulmonary bypass
- Company 1692 - Surgical and percutaneous cardiac valve repair
- Company 1693 - Percutaneous mitral valve repair simulating precision of surgical annuloplasty
- Company 1694 - Pressure and flow sensing systems for vascular and other applications
- Company 1695 - Advanced ECG-heart sound analysis to enable superior diagnosis/monitoring of CHF/ACS patients
- Company 1696 - Minimally invasive interventional radiology/vascular surgery devices
- Company 1697 - PeriVasc
- Company 1698 - Perfusion monitoring for preventing septic shock, the greatest hospital mortality
- Company 1699 - A noninvasive test for endothelial dysfunction using digital (fingertip) thermal monitoring
- Company 1700 - Stentless aortic valve prosthesis to be delivered via catheter
- Company 1701 - Catheter-based therapy which increases cerebral perfusion for the treatment of ischemic stroke and vasospasm
- Company 1702 - Catheter-based devices to reconstruct the ventricle and downsize the heart volume
- Company 1703 - Non-invasive device using muscular counter pulsation (MCP) technology for the treatment of acute and chronic heart failure (CHF) in a clinical, ambulatory, or at-home setting
- Company 1704 - 1-Bio-therapeutic designed from autologous stem cells and committed to a cardiac lineage before implantation, 2-Corresponding catheter for accurate transmyocardial injection
- Company 1705 - Minimally invasive device-based technologies targeting the treatment of hemodynamic instability and perfusion
- Company 1706 - Peptide-based therapeutic to enhance stent/graft patency
- Company 1707 - Biomimetic coronary stent coating that prevents restenosis/reduces the need for extended courses of dual antiplatelet therapy
- Company 1708 - Disposables for drawing blood -- percutaneous or from a catheter -- neonates to geriatrics
- Company 1709 - Electrode sensor array, with integrated lead wires, simple, accurate and repeatable ECGs
- Company 1710 - In vivo plasmapheresis and ultrafiltration to remove excess fluid from CHF patients in clinical trials
- Company 1711 - Noninvasive therapeutic ultrasound to enhance perfusion for treatment of acute myocardial infarction
- Company 1712 - Affordable handheld metabolic monitor (indirect calorimeter) with both medical and consumer weight management applications
- Company 1713 - Unique microsphere-based technology for chronic/acute wounds
- Company 1714 - Technologies that utilize flexible cross linking and sterilization processes which stabilize and sterilize biological tissue for use in orthopedic, wound, oral/dental, spine and neurological, breast, abdominal and thoracic applications
- Company 1715 - Devices for mechanically induced bone growth, together with a "smart device" system for risk management
- Company 1716 - Nitric oxide releasing surface treatments for enhanced biocompatibility in medical devices
- Company 1717 - Automated implantable pump systems for moving fluids around inside the body
- Company 1718 - Minimally invasive surgical access system used in laparoscopic surgery
- Company 1719 - Long-term, miniature drug delivery implant with physician- controllable, zero-order release characteristics
- Company 1720 - 1-Single-use, patented, disposable, hemorrhoid banding system; 2-Two-tier colon cancer diagnostic screen, Fecal Occult Blood Testing (FOBT)
- Company 1721 - Interventional catheter-based system precisely measures stent and arterial size and cardiovascular repair tissue patch products
- Company 1722 - Device for the treatment of mitral regurgitation and heart failure without requiring open heart surgery
- Company 1723 - Light-based therapy for eradication of ulcer-causing Helicobacter pylori
- Company 1724 - Non-invasive medical radar imaging for cardiopulmonary ambulatory monitoring and diagnosis
- Company 1725 - Enteric Dialysis with Kibow Biotics - a food-grade microbial Gel cap formulation towards kidney failure applications
- Company 1726 - IYIA has developed a proprietary, clinically effective device, O2Misly, for treating slow healing foot wounds, primarily diabetic foot ulcers
- Company 1727 - Genetic and personal history based testing to predict age-specific risk of breast cancer diagnosis
- Company 1728 - Controlled fluid delivery system for every medical application without batteries or power cords
- Company 1729 - Non-contact intelligent medical vigilance for the hospital
- Company 1730 - Capture and analysis of heart sounds leading to rapid and accurate diagnosis of cardiac pathologies
- Company 1731 - Blood test that screens/diagnoses cervical cancer without need of a cervical exam/pap smear
- Company 1732 - Implantable Left Ventricular Assist Device (LVAD) for heart failure
- Company 1733 - Bioabsorbable drug eluting stents and stent coatings for treatment of vulnerable plaque and coronary stenosis
- Company 1734 - Electronic pill for oral delivery of low bioavailability drugs
- Company 1735 - Microsyringe delivery of cells, genes, and drugs to the vasculature/deep tissues of the body
- Company 1736 - Percutaneous noninvasive heart valve replacement
- Company 1737 - Molecular FingerPrinting process for early-stage diagnosis of cancer, enabling point-of-care therapeutics based on gene regulation
- Company 1738 - Percutaneous access management system to provide early ambulation/eliminate major complications, leaving nothing behind in patient
- Company 1739 - Totally implantable LVAD that does not interface with circulating blood
- Company 1740 - Blood test for breast cancer measuring 5 protein biomarkers using super-sensitive ELISA with 95% accuracy
- Company 1741 - Ablation technology that delivers radiofrequency energy endoscopically, to eliminate Barrett's esophagus and prevent esophageal cancer
- Company 1742 - A device for the left atrial appendage for stroke prevention in patients with atrial fibrillation
- Company 1743 - Noninvasive monitor to measure exhaled nitric oxide for the management of asthma
- Company 1744 - Microplate-based electronic biosensor system for label-free, real-time cell based assays
- Company 1745 - Interactive intraoperative CT scanning technology for image-guided interventions
- Company 1746 - High Intensity Focused Ultrasound for minimally invasive thermal treatment of disc herniation without disc penetration
- Company 1747 - Percutaneous systems to treat lower back pain
- Company 1748 - Least invasive approach for the delivery of lumbar fusion and motion preservation therapies
- Company 1749 - Telemeterized natural motion elastomer disc
- Company 1750 - Interspinous process implant to treat Lumbar Spinal Stenosis (LSS)
- Company 1751 - Clinical expertise, facility development, new technology, and business services including marketing and contracting
- Company 1752 - Advance and commercialize less invasive spinal deformity surgical treatment without fusion
- Company 1753 - Lumbar, thoracic, and cervical fusion devices including less invasive instrumentation; lumbar and cervical artificial discs
- Company 1754 - Lumbar spine motion preservation via dynamic stabilization utilizing a semi-rigid rod and screw system
- Company 1755 - 1-Stand-alone anterior lumbar IBF device and 2-Stand-alone cervical IBF device
- Company 1756 - Compliant artificial lumbar disc with graduated modulus for restoration of normal spine biomechanics/enhanced durability
- Company 1757 - 1-Synthetic alternatives to autograft/cadaver-based bone material, 2-Surgical hemostat as an adherent matrix/impermeable barrier to blood flow, 3-Bone augmentation material for injections in osteoporotic spines to treat vertebral compression fractures
- Company 1758 - Orthopeutics, LP introduces Intrabrace a new non-surgical, injectable treatment for resisting spinal curvature in scoliosis.
- Company 1759 - Bioactive synthetic bone graft substitute that is osteostimulative, osteoconductive, antimicrobial, and hemostatic
- Company 1760 - Next-generation fusion, motion sparing, and minimally invasive spinal implant products
- Company 1761 - Minimally invasive fusion system
- Company 1762 - Fluidjet devices for open and MIS fusion, discectomy, artificial nucleus, and artificial disc procedures
- Company 1763 - Osteogenica - bone marrow concentration system
- Company 1764 - Dascor Arthroplasty System, spinal implants technology
- Company 1765 - BioDisc, a nucleus replacement product based on an injectable, flexible, and durable protein hydrogel technology
- Company 1766 - Second-generation, viscoelastic artificial disc restoring native function to the spine
- Company 1767 - Three-dimensional surgical visualization technologies and expanding portfolio for digital surgical environment and digital healthcare network
- Company 1768 - Real-time disposable stereotactic navigation devices for biopsy/targeted therapy compatible with CT, fluoroscopy, and MRI
- Company 1769 - Minimally invasive cancer therapy using Magnetically Energized (ME) Thermotherapy
- Company 1770 - Magneto-Optical Enantiomeric Detection (MOPED) for real-time, non-contact analysis of chiral pharmaceuticals
- Company 1771 - First noninvasive, transcutaneous sensor array that continuously monitors peripheral circulation and/or core body temperature
- Company 1772 - Disposable balloon cervical dilator for improved uterine access that decreases pain, avoids tearing and perforations
- Company 1773 - Biological therapeutics for the treatment of neurological disorders including: Alzheimer's disease, epilepsy, Huntington's disease, Parkinson's disease, and neuropathic pain
- Company 1774 - Complete pre-configured system for implementing minimized cardiopulmonary bypass
- Company 1775 - Catheter-based sealing of heart defects associated with stroke, migraine headaches, and other brain attacks
- Company 1776 - Technology for imaging peripheral nerves in regional anesthesiology, pain management, and other markets
- Company 1777 - Nanomagnetic particles enabling controlled drug delivery and elution for drug targeting and medical device applications
- Company 1778 - MRI-compatible, precision- guided laser therapy for the treatment of brain tumors
- Company 1779 - Implantable blood pump with magnetic levitation technology for patients suffering from heart failure
- Company 1780 - Virtual Bone Biopsy MRI scanner add-on, allowing noninvasive imaging of bone microstructure for osteoporosis monitoring
- Company 1781 - The Renaissance(TM) Surgical Guidance System is transforming spine surgery from freehand procedures to highly-accurate, state-of-the-art operations that raise the standard of care with better clinical outcomes
- Company 1782 - Nanotechnology-based cancer therapy with contactless activation of tumor-specific nano-particles, adaptable to all solid tumors
- Company 1783 - Point-of-care platform technology for assessing risk of cardiovascular disease and renal dysfunction
- Company 1784 - Continuous blood gas monitoring and cardiac output measurement for the intensive care unit
- Company 1785 - Non-blood contacting, active implantable direct cardiac compression device for the treatment of CHF
- Company 1786 - Augmented reality simulators that train surgeons in the skills required for minimally invasive surgery
- Company 1787 - Continuous, non-invasive glucose monitor for tight glycemic control at the hospital and at home
- Company 1788 - ERBLAN MIS Surgical Devices allow safe entry into virtually any actual or potential anatomical space
- Company 1789 - Technology that non-invasively measures/monitors mechanical heart function and disease utilizing a disposable brachial cuff
- Company 1790 - Endovenous ablation system for varicose veins with 1320 nm CoolTouch laser
- Company 1791 - Micro-porous ceramic wound treatment device that creates optimal conditions for normal wound healing
- Company 1792 - Direct, real-time vision through flowing blood to guide therapy inside the heart and vessels
- Company 1793 - Cath lab solution providing rapid onset of circulatory support in patients with acute heart failure
- Company 1794 - Novel bone void filler made from magnesium which provides a resorbable and biocompatible binding platform for synthetic bone grafting following trauma
- Company 1795 - AepEX auditory evoked potential depth of anesthesia monitor and aepEX-Fusion servo-controlled anesthesia delivery system
- Company 1796 - Posterior dynamic stabilization device designed to support an injured or degenerated spine without eliminating motion
- Company 1797 - Site-specific biological and drug delivery
- Company 1798 - HistoScanning(TM) is an innovative imaging-based modality available in the Tissue Characterization market; the only one offering accurate 3D detection and localization of cancer lesions
- Company 1799 - Non-irritating dry electrodes now enabling long-term cardiac monitoring
- Company 1800 - Non-incisional female sterilization
- Company 1801 - Biopharmaceuticals targeting osteo-renal indications, including the complications of chronic kidney disease and dialysis, bone and cartilage repair and regeneration, and general dental and oral care
- Company 1802 - Portable, compact, easy-to-use automated external defibrillators with full energy delivery and complete resuscitation solutions
- Company 1803 - Rapid, point-of-care in vitro diagnostics
- Company 1804 - Endoscopy systems allowing physicians to see very small, early-stage cancer and subtle pre-cancerous lesions
- Company 1805 - Surgical instruments employing thermal welding technology to seal and cut tissue
- Company 1806 - Minimally invasive disc replacement for chronic back pain
- Company 1807 - A smart, communicating cigarette case, online support, and daily e-mails delivering an effective stop-smoking method
- Company 1808 - A wireless personal emergency alert system that integrates with, and enhances, existing implanted medical devices
- Company 1809 - Artificial total intervertebral disc capable of normal physiological movement and weight loading
- Company 1810 - Catheters designed to diagnose, terminate, and treat cardiac arrhythmia during EP and ablation procedures
- Company 1811 - Conservative Motion Preservation technology including minimally invasive facet joint replacement
- Company 1812 - BioSilicon, nano-structured porous silicon for applications in drug delivery, diagnostics, tissue engineering, and orthopedics
- Company 1813 - System that prevents embolic events by removing plaque and thrombus found in diseased arteries
- Company 1814 - Bioresorbable polymer implants for use in a variety of orthopedics and spine surgical applications
- Company 1815 - Liposomal formulation of recombinant IL-2 for use as chemotherapy or cancer vaccine adjuvant
- Company 1816 - Helical stent providing enhanced abilities and flexibilities in drug delivery, scaffolding, and embolic protection
- Company 1817 - Trabectome, an FDA-cleared, minimally invasive medical device technology for the treatment of open angel glaucoma
- Company 1818 - ClearSolution represents the next wave in integrated, intra and interoperative physiologic monitoring. ClearSolution enables a non-invasive, wireless solution for continuous, multi-modal patient monitoring for image-facilitated minimally invasive surgery, improved CAD detection, and remote patient monitoring.
- Company 1819 - Prevention of scarring caused by disease, medical intervention, or trauma via a beta emitting biopolymer
- Company 1820 - Noninvasive, site-specific drug delivery technology to deliver compounds to the posterior segments of the eye
- Company 1821 - Real-time, CT-guided, robotically controlled needle drivers for minimally invasive cancer therapy
- Company 1822 - Automated, continual blood glucose monitoring for critically ill patients
- Company 1823 - Molecular diagnostics based on patented, standardized, next-generation, multi-gene expression (StaRT-PCR) products and high margin services
- Company 1824 - THERMOCEPS - a handheld, wireless device that stops bleeding during surgical procedures using focused, thermal coagulation
- Company 1825 - Interventional catheter system for the mechanical recanalization of arterial chronic total occlusions quickly and reliably
- Company 1826 - Portable automated critical care neuro instruments using advanced digital signal processing technology
- Company 1827 - Monitor for autonomic nervous system displaying sympathovagal balance in real-time for diabetes/ anesthesia/cardiology applications
- Company 1828 - Branched endografts for aortic disease
- Company 1829 - Next-generation biomaterials using bioactive-ceramics technology platform
- Company 1830 - Immunodiagnostics of placental recombinant markers to screen the risk of preeclampsia, preterm delivery, and IUGR
- Company 1831 - Methods for eyebrow lifting, non-thermal loading of degradable matrices, and degradable implants
- Company 1832 - Non-invasive modality for the treatment of insulin resistance/diabetic neuropathy
- Company 1833 - Minimally invasive needle biosensor for in vivo glucose or lactate monitoring of intensive care patients
- Company 1834 - P-15: a small peptide attachment factor for bone formation in orthopedics
- Company 1835 - MIST Therapy using non-contact ultrasound to stimulate healthy cells allowing chronic wounds to heal
- Company 1836 - Arthroscopic surgical devices
- Company 1837 - Electronic device that closes the gap between drugs and surgery in osteoarthritis of the knee
- Company 1838 - Cell-based therapy products for the treatment of heart failure secondary to myocardial infarction
- Company 1839 - A five-carbon carbohydrate that increases cellular energy, improving cardiovascular health and tissue function
- Company 1840 - The most advanced Infrared Light Therapy technology available that is clinically proven to reduce sports injury healing time by >60%, with additional applications for oral tissue and migraines
- Company 1841 - Next-generation non-vascular interventional pulmonary and gastrointestinal stenting technology
- Company 1842 - The Hemolung Respiratory Assist System, a respiratory dialysis product comprising a contoller, cartridge, and catheter; intended to replace or supplement mechanical ventilation in Intensive Care Unit (ICU) patients with acute hypercapnic respiratory failure
- Company 1843 - Intravascular temperature management systems and catheters for cardiac and neuro intensive care patients
- Company 1844 - Implantable devices for the endovascular treatment of hemorrhagic stroke
- Company 1845 - Ultrasound catheters for targeted thermal ablation of tumors